The Role of Education in the Treatment of Chronic Pain Patients: A Quantitative Study of Factors that Influence the Self -Management of Chronic Pain by Agan, Donna L., EdD
University of San Diego 
Digital USD 
Dissertations Theses and Dissertations 
2000-05-16 
The Role of Education in the Treatment of Chronic Pain Patients: 
A Quantitative Study of Factors that Influence the Self 
-Management of Chronic Pain 
Donna L. Agan EdD 
University of San Diego 
Follow this and additional works at: https://digital.sandiego.edu/dissertations 
 Part of the Leadership Studies Commons 
Digital USD Citation 
Agan, Donna L. EdD, "The Role of Education in the Treatment of Chronic Pain Patients: A Quantitative 
Study of Factors that Influence the Self -Management of Chronic Pain" (2000). Dissertations. 669. 
https://digital.sandiego.edu/dissertations/669 
This Dissertation: Open Access is brought to you for free and open access by the Theses and Dissertations at 
Digital USD. It has been accepted for inclusion in Dissertations by an authorized administrator of Digital USD. For 
more information, please contact digital@sandiego.edu. 
THE ROLE OF EDUCATION IN THE TREATMENT OF CHRONIC PAIN 
PATIENTS: A QUANTITATIVE STUDY OF FACTORS THAT INFLUENCE THE 
SELF-MANAGEMENT OF CHRONIC PAIN
DISSERTATION
Donna L. Agan 
School o f  Education 
University o f  San Diego
May 16, 2000
Dissertation Committee
Susan Zgliczynski, Ph.D., Director 
Jerome Ammer, Ph.D.
Bill McCarberg, M.D. 
Samuel Herrick, Ph.D.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
© Copyright 2001 
Donna L. Agan 
All Rights Reserved
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Abstract
The factors involved in the successful self-management o f chronic pain are not well 
understood. Many issues complicate addressing these factors. Individual suffering, exhaustion o f 
family resources, and the costs to society for medical care, lost wages, welfare and disability 
benefits demand increasingly more resources each year. At the micro level, patients who live the 
daily rigors o f  chronic pain want medical science to solve their malady. At the macro level, health 
plan administrators want their patients to successfully self-manage pain with the least medical 
intervention and cost, because they know a cure is not probable. In the middle, the medical 
provider must balance the patient’s needs with the limited resources o f  the medical system. As 
managed care becomes the fountain o f medical treatment, health care systems must apportion the 
magnitude o f  services and quality o f life only as for as it balances with the bottom line.
Chronic pain is one o f  the most frustrating problems facing medical practitioners today 
because research has yet to provide definitive solutions. While researchers, pain specialists, and 
patients demand adequate pain control, including the aggressive use o f opioid medications, front­
line providers, medical review boards, governmental regulators and society fear the potential 
crossover into addiction. Medical science can offer care, compassion, pain management, and some 
modalities o f  treatment, but a cure is unlikely.
In a quantitative study, I examined various characteristics o f chronic pain patients, their 
environments, and their utilization o f the health care system, including outpatients’ office visits 
and opioid medications. Included was an analysis of available data on 2,561 patients referred to a 
cognitive-behavioral pain management program in a Southern California HMO. Employing a 
linear model, I explored statistical relationships o f  various factors and their apparent importance in 
managing chronic pain. Briefly, chronic pain knew no boundaries. Demographically, pain was 
similarly reported irrespective o f  age, gender, marital status, education, employment, or disability. 
Also, the higher the reported level o f physical pain, the more pain affected each aspect o f  one’s 
quality o f  life. The collected data suggested that chronic pain was under treated in the health care 
setting and that women received significantly less opioid medication to manage pain.
People who were referred to an education-based, cognitive-behavioral pain management 
program reported significantly less pain and utilized fewer health care services over time. Patients 
attending the program reported high levels o f  satisfaction and found the pain management tools 
useful. However, financial outcomes were similar among patients who attended the program, 
those who dropped out, and those who never attended class. This population, at best, taxes health 
care resources at a rate o f  four times that o f  the mean population. I f  as it appears, chronic pain 
patients were consistently under treated for pain, educational programs for patients will not 
significantly impact medical costs. Only when the current pain management standards o f  care are 
in place and established treatments for chronic pain management are supported by health care 
providers would we expect the financial aspect o f  pain management to improve.
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A Student’s Prayer
Now I lay me down to rest,
I pray the Lord I pass this test. 
I f  I should die before I wake, 
It’s one less test I ’ll have to take.
Anon.




Statement of the Problem 
Pain is essential to basic life, an instinct o f one’s self-preservation. Without pain, 
many species simply could not survive. In rare instances, people are bom with congenital 
indifference to pain, a disorder where one does not possess the ability to feel pain despite 
being healthy in every other way. For them, life is short and full o f disorder because the 
pain they do not feel acts as an early warning system, there is no system to alert them to 
withdraw from noxious substances or situations.
Conversely, chronic pain in America has reached epidemic proportions. By the 
early 1990s, people identified as chronic pain sufferers reached an estimated 11 percent of 
all adults (50 million disabled by pain), with acute pain adding another 5 percent 
(Sheridan, 1992). By the mid-1990s, the population o f  chronic pain patients increased to 
an estimated 90 million Americans with the annual cost o f pain treatment at $ 125 billion 
(Turk & Okifuji, 1998). Chronic pain not only drains our financial resources, but our 
spiritual and social resources as well.
Great successes in medical science have lengthened our expected life span. 
However, the very science that increases our life expectancy has failed “to cure the pains 
o f medically produced old age” (Tyrer, 1992, p. ix). Our diverse culture no longer 
enforces that we endure pain in silence.
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Since we experience pain internally, we know the sensation only as we individually 
interpret that sensation. We consider this subjective information because the only one 
having access to the experience is the person reporting the pain. With indisputable findings 
(e.g., X-rays, laboratory tests, or the appearance o f  a physical abnormality), we may 
understand the cause and appreciate the possible intensity o f pain. Using a positivist 
ontology, the presence o f any physical evidence makes the reported pain believable to 
others, since positivists only acknowledge that which is tangible. Therefore, “patients who 
do not have lesions but do have pain are liable to be considered as not genuine’'’ (Merskey, 
1990, p. 11).
A singular, comprehensive definition o f  pain has yet to be established. In 1979, the 
International Association for the Study o f  Pain (IASP) offered the following definition: 
“An unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms o f such damage” (Morris, 1991, p. 16).
Interestingly, Merriam-Webster (1991) defined pain first as “punishment.” Only in 
the second definition is pain described as “usu. localized physical suffering associated with 
bodily disorder (as a disease or an injury)” (p. 846).
The American Pain Society (APS) emphasizes that the patient is an integral part o f 
the pain assessment. “Pain is always subjective . . .  The clinician must accept the patient’s 
report o f pain” (Laskin, 1998, p. 207).
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According to Donovan, Evers, Jacobs, and Mandelblatt (1999), the notions about 
chronic pain before APA’s guidelines included:
• Chronic pain is a  behavior that is learned.
• Opioid medications should not be used; patients will become addicted to pain 
medications; doctors risk losing their medical license if they prescribe narcotics.
• Psychological tests are needed to discover if  the pain is real.
• Nobody ever died o f pain.
• Chronic pain patients just need to learn to live with the pain.
Nursing scholar Margo McCaffrey describes pain as “whatever the patient says it 
is, existing whenever the patient says it does” (Laskin, 1998, p. 207). This definition, while 
criticized by some as nonscientific (i.e., not positivistic), reveals how much we have to 
learn about pain, both chronic and acute.
The problem with these and other definitions of pain and chronic pain is that they 
fail to encompass the complex interrelationship among the physical, emotional, social and 
causal factors affecting those with long-term painful conditions. While these definitions are 
a  beginning., medicine is for from understanding the total implications and inner workings 
o f  pain.
When health professionals train to combat disease and disorder under the Western 
medical model, their focus is treating acute pain. On the surface, one might assume that 
acute pain treatment regimens work for all types o f  pain. Not so, according to Laskin 
(1998), who summarizes the differences between acute and chronic pain in the Table 1:
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Table 1
Acute Pain versus Chronic Pain
- Acute Chronic
Time span Less than six months More than six months
Location Localized, associated with a 
specific injury
Difficult to pinpoint
Characteristics Often described as sharp, 
diminishes as healing occurs




Elevated heart rate 
Elevated blood pressure 
Elevated respirations 
May be diaphoretic 
Dilated pupils
Normal vital signs 
Normal pupils 
No diaphoresis 
May have loss of weight









Loss o f  libido
Exhaustion and fatigue
Complains o f pain only when
asked
Note. From Pain Management (p. 208), by M. E. A. Laskin, 1998, Albany: Delmar.
Copyright 1998 by Delmar Publishers. Reprinted with permission of the author.
No matter the definition or characteristics, patients want medical science to 
eradicate pain and suffering. Suspecting that a cure may not be possible, providers want 
their patients to self-manage pain with the least medical intervention and cost. The price o f  
managing chronic pain patients far exceeds that o f the general population. One HMO in 
the Pacific Northwest estimates that chronic pain patients have twice the inpatient 
(hospitalization) days and three times the outpatient (medical office) visits per capita 
when compared to patients without a chronic pain disorder (Donovan, 1999). Most health 
care systems offer a  one-size-fits-all model for a variety o f  illnesses, injuries and medical
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mysteries causing chronic pain. As managed care becomes our primary source o f medical 
treatment, we must balance the health care offered to maintain a certain quality-of-life 
standard with the financial well-being o f  the service institution.
Since most patients do not die o f  a  chronic pain condition, the allocation o f limited 
resources creates three ethical dilemmas. First, at what point ought we try more expensive 
treatments when the anticipated positive outcomes are unknown or are less likely to 
resolve the condition? To wit, when does the cost o f  treatment outweigh the expected 
benefits?
Second, how should we rank resources for chronic pain treatment with the 
multitude o f other medical maladies? Accordingly, who receives treatment when complex 
patients and their specialists compete for the same resources? Liver transplantation 
illustrates this dilemma. The population o f  patients awaiting transplantation may include, 
but not be limited to: (a) those who can pay for the services, but unresolved addictive 
behavior created their condition, (b) those who have something to contribute to our 
society, and (c) those most likely to recover and lead normal lives but who cannot pay for 
the operation or subsequent medications. If  only one liver is available for the three 
hypothetical patients, who chooses the recipient and how are those decisions mediated?
Third, at what level o f suffering or disability ought pain be considered tolerable?
At what point are patients expected to live with their condition? Similarly, which 
stakeholders should possess the power to decide?
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Background o f  the Problem 
The difference between acute pain and chronic pain is not standardized. Clearly, 
acute pain signals tissue damage, warns the body o f  harm, and usually requires some form 
o f  medical attention and rest (e.g., sprained muscle, broken bone, heart attack). However, 
the sensation o f chronic pain attaches no such meaning; pain is present but disuse may 
even aggravate the condition. “In many textbooks, the major distinguishing characteristic 
is time, that is, chronic pain is said to persist six months or longer” (Karoly & Jensen, 
1987). Using IASP guidelines, Bates (1996) reports that three months may be the dividing 
line between acute and chronic pain. Further, she cites chronic pain as having “persisted 
past the expected normal time o f  healing and that foiled to respond to usual forms o f 
biomedical intervention” (p. 28). Merskey (1990) suggests that acute pain is primarily 
physical, where chronic pain is primarily psychological. Karoly and Jensen (1987) feel that 
“chronic pain sufferers . . .  are seldom expected to  get better or function normally, in part 
because o f  the enormity o f  their encumbrances (presumed and actual) and partly as a result 
o f the expense and marginal effectiveness of organized, professionally managed 
intervention programs” (p. 1).
The types o f  chronic pain conditions sent to pain management programs are as 
varied as the definition o f  pain itself. Categories include neurological pain (e.g., reflex 
sympathetic dystrophy, carpal tunnel syndrome, amputation stump pain, diabetic 
neuropathy), musculoskeletal pain (e.g., low back pain, arthritis), ischemic disorders (e.g., 
angina pectoris), and others, including dental pain, headache or migraine pain, temporal 
mandibular joint pain, and myofascial pain dysfunction (Karoly & Jensen, 1987).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chronic Pain 7
Drug therapy is the traditional method o f  treating chronic pain. With increased 
litigation and public awareness in drug abuse, many physicians have become wary o f 
prescribing inexpensive, opioid medications. Prolonged use is associated with addiction, 
although a major study conducted in 1980 on opioid (narcotic) prescription use showed 
that only four patients out o f 12,000 became addicted to their pain medicine (Duerksen, 
1992).
Although chronic pain touches many fields o f medicine, family practitioners have 
the primary responsibility for care and referral. With daily news of medical miracles, 
patients demand a cure. While the caring physician tries many things, available tools and 
knowledge do little to provide relief.
With rapidly advancing technology, the need for more focused pain specialties 
emerged. Physician groups banded together to treat chronic pain patients aggressively. 
Specialities developed, such as Anesthesia with block therapies, Physical Medicine, 
Rheumatology, and Oncology. The results have led to the development o f  pain treatment 
centers, also known as multidisciplinary pain programs. Today, these programs, varying 
from two to eight weeks in length, include a comprehensive medical work-up, exercise, 
work hardening programs, biofeedback, relaxation, physical therapy, cognitive 
restructuring and a variety o f  other treatment modalities (Bar kin, Lubenow, Bruehl, 
Husfeldt, Ivankovich, & Barkin, 1996a). Centers are expensive, but offer relief to many. 
However, problems arise when patients return to their home environment. While the active 
patient receives the benefit o f  much attention and practices coping strategies under close
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supervision, the post-treatment world offers its own set o f challenges (Tunics, Bellissimo, 
& Roy, 1990).
Three treatment models are found today, depending upon the facility, the scope o f 
a patient’s disorder, and the pain pathology. The most basic model involves one medical 
provider, usually but not always a  physician, offering a single modality or method o f  
treatment (e.g., drug therapy, acupuncture). The next level, a pain center, incorporates the 
services o f one or more physicians coupled with a psychology professional (e.g., 
cognitive-behavioral programs operating outpatient workshops using a psychological and 
educational approach to self-manage pain). The most elaborate programs, called 
comprehensive multidisciplinary pain centers, include an array o f physicians and may be 
associated with a research institution. Here, professors, medical students, interns, and 
residents conduct research using multimodality treatments (Barkin, et al., 1996a). 
Presently, all types o f pain programs are being scrutinized because o f limited resources 
and the lack o f research justifying the expense and effectiveness o f any one treatment 
method. Multidisciplinary centers and cognitive-behavioral approaches appear to do a  
good job at managing pain, but have not shown significant, long-term effectiveness in the 
self-management o f chronic pain. As the influence o f managed care increases, facilities 
must regularly justify their costs and results. Without evidence o f effectiveness and 
efficiency, pain programs are either terminated (Le., in a health maintenance organization) 
or removed from lists o f approved providers.
Unarguably, cost controls are important. However, the patient’s need for 
screening, more refined diagnoses, tailored treatment plans, and a  method to preserve
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health coverage must also receive high priority. Plan providers want to offer the best 
medical care to the most people at a competitive rate. While health care providers want to 
cut costs and reduce the need for high-cost specialties, they also need to maintain 
enrollment and patient satisfaction. Customer dissatisfaction and the unavailability o f  
affordable coverage attract government attention, regulation, and legislation, ultimately to 
the point o f socializing health care.
Importance o f  the Study
The medical costs associated with chronic pain for exceed those in the general 
population without pain. Some patients seek relief by using high cost multidisciplinary pain 
centers. While these programs enjoy high compliance and short-term effectiveness, over 
time patients often report pain levels similar to those without treatment. The health care 
industry must tackle this problem by offering cost efficient and effective treatment(s).
One-half o f  the information given to new doctors in today’s medical school is 
outdated within five years. C ontinuing education and training are necessary expenses o f 
modem health care. Also, more effective treatment will occur with a better understanding 
o f  pain (Brookofif D., 1999a).
Patients want to be pain-free. Under the current medical modeL, many believe that 
doctors are responsible for pain management, can fix the problems associated with a 
chronic pain condition, or both. Shifting to a perspective where the patient discovers a 
.self-fulfilling approach to his or her own pain management promises individual control 
over one’s own quality o f  life. Families., friends, colleagues, the medical provider, and 
one’s community all benefit from the patient’s increased level o f  function and purpose.
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This study proposes to amass a data base for a large population o f  chronic pain 
patients. Not only does this study propose to look at various features and characteristics 
o f  pain patients, but also proposes to look at patients’ ability to self-management chronic 
pain over time.
Both large and longitudinal projects are lacking in the study of chronic pain. This 
proposal provides an opportunity to explore both aspects o f time and size and lend 
another perspective to this complex problem.
Purpose o f  the Study.
By studying one cognitive-behavioral pain management program and analyzing 
responses to an assessment questionnaire, I am seeking relationships, if any, from 
assessment information and program attendance. Also, by gathering post-treatment data 
on medical utilization and responses to a similar but briefer assessment questionnaire, I 
will study long-term trends in the ability to self-manage chronic pain. Some indicators 
from a patient’s perspective might be: reported lower levels o f  pain, increased activity, or 
both. From a provider’s point o f  view, a patient’s ability to self-manage chronic pain may 
be seen in lower medical utilization, fewer surgeries, and a decrease in the cost o f pain 
related services. By unifying the micro and macro issues, patients and providers may 
discover an interdependence between the needs o f  patients and the duties o f  the medical 
community, uncovering a policy perspective to help resolve the crisis in treating chronic 
pain in America.
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Research Questions
What was the profile o f  patients referred to the Pain Management Program and 
how does that profile compare with the research literature on chronic pain? Eighteen 
hundred thirty-two o f 2,561 patients referred to the Pain Management Program from 
August 1, 1991 to May 15, 1996 completed pre-treatment assessment questionnaires, 
including demographic information, plus responses to the West Haven-Yale 
Multidimensional Pain Inventory (MPI), the Pain Discomfort Scale (PDS), and the 11 
Point Box Scale. Also, program attendance records for these patients were maintained. By 
establishing a data base o f  assessment questionnaires and corresponding attendance 
records, certain variables may present a profile to help understand the characteristics 
leading to program non-participation or dropout. I f  the patients in this pain program 
compare with the prevailing research on chronic pain populations, features o f  this group 
may be generalized for a better understanding o f  pain patients in other settings and may 
help uncover potential barriers to effective treatment. If  the profile o f this group differs 
from those previously studied or from the general population, then differences may help 
uncover characteristics and possible factors affecting patients referred to this pain 
management program. Analyzing a large patient population such as this provides a unique 
opportunity to contribute to an understanding o f  the factors that may influence the self ­
management o f  chronic pain.
Does referral to or participation in the Pain Management Program influence a 
patient’s ability to self-manage chronic pain? From the patient’s perspective, can one 
measure the effectiveness o f  being referred to or participating in a pain management
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program? Using an abbreviated version o f the pre-treatment assessment form, I will send 
surveys to the same set o f patients. Pre-and post-treatment assessment values will be 
compared (e.g., the patient’s sense o f  self-control, th e  patient’s pain affect, the amount o f 
physical activity), and differences may be discovered th a t demonstrate post-treatment 
progress. If  the results are mixed, then possible relationships between individual factors 
and the ability to self-manage pain will be explored. T he survey will also include questions 
measuring patient satisfaction and soliciting quality improvement needs.
What is the economic impact o f  referring pa tien ts to the Pain Management 
Program, particularly the costs o f  and possible savimgs to the medical provider? Using 
medical utilisation records (e.g., the number and cost o f visits to doctors’ offices, the 
emergency room, and urgent care), how does the posi-treatment use o f  medical services 
compare to pre-treatment utilisation? I f  results are mixed, then what relationships exist 
between economic outcomes and program participation, individual factors, or other 
characteristics? This study will look at various factors in chronic pain patients, including 
demographic information, coping styles, support systems, the ability to perform activities 
o f  daily living, and the levels o f  reported pain. The variations in these factors may 
influence one’s medical needs and may indicate the Jewel o f medical attention demanded by 
the patient. Does referral to the Pain Management Program and/or a patient’s participation 
in the program decrease those needs?
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Assumptions Related to the Study
• Because this site is a  health maintenance organization (HMO), the provider 
conducts all medical treatment within the system and patients’ charts record all 
visits.
• Chronic pain will remain a  problem until we better understand the factors 
contributing to and retarding pain self-management.
• A variety o f  factors interrelate with the patients’ pain experience and the medical 
management o f  that experience.
• The available data from one pain management program will reveal factors that 
influence how well patients as a whole self-manage chronic pain.
• If  one can identify factors or characteristics that present barriers to self-managing
chronic pain, then one can design interventions to improve a patient’s ability to 
self-manage chronic pain.
Limitations o f  the Study 
This study focuses on patients referred to a cognitive-behavioral pain management 
program in a Southern California HMO. The research subjects are those patients who have 
already received most, if not all, known standard medical treatments and do not present 
with major psychopathic problems. Physicians refer patients to the pain program after 
thorough medical evaluation, including referral to related specialities, and where patients 
have foiled conventional treatments. Therefore, the only patients under study are those 
who, in their physicians’ view, appear to have difficulty self-managing their own pain. This 
study does not include all chronic pain patients treated in the HMO, but only those who,
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in their provider’s opinion, demonstrate difficulty with pain management and for whom 
known medical cure exists.
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Pain is a more terrible lord o f mankind than even death itself.
Albert Schweitzer
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CHAPTER 2 
Review o f  Literature 
Introduction
Since the beginning o f  time, the art o f  healing and the advent o f  medicine have 
uncovered astounding mysteries in understanding the complexities o f the human body. 
W ith Hippocrates and the arrival o f rational thought, the meaning o f human suffering and 
disease were separated from the will o f  the gods or punishment for past evils. When 
physical evidence began supporting symptoms and physicians exercised mastery over 
certain disease processes, the science (rather than the art) o f  medicine gained a reputation 
for the ability to cure or control many afflictions.
As the result o f  that progress, however, medicine may have created a  new set o f 
disorders. Curing epidemic disease with immunization, successfully treating cancer with 
surgery, chemotherapy, and radiation, as well as managing a  host o f other life-shortening 
ailments have prolonged our lives, leaving open new systems o f  disease and breakdown o f 
functions.
This chapter explores the evolution o f  health care as it pertains to chronic pain. A 
comprehensive examination o f  where chronic pain treatment is today, in addition to a 
multitude o f factors that influence that treatment, will lay the foundation for understanding 
the complexities o f  this medical, psychological, social, and spiritual problem. Reviewing 
the roles o f  physicians and their patients, exploring medications and alternative therapies,
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and examining biological and non biological components in chronic pain, we may gain an 
understanding o f how to assess and measure the quality and effectiveness o f health care 
interventions. Chronic pain conditions require that patients and their providers negotiate a 
change process to improve both the quality o f  life and longevity. In using principles set 
forth by leadership scholars and knowledge from medical researchers, we may create 
opportunities for enhancing the well-being o f  chronic pain patients.
Historical Perspective on the Problem
In ancient times, people often interpreted pain as a message from the gods. 
Aristotle, “considered pain an emotion, like joy, whereas Descartes saw it as a sensation, 
like heat or cold” (Morris, 1991, p. 15). Asian thought suggests pain is the absence o f  
harmony.
Hippocrates first steered Western medicine in the direction o f  rational thought. 
Separating disease from the supernatural, followers o f  Hippocrates developed models o f 
scientific inquiry emphasizing a disease's tangible cause and cure. Today, medical 
examinations rely heavily on tactile and visual cues, patterns, and quantifiable laboratory 
tests. The physical aspect o f  the individual is isolated, almost surgically removed, from the 
psychological, social, and spiritual components that make up one's being.
The history o f Western medicine shows little differentiation between chronic and 
acute pain. However, chronic pain is different from acute pain. In numerical terms, chronic 
pain is any painful condition lasting six months or more, whereas acute pain is o f shorter 
duration and has a beginning and an end. In a biological sense, acute pain signals the 
incidence or increased harm o f  injury, but rest and reprieve can reverse the sensation o f
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pain. Because the onset o f  acute pain has a well-defined proximal cause and is 
autonomically activated, the concentration on the physical self works well in healing acute 
(time-limited) injury and disease. On the other hand, chronic illnesses are long-term, 
meaningless, irreversible, persistent, often obscure, with autonomic adaptation and 
vegetative signs (BrookofF, 1999b). The word cure is not often used.
We may compare acute pain with a play performance where the patient plays a sick 
role o f predetermined length The patient is a mere observer and the actor is the pain. In 
the last scene, the pain predictably ends with either complete recovery or dramatic death 
With chronic pain, the patient’s part is not as the audience, but as the star character. The 
performer is married to the pain, which constantly interferes with the actor’s other 
demanding roles (Good, Brodwin, Good, & Kleinman, 1992).
While Western medicine has made remarkable advances in the quality and 
longevity o f  human existence, chronic pain has not responded well to the mechanistic 
models o f  modernist thought. Different pain treatment regimens are currently in place 
using a  variety o f time-honored and research-supported techniques. Multidisciplinary 
programs are enhanced medical models, typically combining the fields o f  anesthesiology, 
psychology, physical medicine, and family practice. Cognitive-behavioral programs work 
to improve function while ignoring or working through the pain sensation. Techniques 
outside Western medicine, such as acupuncture, acupressure, chiropractic, herbal 
remedies, massage, and mind-body-spirit connections, are slowly gaining respect by 
patients and some medical practitioners.
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In the present Western medical model, the role o f  the physician is to treat the acute 
injury while the patient endures the chronic condition. Arthur Kleinman (1988) labeled 
these notions sickness and disease. "(S)ickness (is) the understanding o f a disorder in its 
generic sense across a  population in relation to macrosocial (economic, political, 
institutional) forces" (p. 6). Sickness is what the patient experiences. "Disease, however, is 
what the practitioner creates in the recasting o f  illness in terms o f theories o f  disorder" (p. 
5). Disease is central to treatment, but by concentrating solely on the biological 
component, the practitioner treats the patient for only a fraction o f  the sickness.
By ignoring the larger part o f sickness, chronic conditions serve no purpose in the 
medical establishment. The scientific community assumes a positivistic stance where every 
symptom must have a tangible explanation. The disease itself becomes suspect when it 
defies rational thought. In positivism, if  no tangible evidence exists explaining the cause 
and level o f pain, then the pain must not be real. I f  the suffering accompanying an illness 
has no explanation in Western medicine, it holds no meaning. Since American culture is 
based on rational thought and mastery over nature, the failing o f science to cure or explain 
chronic pain leaves the patient with little hope.
To find meaning in chronic pain, one must question one's own existence, as 
chronic conditions influence many areas that form one’s identity. Viktor Frankl (1985) 
spent considerable time contemplating the meaning o f  life and suffering during and after 
his experiences in Nazi concentration camps. One problem, as he quoted Edith Weisskopf- 
Joelson, is that our culture views happiness as the meaning o f  life. "(O)ur current mental- 
hygiene philosophy stresses the idea that people ought to be happy, that unhappiness is a
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symptom o f maladjustment. Such a  value system might be responsible for the fact that the 
burden o f  unavoidable unhappiness is increased by unhappiness about being unhappy" (p. 
136). Suffering and unhappiness are the inevitable, opposing forces to happiness. This 
tension between adverse powers creates options, albeit difficult or unpleasant ones. These 
new, difficult choices generate opportunities to develop moral values and beliefs. 
According to Frank!, the key to a successful life is therefore not dependent upon achieving 
happiness, but in finding meaning in one's suffering.
Much o f  Western medicine proves effective in short-lived (acute) conditions while 
Eastern medicine enjoys a reputation for its long-term emphasis on health and harmony. 
Eastern philosophy concentrates on achieving balance, believing that equilibrium is the key 
to wellness. "(B)odily complaints are also moral problems: They are icons o f disharmonies 
in social relationships and in the cultural ethos" (Kleinman, 1988, p. 12). By successfully 
treating physical, psychological, social, and spiritual components, health and wellness 
follow.
Morris (1991) described a  study by Mark Zborowski that looked at responses to 
pain by various ethnic groups. Zborowski noted that ethnic origin predicated the 
verbalization o f  pain (e.g., Jews and Italians being expressive, Irish and Old Americans 
being silent and stoic). Also, one's social class influenced the assignment of meaning to 
pain, with lower classes interpreting pain as a threat to one’s job and financial security. 
Zborowski deduced “People responded to their pain not only as individuals, but also as 
Italians, Jews, Negroes, or Nordics" (Morris, 1991, p. 52).
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One cannot overlook the social structure o f various cultures. In most cultures, the 
extended family assumes the financial and physical maintenance o f  those who suffer from 
most chronic conditions. In the United States, chronic ailments often lead to job loss, 
massive medical bills, disability claims, lawsuits, and welfare. I f  the family fails to support 
its suffering members, then the larger community (i.e., American society) must grapple 
with the ethics o f what ought to be done to support the individual When individualistic, 
privately-funded health and disability coverages become inadequate, sufferers expect a 
caring society to provide at least subsistence-level support.
The evolution o f America’s management of chronic pain is relatively short. In this 
chapter, we explore chronic pain treatment and those who provide care. As important as 
the medical interventions themselves, the support mechanisms that address the 
psychological, social, spiritual, and financial aspects o f  pain are investigated Also, the 
increased emphasis on individualism as a cultural value in the United States affects the role 
o f  science and societal support.
A review o f the more common assessment measurements for diagnosis and 
treatment helps us understand how our society, including the scientific community, views 
chronic pain. Finally, as with any research document incorporating leadership studies, the 
role o f leadership and the ability to influence change also will be scrutinized.
What is Pain?
Before discussing how to treat pain, a rationale of how pain occurs under the 
Western medical model is needed. Today, the most commonly accepted model o f pain is 
the gate control theory.
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In 1965, Patrick Wall and Ronald Melzack proposed a simplified explanation of 
how the body perceives pain (Laskin, 1998). Melzack & Wall believed that nerve impulses 
descend from the brain to the spine (motivational-affective and cognitive components), as 
well as ascend from the extremities to the spine (sensory components). At the 
convergence o f these nerve fibers in the dorsal horn o f the spine, a  gate-like mechanism 
directed pain messages, causing certain communications to be sent to the cerebral cortex 
for interpretation (perception). “So many nerve cells converging in one place creates [s/c] 
something o f  a bottleneck, like a toll booth on an expressway, profoundly affecting the 
perception o f pain. Some messages have to wait to get through, while others may not get 
through at all” (Brand & Yancy, 1988, pp. 70-71). Instead o f the simple cause-and-effect 
pain model introduced some three centuries early by Descartes, this new model explains 
why, in some circumstances, people have a heightened sense o f pain (e.g., anticipating a 
heart attack), while the same people also display remarkable pain tolerances (e.g., running 
away from danger with a broken leg). When the pain gate is open, the pain sensation (i.e., 
sensory, cognitive, and/or motivational-affective messages) gets through to the brain. If 
the gate is closed, no pain message is received.
Since chronic pain has no meaning (e.g., does not signal further tissue damage), an 
effective model o f  alleviating chronic pain would need to interfere with the pain messages 
at some point along the conduction path. Four known steps to create or advance pain 
impulses are transduction, transmission, perception, and modulation (Laskin, 1998).
The transduction phase occurs in the periphery, the noxious site where pain 
originates. Here, two types o f nerve fibers transmit signals. Imagine a paper cut. The first
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pain sensation is from the A-delta fibers and feels sharp and stabbing. The specific location 
o f  pain is clear in one’s mind. Because A-delta nerve fibers have myelinated (insulated) 
sheaths, the pain impulse travels rapidly to the brain. Soon after, the C-nociceptors 
(unmyelinated sheaths) send signals o f  diffuse, deep aching pain. A-delta pain is typically 
associated with acute pain, while C-nociceptive messages are more aligned with chronic 
pain.
Pain is electrochemically transmitted along afferent nerve fibers to the spine. In the 
transmission phase, chemicals called neuropeptides (including substance P) are released 
from the nerve endings, travel across the synaptic gap, and attach to pain receptors in the 
spinal cord. When this transmission is complete, pain impulses are received in the thalamus 
o f the brain.
Perception, or the subjective sense o f  pain, is interpreted by how the thalamus 
transmits nociceptive messages to the cortex of the brain. The pain impulse “terminates in 
two areas in the parietal lobe: the somatosensory cortex (associated with the intensity and 
quality o f  pain), and the association cortex (associated with affective types o f pain). The 
signal also terminates in the limbic system (associated with anxiety)” (Laskin, 1998, p. 
210).
Once pain is perceived, the brain can modulate the pain signals by releasing 
chemicals such as serotonin, norepinephrine, and endorphins. These substances “bind to 
the afferent neuron and prevent the release o f  substance P” (p.210), thereby inhibiting the 
transmission o f nociceptive pain.
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Organic, psychosocial, and functional processes combine to form the pain 
experience. Each is an element o f the whole patient and needs to be evaluated accordingly. 
The impact on pain perception also includes how a patient physically expresses pain (pain 
behavior) and the level o f  distress (suffering) that accompanies pain. Organic evaluations 
(physical exam and lab work) approximate but do not directly measure symptoms or 
function. For example, 85% o f  patients complaining o f  low back pain have no organic 
explanation for the pain. “By contrast, measures to assess a patient’s functional status can 
quantify symptoms, function, and behavior more directly” (Turk & Okifuji, 1999, p.
1786).
Pain behavior is the outward body language o f  pain. Initially, behaviors such as 
limping or grimacing serve as warnings and protect a person from further injury. If  that 
body language is reinforced by the environment (e.g., more attention, avoidance o f 
unpleasant activity), then its adoption as a habitual pattern may elicit positive 
reinforcement, with or without the pain. Unlike malingering, which is the “conscious and 
purposeful faking o f  a symptom to achieve some benefit, usually financial,” (p. 1786), pain 
behaviors are unconscious and unintended but influence pain and evoke positive social 
support. Interestingly, pain behavior is the most predictive factor in whether an 
Administrative Law judge grants disability under the Social Security Act. I f  applicants 
look like they are in pain, then they must be in pain (Turk, 1999).
Suffering is the degree o f  distress accompanying events because o f  the threat or 
perception o f a  threat to one’s identity and purpose. ‘Tatients with pain are at risk o f 
suffering because the effect o f  pain on functional ability puts their physical, psychological,
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occupational, and social integrity in jeopardy” (Turk, et. aL, 1999, p. 1785). Once 
recognized and addressed, usually through a cognitive-behavioral approach, a patient may 
learn to lessen suffering, therefore reducing the perception o f pain.
The Physician’s Role 
Organized medicine in the United States may also be called scientific medicine. 
This form o f  treatment revolves around “the established body o f conventional, orthodox 
or mainstream knowledge . . .  based on standard methods o f prevention, diagnosis and 
treatment. New treatments undergo extensive review involving medical schools, research 
centers, professional organizations and their journals, and regulatory offices o f the 
government” (Mayo Foundation, 1998, p. 2). Medical providers assess and treat their 
patients using established medical techniques and therapies. The antithesis o f scientific 
medicine is quackery, or the selling o f  treatments proven to be worthless.
Often, those with chronic pain disorders are labeled difficult patients. When 
standard medical interventions prove ineffective, the practitioner may blame the patient. At 
these times, the patient is described as noncompliant, complaining about fees, coverage, 
outcomes, or the access to specialty physicians or treatment programs. Often, the medical 
chart notes these patients as angry, cranky, too independent (or too submissive). Talarico 
(1998) explains that the difficulty probably lies in the communication between the doctor 
and the patient. When health care providers are aware o f their own emotional triggers, 
then those providers will not be “misled by their own idiosyncratic responses to people 
who ‘push their buttons’” (p. 168).
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Lowenhaupt (1998) suggests that a  “more effective management o f difficult 
patients comes from identifying and dealing with.. . .  the underlying drivers o f difficult 
behaviors” (p. 29). Instead o f  focusing solely on the biological aspect o f pain, physicians 
need to understand the social, financial, and personal characteristics o f  their patients. In 
building a trusting relationship with patients, the emphasis o f a partnership approach 
(physician-patient) gives the individual personal responsibility for and direct involvement 
in one’s own care. Another important factor is discovering the patients’ expectations and 
developing mutually acceptable and reasonable goals.
Suggested methods o f care must take into account medical insurance coverage and 
uninsured/uncovered treatments. This does not to suggest that treatment should be 
withheld for lack o f  insurance, but rather that compliance to a treatment regimen also 
relies on the affordability o f  that plan. Writing prescriptions is no assurance o f compliance 
when a patient simply cannot afford to buy the medications. “Reassure patients that 
whatever the financial model o f  their plan. . .  (they will receive) good care and that cost 
will never be the primary driver o f  care” (Lowenhaupt, 1998, p. 30).
The physician must also assume the roles o f  educator and cheerleader, giving 
patients the tools and confidence needed to manage their own disorder successfully. I f  
difficult behavior lies in psychological, social, or financial problems, the physician can 
provide an important service by directing and encouraging patients to seek assistance 
within a variety o f  programs.
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Primary Care
Also known as family practice, general practice, internal medicine, and sometimes 
gynecology, primary care physicians act as the gatekeepers of a patient’s overall care. As 
generalists, primary care providers view their patients as whole systems, seeking out 
patterns o f  symptoms to identify specific disease processes. Common disorders are 
diagnosed and treated completely under the purview o f  primary care services.
Secondary Care
When diseases and disorders become complex enough to require extensive 
specialized medical training, the prim ary care provider refers the patient to others who 
have concentrated their studies and practice to specific biological and/or psychological 
processes. For patients with chronic pain, these secondary care providers may include the 
following disciplines: Anesthesiology, rheumatology, physical medicine, neurology, 
psychology/psychiatry, orthopaedics, oncology, occupational medicine, and physical 
therapy.
The outcomes o f  secondary care referrals are twofold: first to diagnose the disease 
or disorder, and second to put effective treatment into place. Often, when patients are 
stabilized on a treatment regimen, they then return to the primary care provider for the 
routine care o f  that disorder. Return to specialists may be limited to annual visits and 
unforseen complications between follow-ups.
Pain Treatment Facilities
Shortly after World War H, anesthesiologists recognized the need for specialized 
clinics to deliver anesthesia block therapies to those with pain. This method o f treatment,
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while effective for specific disorders or patients, did not serve the general pain population 
adequately (Turk & Okifiiji, 1998). Soon, other specialty pain programs arose offering a 
variety o f single modalities or a  combination o f  therapies.
In 1973, the International Association for the Study o f  Pain (IASP) was founded. 
One o f IASP’s tasks was creating a definition o f  pain that would gain universal acceptance 
for scientific research (Morris, 1991). Also, IASP sets the standards for the delivery o f 
multidisciplinary pain treatment.
The IASP defines a pain treatment facility as “A generic term used to describe all 
forms o f  pain treatment facilities without regard to personnel involved or types o f  patients 
served” (IASP, 1999, p. 1). Using this definition, a  variety o f  pain services could qualify as 
a pain treatment facility.
Modality-oriented Clinic
In pain management’s infancy, as well as today, modality-oriented clinics offer 
services based on a particular theory o f treatment. Often a sole practitioner or a single­
discipline group, this type o f facility offers a regimen based on one discipline (e.g., 
anesthesia, physical medicine, chiropractic, or cognitive-behavioral) rather than a 
comprehensive assessment and/or management o f  pain patients.
Pain Clinic
Some pain centers concentrate their practice to the treatment o f a specific 
diagnosis or to a certain part o f the body. Called pain clinics, they may specialize in any 
one o f  many common disorders (e.g., headaches, back pain). A pain clinic employs a 
group o f specially trained individuals, not just one practitioner. While assessment in a pain
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clinic is not interdisciplinary, at least three different specialities or disciplines o f providers 
interact with each other to provide diagnostic and therapeutic treatment. One o f  the 
providers present must be either a psychiatrist or clinical psychologist. Patients are 
typically treated for a specific length o f  time depending upon the disorder and pain 
severity, but all are eventually discharged back to the primary care physician for 
management with periodic follow-up (IASP, 1999).
Multidisciplinary Pain Clinic
Because pain is a  complex phenomenon, evaluation and treatment must stem from 
a variety o f medical disciplines. A multidisciplinary pain clinic is “staffed by physicians o f 
different specialties and other non-physician health care providers who specialize in the 
diagnosis and management o f  patients with chronic pain” (IASP, 1999, p. 2). Enough 
specialties need to be incorporated, including a psychiatrist or clinical psychologist, to 
ensure a thorough evaluation o f  the physical and psychosocial components o f chronic 
pain.
Joined in one setting, with both inpatient and outpatient clienteles, 
multidisciplinary pain clinics enjoy the most success in controlling pain. “Although no 
official statistics exist, physicians’ associations count as many as 1,200 pain care clinics or 
centers in the United States, some 3,000 physicians who focus their practices on pain 
management, and more than 6,000 pain management specialists and administrators” 
(Valigra, 1998, p.33). Here, heterogeneous populations o f pain patients are treated using 
the multidisciplinary approach, which may include specialty physicians, education, physical 
and/or occupational therapy, psychologists, anaesthetic pain blocks, and surgery.
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“There is no standard treatment protocol or specified set o f  clinicians who make 
up the treatment team” (Turk & Okifuji, 1998, p. 185). As such, the efficacy and 
efficiency o f  multidisciplinary pain clinics are difficult to assess. In the end, the one 
common goal is that patients are capable o f  self-managing their pain.
Multidisciplinarv Pain Center
Multidisciplinary pain centers provide all o f  the services offered in multidisciplinary 
pain clinics. In addition, these centers incorporate research, employ basic scientists, and 
provide educational opportunities to teach the latest skills and theories to health 
professionals, and advance the understanding o f pain to pain specialists and other health 
care providers. Multidisciplinary pain centers sire usually associated with major health 
institutions, medical schools, and research universities.
The cost o f  multidisciplinary treatment is expensive, an estimated $8,100 per 
patient (Turk & Okifuji, 1998). Yet so are standard treatments, including surgery. 
Interestingly, third party payers are more likely to spend an average o f  $15,000 per 
surgery to treat low back pain than to refer a patient for multidisclipinary treatment. Over 
time, “only 17% o f surgical patients viewed themselves as improved compared with 38% 
o f the nonsurgically-treated patients” (p. 189) with low back pain.
Cognitive-Behavioral Pain Management 
Because this study focuses on patients referred to a cognitive-behavioral pain 
management program, further exploration o f  this type o f  modality-oriented clinic warrants 
a closer look. First, I will review the cognitive-behavioral therapy model and why 
cognition and behavior are important components o f  pain relief. Then, a review o f  the
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paradigm for the Pain Management Program should reveal similarities and differences in 
this model o f  therapy.
Cognitive-Behavioral Model
Cognitive therapy is “a treatment method that focuses on revising a person’s 
maladaptive processes o f thinking., perceptions, attitudes and beliefs.” Behavioral therapy 
is “a form o f  psychotherapy that focuses on modifying observable problematic behaviors 
by systematic manipulation of the environment” (Depression Guideline Panel, 1993, p. 
149). In psychotherapy, cognitive-behavioral approaches are characterized by active leader 
involvement (Le., a therapist) in teaching and directing preset topics and activities. 
Participants must also be active and are charged with applying the information and 
techniques to their own lives.
Cognitive-behavioral formats are also known as behavior therapy (see above), 
rational-emotive therapy (RET), and reality therapy. RET is characterized by a leader who 
points out faulty thinking, while participants challenge self-deprecating thoughts. How one 
thinks is the primary concern, more important than how one may feel (Corey, 1990).
Reality therapy focuses on the idea that human behavior is purposeful, where 
individuals choose how to react, dispelling the notion that behavior originates in the 
external environment. Also, total behavior consists of: 1) doing; 2) thinking; 3) feeling, 
and 4) physiology. Keeping with the here-and-now, total behavior is examined, rather 
than looking at the individual components as if  they were separate from total behavior. As 
such, the leader emphasizes that participants must be responsible for how they live their 
lives. Also, the participants decide which changes they should make (Corey, 1990).
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Traditional cognitive-behavioral programs meet on a  regular basis, (Le., once or 
twice a week) and for a specific length o f time (i.e., six to twelve weeks). Cognitive- 
behavioral therapy is often provided in a small group setting (Le., ten to thirteen people), 
usually reducing the cost o f participation and administration when compared with 
individual therapy. The same group size and duration applies to pain management 
programs as welL
To see how the cognitive-behavioral model meshes with pain management, we 
must understand how thought and behavior affect pain. Brand and Yancey, (1993), uses 
the term orphan sense when describing one’s experience o f  pain. With other senses (e.g., 
smell, sight), we may gauge our own thoughts with what others observe. As an example, 
one’s idea o f a  beautiful sunset may be shared, even enhanced, through communication 
and by living the experience with others. However, the pain one may feel with a broken 
arm is unique and will not be felt in the same way as someone else with a broken arm. 
“What takes place in a person’s mind is the most important aspect o f  pain - and the most 
difficult to treat or even comprehend” (p. 203). Hence, cognitive-behavioral approaches 
look at the conversation in one’s own head as a means o f treating and understanding pain.
“The cognitive component o f  pain perception can have a powerful influence on the 
effectiveness o f interventions” (Laskin, 1998, p. 214). How a patient thinks about pain 
dramatically affects the way one feels about pain. “Cognitive therapy helps patients 
identify negative thoughts and beliefs that may contribute to their perception o f pain or 
ability to cope. Learning how to gain control over these thoughts and beliefs helps them 
reduce their pain and distress” (Robischon, 1998, p. 21).
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As much as pain sensation and cognition influence pain perception, how a  patient 
behaves around pain is equally important. “Behavioral therapy helps modify their pain with 
new ways o f  behaving, identifying dysfunctional reactions to pain and stress in their 
everyday lives” (p. 21).
Coping skills are paramount in successfully managing chronic pain. Here, “coping 
refers to cognitive and behavioral responses to stressful events that strain a person’s 
capacity to adjust” (Barkin, Lubenow, BruehL, Husfeldt, Ivonkovich, & Barkin, 1996b, p. 
474). By learning and adapting to a new set o f  behaviors, patients may avoid or alter 
previously painful events. Also, those who positively cope with pain experience less 
depression, greater life satisfaction, more activity, and less disability than other patients.
Cognitive-behavioral pain management programs, using the cognitive-behavior 
counseling model, consider the significant adjustments one must negotiate to function 
successfully in society. While most patients desire a return to their lives before chronic 
pain, the essential element in cognitive-behavioral pain management is developing new 
tools and life skills to negotiate life with chronic pain (Arbuthnott, 1994). Similar to 
cognitive-behavioral programs focusing on other psychological or counseling issues, pain 
management participants learn techniques to lessen pain sensation, including meditation, 
imaging, relaxation, and biofeedback. Emphasis is placed upon patients’ assuming the 
responsibility for their own treatment with emphasis on developing a full, fulfilling, and 
functional life. Classes are usually taught by therapists, counselors, and health educators.
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Pain Management Program
The pain managem ent program under study follows the basic components o f  
cognitive-behavioral therapy:
• An intake questionnaire was completed by participants before being scheduled for 
a group.
• Meets once a week for two hours for eight weeks.
• Topics and activities follow a preplanned schedule.
• Presentations are leader-driven; participants must apply the information to then-
own situations.
• Participants commit to attending all sessions.
When looking at the fundamental purposes and presentation o f the pain 
management program, one sees how these classes are patterned off"a cognitive-behavioral 
model. However, some important differences exist in this study’s pain management 
program that deviate from the traditional model:
• The program is funded and staffed by primary care without the involvement o f  
psychiatrists, psychologists, or therapists.
• Classes are free o f  charge.
• All program participants have a  comprehensive review o f their medical chart 
summarized by program staff.
• Participants have phone access to and receive a phone consultation with the 
program physician/pain specialist.
• Class size varies from 20-35 participants.
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• Ongoing monthly support group meetings for program completers are facilitated 
by the director/physician and/or the coordinator/masters-Ievel educator.
• Director/physician may prescribe pain-related medications to referred patients.
Medications used in Chronic Pain Management 
Prescription and over-the-counter (OTC) analgesics are the most commonly used 
method to control chronic pain today. While pain medications are routinely dispensed, it is 
the very lack o f understanding or knowledge about these analgesics that primarily causes 
the undertreatment o f  all types o f pain.
Many factors determine how one responds to analgesic medications. Age, for 
example, influences how fast one metabolizes opioids; fester in young adulthood, slower 
as one gets older. One’s response to various medications differs from another, especially 
in experiencing side effects.
As the body metabolizes medications, some analgesics become less effective over 
time. This progressive reduction in effectiveness is known as a tolerance and increased 
dosages are required to achieve the same level o f  relief. When the withdrawal o f  
medication produces its own side effects, requiring one to taper the dose to discontinue 
(as opposed to stopping all at once), the term physical dependence is used. At some point, 
many drugs have a ceiling effect, or a point at which any increased dose will not produce a 
corresponding increase in pain relief.
Three classes o f  analgesic medications affect or interfere with different 
components o f pain impulses. Categorized as nonsteroidals, opioids, and analgesic
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adjuvants, each group offers benefits, and side effects, when used alone or with other pain 
medications (Laskin, 1998).
Nonsteroidals
Nonsteroidals are analgesic medications used in treating mild to moderate pain. 
They work at the pain site by blocking the production o f prostaglandin. Prostaglandin 
sensitizes the pain receptors in the peripheral nervous system, aiding in the transmission o f 
pain messages to the spine. Without prostaglandin, sensory neurons are less likely to 
receive and transmit pain impulses.
Three types o f  nonsteroidal medications, mostly sold OTC, are used by millions o f 
people each day for acute and chronic pain. The first group, salicylates (including aspirin), 
have both analgesic and anti-inflammatory agents. Acetaminophen (e.g., Tylenol®), has 
similar analgesic properties, but lacks the anti-inflammatory effect. The last group, 
nonsteroidal anti-inflammatory drugs (NSAIDs), vary in strength and effectiveness across 
the spectrum. Some (e.g., ibuprofen) are comparable to aspirin and acetaminophen, while 
other NSAIDs are much stronger and require a prescription.
The advantage o f  nonsteroidal medications is that the body does not build up a 
tolerance to or physical dependence upon the medication. Conversely, nonsteroidals have 
a  ceiling effect. At some given dosage, additional pain relief is not achieved.
Opioids
Opioid medications (e.g., morphine derivatives) have been used routinely to treat 
severe acute pain and chronic cancer pain. Their use for severe chronic non-cancer 
(nonmalignant) pain, however, remains controversiaL
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chronic Pain 37
Opioids work throughout the central nervous system, particularly in the spine, and 
share a  similar chemical shape as substance P. When opioids are introduced into the body, 
they bind to the pain receptor sites in the dorsal horn o f the spine and prevent substance P 
from stimulating  the spinothalamic nerve fibers, thereby blocking pain messages from the 
spine to the brain.
Analgesic Adjuvants
Adjuvants, while not true analgesic drugs, show analgesic properties when used 
alone or with other medications. For example, some anticonvulsants, anesthetics, and 
tricyclic antidepressants help reduce neuropathic pain. While some adjuvants alter mood, 
others appear to potentiate opioids.
Addiction and Physical Dependence
Fear o f  addiction is the largest concern among medical practitioners, and it causes 
the prolonged undertreatment o f both malignant and nonmalignant pain. The 
undertreatment o f  pain is conceivably a  major factor to suicides, attempts o f suicide, and 
the movement for physician-assisted suicides (Brookoff 1999a). Although the incidence 
o f  addiction to opioid pain medications is extremely low in chronic pain patients, societal 
pressures for a War on Drugs, zero tolerance to drugs, FDA regulations, and the threat of 
litigation all contribute to physicians choosing to err on the side o f  caution (e.g., 
undertreating pain).
Often, the terms addiction and physical dependence are used interchangeably. 
Again, physical dependence will cause withdrawal symptoms when those medications are 
stopped. Hypertensive, thyroid, insulin, and corticoid medications, to name a few, cause
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the body to build up a physical dependence; to discontinue using them without discomfort, 
one must taper or wean off these drugs. But these drugs are hardly considered as having 
addictive potential.
“Addiction is defined as an overwhelming preoccupation with obtaining and using 
a drug for its psychic effects” (Laskin, 1998, p. 217). Addiction is a behavior, not a 
physical dependence or state o f being. With addiction, one has lost control over drug use, 
is a compulsive drug user, and continues to use drugs despite knowledge o f additional 
harm.
Brookoff (1999a) proposes behaviors commonly seen in a medical practice that 
may predict addictive behavior:
• Selling prescription drugs
• Stealing or borrowing drugs from others
• Injecting medications intended for oral use
• Obtaining prescription drugs from a non medical source
• Concurrent abuse o f  alcohol or use o f  illicit drugs
• Multiple dose escalations or other noncompliance with treatment despite warnings
• Seeking prescriptions from other physicians, urgent care, or emergency rooms
without informing the prescriber or after warnings to stop
• Evidence o f deterioration o f function related to drug use
• Repeated resistance to changes in treatment despite adverse effects from the
medication.
To the contrary, the following behaviors may be related to the undertreatment of pain:
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• Aggressive com plaining about the need for more medicine
• Drug hoarding during periods o f  reduced symptoms
• Requesting specific medications
• Unsanctioned dose escalation or noncompliance on one or two occasions
• Unapproved use o f  the medication to treat another symptom
• Reporting psychic effects not intended by the physician
• Resistance to a  change in treatment despite some side effects with anxiety about 
return o f symptoms.
Intractable Pain Treatment
Up through the 1980s, physicians were (and still are) reluctant to prescribe opioid 
medication for severe chronic pain, being fearful o f discipline, loss o f license, and/or 
criminal prosecution. While the need to relieve cancer pain has received attention in the 
form o f  research dollars and compassion for its terminal prognosis, nonmalignant pain 
treatment with opioid medications strikes up images o f addiction and secondary gain.
The conduct o f  physicians and other health care providers is regulated at the state 
level. No one law covers how and when to use opioid medications in all the United States. 
In 1990, the State o f California enacted the Intractable Pain Treatment Act (similar laws 
have been enacted in other, but not all states). In Section 2241.5 o f  California’s Business 
and Professions Code, this Act recognizes that “a physician and surgeon may prescribe or 
administer controlled substances to a  person in the course o f  the physician’s and surgeon’s 
treatment o f that person for a diagnosed condition causing intractable pain.” Further, it
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defines intractable pain as “a pain state in which the cause o f the pain cannot be removed 
o r otherwise treated and which . . .  no relief or cure o f  the cause o f  the pain is 
possible. . . ”
Corresponding to the rights o f  physicians to prescribe opioid medications without 
fear o f  prosecution, California established a Pain Patient’s Bill o f  Rights in October 1997 
(Part 4.5, Section 124960, Division 106, Health and Safety Code). This act recognizes 
that the undertreatment of chronic pain poses a  significant health problem and pain 
management may be the only source o f  relief. As such, “A patient who suffers from severe 
chronic intractable pain has the option to choose opiate medications to relieve (that) pain 
without first having to submit to an invasive medical procedure.”
The Pain Patient’s Bill o f  Rights does not require that physicians prescribe opioid 
medication. However, if he or she refuses, the physician must inform the patient that there 
are physicians and specialists who will.
Euthanasia and Physician-Assisted Suicide (PAS)
The debate surrounding euthanasia and PAS is nothing new. Twenty-four hundred 
years ago, Hippocrates incorporated into The Oath, ‘T will give no deadly medicine to any 
one if asked, nor suggest any such counsel.” Then and now (at least in all states but 
Oregon), merely suggesting this course o f  action can be a cause for sanction (Lema & 
Lema, 1998). The difference now is that medical technology is capable o f artificially 
prolonging life. Unfortunately, the lag time between when that technology is introduced 
and when the ethical and moral values are debated and developed are years apart.
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What standard o f  care must physicians offer their patients, especially those who are 
te rminal or in intractable pain? First is the generally undisputed theme that a patient has 
the right to reject unwanted treatments and interventions. Second, the patient has the right 
to relief from suffering. Neither o f  these tenets, however, supports an automatic rationale 
supporting PAS or euthanasia (Emanuel, L, 1998).
To address a patient’s request for PAS, the underlying cause o f  the request must 
be investigated. Unfortunately, today’s practitioners are not routinely trained in how to 
respond to these probes. Depression plays a large role in patient requests for PAS, 
however, it is essential to treat the depression rather than focus on hastening death. Also, 
PAS requests may point to treatment failure, beyond the scope o f  the practitioner’s ability. 
Again, hastening death is no answer; patients must be referred to those with more 
specialized training.
Emanuel, Daniels, Fairclough, & Clarridge (1998), propose that the following 
requirements exist, called primary safeguards, if PAS is legalized:
• The patient must be terminal (life expectancy o f  less than six months),
• The patient must be competent; must initiate, and repeatedly request PAS or
euthanasia,
• The patient must have intractable pain and/or suffering, and
• The patient must be evaluated by another physician (preferably a psychiatrist).
In the 1980s, public opinion in the United States favored zero tolerance with
respect to drug use. Physicians prescribing too many pain medications faced formal 
disciplinary action and/or loss o f  medical licenses. In the 1990s, the pendulum began
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swinging in the opposite direction. For the first time in this nation’s history, one state’s 
medical board has taken disciplinary action against a physician for undertreatmg pain. The 
message being sent to the medical community is that, not only are sanctions in place when 
a practitioner causes death by over treating pain, but one must also not under treat that 
pain (Barnett, 1999).
Still, what is the difference between euthanasia and PAS? In looking at a patient 
who dies o f a  drug overdose (be it narcotics, barbiturates, or benzodiazepines), if the 
physician injected, or ordered an injection constituting a lethal dose, then euthanasia has 
taken place. On the other hand, if  the patient dies of taking an overdose o f  prescribed 
medication, and the physician was aware o f  the patient’s intent to overdose but prescribed 
them anyway, PAS has occurred. In euthanasia, the physician plays an active role in 
ending a patient’s life. For PAS, the means o f  hastening death are provided (passively), 
but the action must be that o f the patient.
A more important point, what is not euthanasia or PAS? Withholding life- 
sustaining measures such as food, antibiotics, or blood transfusions is neither euthanasia 
nor PAS. Nor is administering increased doses o f  opioids for pain control, even if doing so 
may shorten one’s life (Emanuel, et. al., 1998).
By 1997, the United States Supreme Court ruled against sanctioning PAS. That 
same year, the Supreme Court also unanimously upheld the right for states to decide 
whether to prohibit or permit PAS. In 1998, the State o f Oregon became the first and only 
state to legalize PAS, and only under certain circumstances.
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Placebo effect
Placebo is a  Latin word meaning I  shall please. Long associated in medical science 
as a pejorative term, placebos are considered medications or treatments given to patients 
even though those regimens possess no known, scientific explanation or documented 
activity causally related to cure. As opposed to quackery, the placebo does no harm, but 
possesses little o r no explainable value.
Returning to Kleinman’s (1988) definition of illness (i.e., disease, disorder) and 
sickness (Le., suffering), we may understand how the placebo effect contributes to health 
and wellness. A  health care provider in the western model o f  medicine concentrates on the 
biochemical and structural disease process while patients experience the biopsychosocial 
and spiritual aspects o f sickness.
Lifestyle choices have a  profound effect on the state o f  one’s health. (Harvey & 
Hofimann, 1997). Not only do biochemical and structural changes influence health and 
wellness, but also how one reacts to the disorder, one’s adherence to treatment regimens, 
and one’s sense o f  control over the limiting effects o f that disorder. However, one’s 
subjective treatment experience, sometimes called the placebo effect, is as real as objective 
diagnostics, surgeries, and drug therapies.
“People seek medical consultation because they want symptom relief. But almost 
as important they want a label, an explanation for their symptoms” (Brown, June 1998, p 
50). Responding to  the complaint, if the patient feels a thorough examination is 
performed, that an understanding o f  the likely prognosis is achieved, and believes that 
something is being done, then a  healing ritual has occurred.
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One research study after another has clearly demonstrated the power o f  a  positive 
treatment experience. In a British study o f 200 patients with nonspecific complaints, 100 
were told that they should feel better in two weeks while the other 100 were told by 
doctors that they did not know what was wrong with them. After two weeks, 64% o f the 
first group was better. Only 39% o f  the second group reported improvement (Brown, July 
1998).
In a study o f  patients with nonspecific chest pain, 176 patients received an ECG 
and serum creatinine phosphokinase test. Outcomes were compared with similar patients 
where no tests were performed. O f those receiving testing, 80% o f patients reported 
improvement. In patients who did not undergo testing, only 54% reported improvement 
(Brown, July 1998).
O f course, not all disorders respond equally well to a placebo, or positive healing 
ritual. Brown (June 1998) suggests that disorders that are both subjective and distress 
related (including mild hypertension, depression, anxiety, panic disorder, insomnia, 
allergies, and moderate pain) can benefit by the hopefulness and attention given in the 
therapeutic office visit. Chronic pain disorders also see improvement with a  positive 
response to treatment (placebo effect): conditions such as arthritis, low back pain, and 
headaches.
Alternative medicine “offers the healing ingredients o f the treatment situation: 
healing rituals and symbols, thorough evaluation, a healer’s enthusiasm and commitment, 
encouragement, attention, positive regard, and high expectation for improvement”
(Brown, June 1998, p 48). Before the arrival o f managed care, most physicians had the
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time to listen to patients and provide these fundamental rituals. But today, in the name of 
efficiency, when the third, fourth, or fifth patient comes in with the same virus, the 
physician can recognize the cough upon entering the room, and dismisses any need for a 
physical exam* He or she then pronounces that nothing can be done, no medicine is given 
because it is a  virus, and the patients should go home and rest (and the physician may 
forget to tell them that they should be better in four days). Fast visit, money saved, and 
more patients seen. However two days later, these same patients tend to show up in the 
more costly urgent care and emergency settings with the same complaints and demand an 
antibiotic (which can cause harm and does not provide any healing benefit for viruses). 
Patients then take their medicine and are better in two days. One wonders what would 
have happened if, in the first visit, the health care provider had taken a few minutes to 
listen to the patient, performed a healing ritual, and written down on a prescription pad 
some OTC medication with dosages to help relieve the symptoms? Perhaps those patients 
would have healed on their own in four days with less suffering, taking no unnecessary 
medications, and not returning for additional visits.
The opposite o f  the placebo effect is the nocebo effect. The placebo response is 
the optimistic reaction to a treatment situation. In the nocebo response, pessimism 
prevails. There are “three ways in which the nocebo effect is activated: (1) negative 
messages from the healthcare environment, (2) negative messages from the patient’s social 
and psychological milieu, and (3) secondary gain” (Harvey & Hoflfinan, 1997, p 34).
In both placebo and nocebo, the patient responds to his or her own belief or 
assessment o f  the presenting condition. The practitioner also has overt and covert
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expectations o f  the treatment outcome. In addition, the interaction or relationship between 
the person and the provider affects one’s own perception.
From reviewing the literature, the placebo and nocebo may not be fakery, as some 
in medicine may believe. The effects o f the psychosocial and spiritual components o f 
healing are not easily measured. The value o f  one’s sense o f  control, proactive rituals, and 
optimism is not understood. A  ritual which does not fit the mold o f a positivist ontology, 
one without a direct cause-and-eflfect outcome, that is not predictable or replicable, is 
nonetheless very real.
Measurements to Assess Chronic Pain Patients 
At the dawn o f any new scientific field, previously standardized testing for general 
use is tried on specific populations. Even today, the Minnesota Multiphasic Personality 
Inventory (MMPI), the Beck Depression Inventory, and the State-Trait Anxiety Inventory 
are popular instruments used and misused to assess the level o f  psychological distress in 
those with chronic pain. One problem is that, in spite o f high internal and external validity, 
reliability, and extensive research justifying standardization, these tests were designed to 
diagnose potential psychological problems in normal, medically healthy populations. 
Targeting this assessment to the medically unhealthy violates the established external 
validity. For example, the MMPI, developed specifically for assessing psychopathology in 
psychiatric populations, fails to discriminate between “organic (and) psychogenic etiology 
o f chronic pain (Etscheidt, Steger, & Braverman, 1995, p 30). The 566 true/false 
personality questions are inordinately long and o f questionable value, especially when 
compared with the 61-question MPI.
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Chronic pain, by itself causes increased stress, uncertainty about the future, and 
even depression. Many feelings and symptoms shared by those with, chronic pain are also 
indicators o f  major depression and mood disorders. Populations with higher incidences of 
major depression include those who earn less than $20,000 per year, those who are 
single/divorced/ widowed, women (more so than men), and those with insomnia, guilt, and 
low self esteem (Cassem, 1998).
The two-question PRIME-MD test used in primary care settings, touted a 96 
percent sensitivity in screening for major depression. According to Brody, Hahn, Spitzer, 
Kroenke, Linzer, deGruy & Williams (1998, p 2469), the physician asks the patient i f  in 
the last month he or she has often been bothered by:
• little interest or pleasure in doing things (anhedonia) and
• feeling down, depressed or hopeless (depressed mood).
The question then comes to mind, are these standardized tests really uncovering mental 
illness or merely confirming symptoms and feelings shared by chronic pain patients?
Some measurement scales and inventories have been specifically adapted or 
developed for use in assessing pain in a  clinical setting. Those listed below were completed 
by and analyzed for the pain patients incorporated into this study. What makes these 
inventories different is that they are specifically targeted to compare one chronic pain 
patient with another chronic pain patient, not to the general population. At the time these 
inventories were completed for this study, between 1991 and 1996, these three test 
instruments represented the most common, reliable and valid surveys in the study o f 
chronic pain.
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The Multidimensional Pain Inventory fMPD
“Chronic pain is a  complex, subjective phenomenon that is uniquely experienced by 
each patient” (Kerns, Turk, & Rudy, 1985, pg. 345). The chronic pain experience is not 
the same within similar age groups, diagnostic conditions, or treatment methods. In other 
words, one cannot predict a pain course, foretell treatment outcomes, or measure levels of 
pain by using a mechanical, biological approach. As such, the assessment of chronic pain 
patients must encompass more, including an evaluation o f the psychosocial aspects to 
pain. I f  one appreciates the behavior, affect, and cognition variables o f  the pain 
experience, then one may set up treatment options compatible with the patients’ 
perception, environment, and motivation. By grounding a written assessment in a 
cognitive-behavioral model, one may “broadly define, clarify, and synthesize a diversity of 
variables hypothesized to measure the impact o f  chronic pain on the patient’s physical, 
psychological, social, and behavioral functioning” (Turk & Rudy, 1988, p. 233).
The MPI (formerly known as The West Haven-Yale Multidimensional Pain 
Inventory, or WHYMPI) was designed to fill the gap between empirical, biological data 
and patients’ pain perception by developing some “comprehensive assessment protocols 
that are designed specifically for use with chronic pain patients” (Kerns, et al, 1985, p. 
346). While the MPI is comprehensive, it also has the advantage o f being brief and self­
administered.
The 61-question MPI is ordered into three sections. Using Likert scales, “all items 
are responded to on a seven-point scale anchored by ‘never’ and ‘very often’” (Bernstein, 
Jaremko, & Hinkley, 1995, p. 956). Twelve unique scales develop within these sections
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and rate various aspects o f  the pain experience. A 13th scale, known as the General 
Activity Level, is a combination o f the four Activity Level scales. According to D. C. Turk 
(personal communication, October 5, 1998) and Kerns, et. at. (1985), the components and 
scales o f the MPI are shown in the following table.
Table 2
The Breakdown o f MPI Parts and Scales
P a r t i Perceived pain intensity and impact on 
patients’ lives
Scale 1 Pain Severity
Scale 2 Interference
Scale 3 Life Control
Scale 4 Affective Distress
Scale 5 Support
P a rt II Responses of others as perceived by the 
patient
Scale 6 Punishing responses
Scale 7 Solicitous responses
Scale 8 Distracting responses
P art III Activity level
Scale 9 Household chores
Scale 10 Outdoor work
Scale 11 Activities away from home
Scale 12 Social activities
Scale 13 General activity level
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“Assets o f the (MPI) inventory are its brevity and clarity, its foundation in 
contemporary psychological theory, its multidimensional focus, and its strong 
psychometric properties” (Kerns, et al, 1985, p. 345). The value o f  a  subjective 
measurement is justified because pain is a personal and individual experience; perceived 
areas o f control directly correlate to one’s motivation for adhering to treatment regimens. 
Also, how one perceives the pain experience carries over into how one projects pain affect 
and intensity to others, including loved ones and health care providers.
Using the multivariate statistical procedure o f  cluster analysis in two different 
studies, one on a group o f heterogeneous pain patients (Turk & Rudy, 1988) and one on a 
group experiencing temporomandibular disorder (Rudy, Turk, Zaki, & Curtin, 1989), 
three statistically significant clusters appeared. Three emergent groups identified 
categories o f  coping styles, namely dysfunctional, interpersonally distressed, and adaptive 
copers. Those results suggest that the MPI may possess high external validity in assessing 
both heterogeneous and some homogeneous groups o f  pain patients.
The 61 questions on the MPI calculate into 13 scales. Nine o f  those scales are used 
to cluster coping styles: ‘Tain Severity, Interference, Life Control, Affective Distress, 
Support, Punishing Responses, Solicitous Responses, Distracting Responses and General 
Activity Level” (Walter & Brannon, 1991, p. 476). Each cluster displays unique, patterned 
responses in these nine scales.
In the article, A cluster analysis o f  the M ultidimensional Pain Inventory (Walter & 
Brannon, 1991), a  Houston headache clinic administered the MPI to 79 volunteers to see 
if  a  cluster analysis o f  the MPI on headache sufferers would yield similar results. O f the
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three calculated headache clusters, Cluster EH and Cluster II closely resembled the 
categories o f  dysfunctional and adaptive coper respectively. Cluster I («=8) displayed 
unique characteristics when compared with Clusters II and DI, but was too small 
statistically to correlate with interpersonally distressed copers.
In the table below, information about the MPI cluster characteristics and a 
comparison o f  those characteristics with the cluster groups developed in the headache 
study are extracted from the article’s discussion o f results:
Table 3
MPI Cluster Comparison














Pain severity High Lower High High Lower
Interference High Lower High Low Lower
Affect
Distress
High Lower High Low Lower
Life control Low Higher Low High Average
Activity level Low Average Low Average












Bold type above indicates agreement.
With another homogeneous pain population verifying the cluster analysis o f the 
MPI, this study “suggests that the MPI is a valid measure o f  the cognitive, behavioral and 
affective aspects o f  pain” (Walter & Brannon, p. 476). Since pain experiences correlate to
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coping style more than to diagnosis, researchers and medical professionals may design 
more effective pain management programs and treatment strategies addressing the issues 
o f  each cluster, in addition to each disorder.
“The reliability (internal consistency) estimates for all MPI scales appear to be 
quite satisfactory, ranging from 0.70 to 0.90” (Kerns, et al., 1985, p. 351). However, the 
inter-correlations between scales remain low (from 0.00 to 0.58), demonstrating that each 
scale encompasses its own unique measurement.
The MPI shows good convergent validity in all three parts, suggesting that the 
model relates to observable data. Also, construct validity rates high when compared with 
several well-established questionnaires.
“(S)everal o f  the scales (e.g., Interference, Self-Control, Negative Mood, Pain 
Severity, and the Activity Scales) might be important dependent measures in the 
evaluation o f  cognitive-behavioral and other comprehensive pain treatment approaches” 
(Kerns, et aL, 1985, p. 355). Because these scales stood on their own, selected scales may 
be used in an abbreviated, follow-up survey with confidence in the accuracy o f the 
particular scale measurement.
Pain Discomfort Scale
The Pain Discomfort Scale (PDS), is a ten-item instrument intended to measure 
pain affect (Jensen, Karoly, & Harris, 1991). Pain affect differs from pain intensity in that 
intensity describes the level o f the physical sensation o f  pain and pain affect measures 
unpleasantness, upset, or suffering (what one does cognitively with pain). In testing for 
reliability, Jensen, et al. (1991) found that the PDS, with a coefficient alpha reliability o f
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0.77, has good internal consistency. An interesting note: when the authors tested construct 
validity, they found, that the PDS correlated highly to depression as measured on the Beck 
Depression Inventory (r = 0.58, p  < 0.001, two-tailed test).
Eleven Point Box Scale
For the measurement o f  pain intensity, the 11 Point Box Scale is included in both 
pre- and post-treatment questionnaires. The 11 Point Box Scale simply asks patients to 
rate their level o f  pain from zero (no pain) to 10 (pain as bad as it can be). This method o f 
rating pain is a standard practice in Western medicine today.
Individual Factors that Influence Chronic Pain
Included in an overall review o f medicinal responses to chronic pain problems, 
review o f  individual characteristics or factors may also influence the self-management o f  
chronic pain. Facto-rs include one’s locus o f control, coping style, socioeconomic status, 
and family support system. By using the MPI, I will explore the importance o f depression, 
pain intensity or affect, suffering, interference, dissatisfaction with function, support, 
perceived life control, affective distress, and activity levels (Kerns, et al, 1985) to one’s 
continued commitment to workshop attendance and effective pain self-management over 
time.
Measuring Effectiveness o f  Pain Treatment
Another difficulty in assessing the efficacy o f  any treatment program is an 
agreement o f  how to  measure outcomes. Evaluated by multiple stakeholders, success 
through one lens m ay not be seen as success by another.
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Table 4
Review o f Stakeholders
Stakeholder Measurement of success
Patient Elimination or reduction o f pain 
Reduction in emotional distress
Worker’s compensation and/or disability 
insurance company
Return to gainful employment 
Claim closed
Managed care organization Decrease in use o f  health care system
Referring physician Reduction in opioid use
Adapted from Turk & Okifiiji, 1998.
For the purposes o f  this study, I will be looking at effectiveness from the 
standpoint o f the patient and the managed care organization. Effectiveness from the 
patient perspective will look at differences pre- and post-treatment in pain severity, 
dysfunction, and dependence upon and satisfaction with the health care system. From the 
HMO’s perspective, medical utilization pre- and post-treatment will be compared to 
program attendance, demographic information, satisfaction and coping style. Comparing 
coping styles with the other variables may help us understand the economic effectiveness 
o f  chronic pain management for all program participants. If medical utilization and 
customer satisfaction are affected by any o f  these factors or variables, we may see a  need 
for tailored services, matching referrals to individual needs for more efficient and effective 
treatment.
Size and Scone o f  Typical Research Projects in Chronic Pain 
Throughout this chapter, I have described various research projects delving into 
the issues surrounding chronic pain. To appreciate the size and scope o f  this study and the
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magnitude and character o f  other (nonmalignant) chronic pain research, a summary of 
various other studies is shown in Table 5. Sixteen study populations, all since 1988, range 
in size from 56 to 875 participants. The gender mix ranges from 50-percent male to 96.6- 
percent female. Average (mean) age, for the most part, centers in the 40s and early 50s, 
with a wide array o f ages, from a three-year-old to an 86-year-old.
Since the most liberal definition o f  chronic pain starts at three months, we see that 
the reported time with pain ranges from three months to 56 years. Average (mean) years 
in pain for these studies report participants experience from 1.5 years to 11.58 years with 
pain.
Finally, the subject and purpose o f  these chronic pain studies, while varied, reflect 
the nature o f research within today’s medical community. These studies focus on a better 
understanding o f  chronic pain disorders, looking beyond the Western medical (biology- 
centered) model, and call for more investigation o f the biopsychosocial aspects o f chronic 
pain.
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Table 5












Pain (x )  &  
Range (yrs)
Subject of Study
Etscheidt, Steger & 
Braverman





(.25 -  25yrs)
MPI profiles














4.36 Low back pain
Lcdingham, Doherty 
& Doherty











353 25.2% M 
74.8% F (18+)














1998 185 36% M 
64% F
46 2 Rheumatology vs. 
psychiatric pain





Stirling, Reid, Pollard 
& Ondrack




6.48 Chronic Fatigue 
symptoms survey
Turk & Okifuji 1997 63 4.8% M 
95.2% F
46.84 9.4 Pain behaviors 
(fibromyalgia)






Trauma vs. insidious 
pain
Turk, Okifuji, Sinclair 
& Starz
1996 117 3.4% M 
96.6 F
46.75 10.5 Fibromyalgia
Turk & Rudy 1988 122 79.5% M 
20.5% F




1992 88 40.9% M 
59.1% F
41.8 1.5 Personality & 
chronic pain




11.58 MPI clusters 
(headache)
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Size and Scope o f Past Research at the Pain Management Program 
A research project funded by the HMO looked into the effectiveness o f  this study’s 
pain program (McCarberg & W olf 1999; Ershoff 1995). In 1992 and 1993, 353 
physician-referred patients completed the pre-treatment questionnaires. In that study, the 
pain program staff randomly assigned patients to one o f two groups. The first group 
(initially considered the control group) received a  program workbook for home study and 
was told that if they had any questions or problems, they could call the pain physician or 
his staff. The second group (the treatment group) received the workbook materials, could 
call the pain physician or his staff and attended the workshop.
At six and twelve months post-treatment, the program’s staff mailed the same 
questionnaire to both groups for completion. Also, they collected data on medical 
utilization via individual chart review on all subjects to learn the total pain related and non 
pain related costs one year prior and one year post assignment to a workshop group.
Ershoff (1995) performed several parametric and nonparametric tests to analyze 
the data (including Kruskal-Wallis ANOVA by Rank Test, Wilcoxon Signed Rank Test, 
paired /-tests, ANCOVA, and Chi Square). In the preliminary findings, the statistics 
detected only a few areas where significant differences arose between the two groups. 
Interestingly, both groups experienced significantly less pain-related medical utilization 
post-treatment. Overall, most patients got better. However, only those patients completing 
the workshop expressed satisfaction with the program.
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Validity and Reliability 
Because chronic pain is such a  complex and subjective issue, valid and reliable 
measurements for pain patient populations have been difficult to establish. The widespread 
use o f  psychological testing, designed to identify and select psychiatric disorder in 
otherwise healthy populations, has been adopted by psychologists and psychiatrists also 
involved with chronic pain patients. The fallacy, however, is that validity and reliability 
testing was normed by comparing medically healthy patients to those with mental illness. 
Because there are various biopsychosocial issues in patients with chronic pain, truly 
reliable and valid testing must be normed by comparing one set o f chronic pain patients 
with other sets o f  chronic pain patients.
Three measurement instruments discussed previously and designed specifically for 
chronic pain patients were also used in the Pain Management Program pre-treatment 
questionnaire. They were: a) the Multidimensional Pain Inventory (MPI), b) the Pain 
Discomfort Scale (PDS), and c) the 11 Point Box Scale. At the time these assessments 
were administered to the study’s population, these three surveys represented a 
comprehensive array of topics thought important in understanding the various aspects o f  
chronic pain, how pain influences one’s quality o f  life, and the need for medical services or 
interventions.
Leadership Issues in Chronic Pain 
When reviewing the importance o f  leadership in the treatment o f chronic pain, I 
will be using Rost’s (1991) definition as a foundation: “Leadership is an influence 
relationship among leaders and (collaborators) who intend real changes that reflect their
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mutual purposes” (p. 102). This view o f  leadership as a  process contains the same 
essential elements as does the relationship between healing professionals and chronic pain 
patients: (a) art influence relationship, between the practitioner and patient; that (b) 
intend(s) real changes, where the patient may learn to accept chronic pain and adopt pain 
management strategies and techniques; and that (c) reflect(s) their mutual purposes, the 
advancement o f  a healing process through increased activity, appropriate opioid 
medication use, and less demand for medical intervention, to name a few.
O f interest to educators and leadership scholars, I propose that the study of 
chronic pain patients may. reveal essential elements necessary for individuals and their 
supporters to negotiate a change process. Serving as facilitators, those who conduct pain 
programs (e.g., cognitive-behavioral pain management training) collaborate with patients 
to find solutions and adaptations, thereby actively participating in the leadership process.
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Outcome measures will be the currency o f  health care 
in the new millennium.
Steven D Waldman, MD 
Director, Pain Consortium o f  Greater Kansas





In this chapter I will discuss abstract notions o f  effectiveness, efficiency, and 
predictability, and explore ways to measure them, using readily obtainable data. This 
chapter will review information about one pain management program, available data on 
program participants, and information needing to be gathered to quantify success and 
explore improvement possibilities.
Methodological Overview
The justification for offering any pain management program must be weighed 
against many variables. Primarily, is the treatment effective? I f  it does not benefit those 
referred to the program, then who does benefit, and are any patients harmed by the 
treatment? Are these patients satisfied with the treatment they receive from their health 
care provider?
Second, is the proposed pain management program efficient? In vying for limited 
resources, does this program offer an anticipated standard o f effective care at a reasonable 
cost?
Third, is there a  predictive quality in the information gathered from a patient at the 
time o f  referral that may foretell successful pain management or suggest the need to
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modify treatment modalities? If  an aspect about certain types o f  patients hinders their self­
management process, can an intervention be designed to address those areas o f  concern?
The pain management program under study was an eight-week cognitive- 
behavioral workshop at a Southern California HMO. For two hours each week, groups of 
twenty to thirty-five patients learned various techniques to help manage chronic pain. The 
discussions were lead by a primary care physician/pain specialist and a  program 
coordinator/master’s level educator. Homework assignments were given each week so 
that participants could practice techniques introduced in the program. Referrals to the 
program came from a variety o f treating physicians and health care professionals. The 
program was ofiFered free o f  charge and is outlined as follows:
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Table 6
Pain Management Program Outline
W EEK TOPIC HOM EW ORK
1 Event - Thought 
Where pain comes from 
Concept o f pain gate 
Morning logs
Record one event - thought each day. List 
automatic thought(s) and automatic 
response(s). Then suggest alternate 
thoughts and responses.
2 Review Event - Thought 
Establish phone partners 
Relaxation & focusing
Contact phone partner at least once per 
week (ongoing).
Practice relaxation techniques (ongoing).
3 Doctors and expectations 
The health care system 
Requests and promises
Requests and promises - practice saying 
no.
4 Review saying no 
Anger, acceptance, and loss 
Problem solving
List one problem, brainstorm alternatives, 
select best option(s).
5 Medications used to treat pain 
Addiction vs. tolerance 
Exercise
Design & execute an appropriate exercise 
program (ongoing).
6 Review exercise program 
Depression and chronic pain 
Fact vs. opinion
Record statements and determine if  they 
are facts (cannot be changed) or opinions 
(open to interpretation).
7 Review facts and opinions 
Life evaluation
Set up a one month goal and a one year 
goal.
8 Review goals 
Biofeedback
Dealing with families and 
significant others
Attend two follow-up support group 
sessions.
After an initial chart review and phone consultation with the program’s physician, 
patients received an invitation to participate. Admission, however, could only occur until 
after the completion o f an eight-page pre-treatment questionnaire (Appendix A).
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Research Design
This study reviewed data on all 2,561 patients referred to a Southern California 
HMO’s pain management program from August 1, 1991 to May 15, 1996, including 353 
patients in the McCarberg & Wolf (1999) and ErshofF (1995) studies. O f this population, 
1,832 patients were listed as having completed the pre-treatment assessment, but 103 
questionnaires could not be located. I  entered 1,729 pre-treatment assessment 
questionnaire responses into a database for statistical analysis.
Pre-treatment questionnaires asked for demographic information, including marital 
status, current employment, and level o f  education. In addition, attendance records for 
each patient’s workshop participation were entered into the database, including those who 
successfully completed the program, those who dropped, those who signed up for class 
but did not attend any session, and those who never signed up to participate.
A one-page (two sided), post-treatment survey was also mailed to the 1,832 
people listed as having completed pre-treatment questionnaires (see Appendix B). This 
survey was the screening version o f  the MPI (eight questions), the 11 Point Box Scale, 
three quantitative and two qualitative questions related to patient satisfaction and 
continuous quality improvement. A 4" x 7" refrigerator-type mood magnet was sent along 
with the follow-up questionnaire as an incentive to respond. A second post-treatment 
survey was sent to non responders six months after the initial mailing. Seven hundred 
thirty-one replies were received (39.8% response rate), o f  which 15 were incomplete. 
Eleven point Box scores and MPI responses were compared with the pre-treatment 
survey.
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Computer records listing each patient’s medical utilization were available on 2,430 
subjects from January 1994 through August 1997. One hundred thirty-one patients did not 
visit the HMO during that time, I assume because they expired, changed medical insurance 
coverage, sought treatment outside o f  the HMO, or gave up on traditional Western 
medicine. The utilization records included both the number and type o f doctor visits and 
any prescription opioid medicines purchased through the HMO. Unfortunately, these 
records did not distinguish between pain related treatments and other types o f  medical 
maladies. Because the goals in the Pain Management Program included se lf efficacy, a 
review o f  total medical utilization pre- and post-treatment could detect changes in patient 
perceptions centered around using and misusing the medical system.
This research project incorporated a total patient population. Because o f  the size 
o f  the group and the vast amount o f available data, the first purpose o f this study was to 
construct and present descriptive statistics about a large group o f  chronic pain patients.
As is common in a  study with human subjects, a true experimental design was not 
possible. This study looked retrospectively at referred patients, their participation in the 
pain workshop, and medical utilization information. The strongest statistical model 
available for the pre- and post-treatment questionnaires was found in the quasi- 
experimental set o f statistical designs. More specifically, this project utilized the self­
selected experimental group design, part o f  the nonequivalent control group designs. 
According to Huck, Cormier, & Bounds (1974), “The nonequivalent control group design 
has two groups that are compared to observations before and after the exposure o f  one 
group to the treatment” (p. 302). While similar to pretest-posttest control group designs
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(both true experimental and pseudoexperimental), the nonequivalent control group differs 
in that there is no random assignment to groups. The self-selected experimental group 
design, “consists o f subjects who volunteer, are se lf selected, or seek to be exposed to the 
treatment, whereas the control group subjects do not seek exposure” (p. 302).
Quasi-experimental designs, when compared to true experimental designs, have 
better control over external threats to validity, making the results more generalizable. 
However, increased threats to internal validity include uncertainty about whether group 
se lf selection is equivalent, and if  so, whether history and maturation play a  part in that 
selection. Also, Huck, et al (1974) point out that regression to the mean and mortality can 
threaten validity, especially if  groups were selected based on extreme scores.
Because this study was enormous in size, I could test these threats to internal 
validity. By comparing various descriptive statistics in each group, using either two- 
sample case o f  the mean or ANOVA, minute differences in groups could be detected. In 
the case o f  the number o f  years in pain, the assumption o f  a  normal distribution was 
violated, requiring the nonparametric test, Kruskal-Wallis One-way ANOVA, to detect 
differences among the groups.
Utilization data, both DO Vs and opioid medications, followed another quasi- 
experimental design, namely a multiple-group time-series. Here, “the multiple-group time- 
series design includes a series o f  observations or measurements before and after treatment, 
while the nonequivalent group design includes only one observation before and after 
treatment for the groups” (Huck, et. al., 1974, p. 319). Utilization information was 
calculated into the number o f days pre- and/or post-treatment. Sixty-three pain
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management workshops were conducted from October 1991 through May 1996. For the 
purpose o f  determining number o f  years pre- and post-treatment, those patients who did 
not sign up for class were assigned to workshops with similar referral dates. Whole years 
o f utilization information were then calculated. The eight weeks o f  the pain management 
program were eliminated from the study, so that one year pre-treatment included the 365 
days before the first day o f class and one year post-treatment contained the 365 days after 
the last day o f  class. Because outcome data spanned three years and eight months, 
approximately one-half o f  the group could be banded into two complete years while the 
other one-half incorporated three complete years o f  medical utilization. The total range 
extended from two years pre-treatment to five years post-treatment.
Once statistical significance was found, linear models were employed to see if 
associations existed among various sets o f  data. I was most interested in uncovering 
correlations between pre- and post-treatment questionnaire responses, participation in the 
program, and outcome data.
One important aspect considered was the comparison o f  the stereotypical chronic 
pain patient versus the actual demographic information on these study participants. The 
pervasive societal model o f  chronic pain patients paints them as unemployed, seeking 
disability benefits, and abusing their prescription drugs. They are excuse makers 
determined to make society pay so they will not have to work. Psycho logically, they suffer 
from a variety o f mental illnesses and social maladaptations that, if treated, would make 
their pain go away.
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These observations are still supported by many physicians who believe in pre-1990 
models o f  chronic pain. “Most clinicians and managers (share) a  paradigm composed o f 
misconceptions rather than the latest scientific findings” (Donovan, et aL, 1999, p 41). In 
1991 and again in 1995, the American Pain Society (APS) published standards for 
understanding the mechanisms behind and effectively treating chronic pain, revolutionizing 
the world view o f pain patients. By looking at the profiles o f  patients in this study, 
outcome measurements, and questionnaire responses, we can see how this population 
differs from pre-1990 beliefs.
The pre-treatment questionnaire responses aided in statistical analysis as follow in 
Table 7 (full version in Appendix A):
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Table 7
Available Variables (Factors) and Their Attributes





Identification control; to be converted to 
case number for privacy purposes.
Age Continuous, Ratio Is age a  factor?
Sex Discrete, Nominal Do men experience or report pain 
differently than women?




Does marital status influence outcomes?
Who living with Continuous,
Nominal
Importance o f  social support.
Education Continuous,
Ordinal




Indicates level o f  disability.




Does length o f time with pain affect 
outcomes?
Location o f  Pain Continuous,
Nominal
Any relationship to other variables?
MPI Continuous,
Interval
Evaluates perceived pain and its impact 
on self, perception o f  others, and activity
11 Point Box Scale Continuous, Ratio Does intensity o f pain affect outcomes? 
What is change in pain over time?
PDS Continuous,
Interval
Shows pain affect. Also, correlates 
highly to depression.





Does being an active coper, 
interpersonally distressed, or 
dysfunctional affect outcomes?
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Included in this analysis were various profiles o f  typical patients referred to the 
pain management program. By obtaining additional demographic information from the 
medical provider (e.g., age, gender), variations could be seen between pain patients and 
the general population as a whole. Other attributes inferred from the questionnaires, 
including location o f  pain and disorder or cause o f  pain to see if other associations existed.
With patients analyzed by number o f  years post-treatment, I evaluated the medical 
utilization and costs to see if any trends appeared. For example, in Ershofif s (1995) study, 
the cost o f medical care one year post-treatment on average was approximately one-third 
o f the medical costs for the year before referral. Because the long-term effects o f  pain 
management programs are not understood, reviewing patients’ records over time could 
demonstrate whether these cost savings continued. I f  there was a point in time when the 
effects o f this treatment strategy appeared to wear off, then interventions could be 
designed to reinforce the self-management tools presented in the workshop.
Data Collection
The HMO providing this pain management program graciously awarded a $4,800 
grant to cover the data gathering expenses. In exchange, I proposed and received approval 
for this study from the HMO’s Internal Review Board (TRB) and promised to deliver a 
copy o f  this dissertation to the IRB when completed. Predating the proposal, I secured a 
paid, part-time position with the pain management program because o f my volunteer 
efforts and interest o f  study in this field (April 1997). There were no monetary incentives, 
job guarantees, or other benefits expressed or implied based upon the results o f this study. 
Because I am an employee o f  the HMO, this project served as an inexpensive, in-house,
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secondary analysis o f  the efficiency and effectiveness o f  the Pain Management Program to 
the health care organization. As a former participant and present employee, I recognize 
that I have biases toward the program as I have seen it work for many people. However, 
as a researcher, I adhered to strict rules o f  impartiality and think that is represented in the 
data analysis and conclusions.
With the grant money, I mailed follow-up questionnaires, including the cost o f  
printing and postage, and paid for the computer time and programming needed to capture 
utilization information. The Pain Management Program made the eight-page pre-treatment 
questionnaires available to me for input into a data base.
Using the talents o f  the Information Systems people at the HMO, I received a 
comprehensive list o f  utilization data on each participant. This information included 
outpatient doctor visits, emergency room  visits and urgent clinic appointments. Diagnostic 
codes were not available. Also, opioid medications purchased at one o f  many HMO 
pharmacies were included. Not all benefits, including drug coverage, were consistent over 
the entire population.
Entry to the Population 
In 1992,1 participated in this pain management program as a  chronic pain patient. 
Since then, I have observed six additional workshops and, until 1997, participated 
regularly in semimonthly support group meetings. At times, I have served as a volunteer 
phone partner and resource for chronic pain patients diagnosed with Reflex Sympathetic 
Dystrophy. Over the years, I have come to know both the Director and Coordinator o f  the 
program.
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Since April 1997,1 have been employed by the HMO as a Staff Specialist in the 
Pain Management Program. My duties include reviewing medical charts for program 
participants. Also, I regularly interact with patients, encouraging them to participate, 
helping reinforce program techniques, and serving as a  liaison among the patients, 
Coordinator, and Program Physician.
Due to the vast amount o f  data already collected by the HMO for this program 
(but not analyzed), my personal interest in the study o f  chronic pain self-management, the 
Director’s interest in further research, and the support I have received from the HMO, I 
feel secure in developing this topic and in using this site for my dissertation study.
Site Selection
The medical facility housing the Pain Management Program is a Southern 
California HMO. However, it is also part o f  a  large, national HMO. Due to its size, 
treatment methods and patient populations are stable. All medical services are provided 
within the HMO, except certain captured costs for workers’ compensation. Another 
benefit o f  this site is that an HMO setting serves as a  standard o f care model as our society 
shifts to managed care.
The pain management program under study offers one type o f  low-cost treatment 
for chronic pain patients. Currently, HMO administrators are replicating this program at 
other sites throughout the nationwide system because they perceive it as having some 
success in managing this difficult patient population.
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Selection o f  Subjects 
The Pain Management Program is a cognitive-behavioral workshop designed for 
patients who have undergone most or all known standard medical treatments and are 
having trouble self-managing chronic pain. To participate, one o f the patient’s health care 
providers (e.g., physician, social worker, physical therapist) sends a referral to the pain 
program. According to the procedures at the time, staff members completed a chart 
review and patients received a phone consultation with the program physician. Afterward, 
participants received a questionnaire for completion. The questionnaire served as an entry 
ticket to the program, as it had to be completed and returned before a class space was 
reserved for the patient. At the time I requested this information, 4,511 referrals had been 
sent to the program (from the March 1987 program inception through May 1997). Two 
thousand twenty questionnaires were completed. Available attendance records existed for 
2,684 participants. I focused this study on a narrower time span because attendance 
records did not begin until October 1991, and I wanted to have at least one complete year 
o f post-treatment information available. Also, the HMO did not record medical utilization 
records for all patients until January 1994.
Protection o f Subjects 
Before collecting any data, I received human subjects research approval from two 
different sources. First, the University o f  San Diego Human Subjects Committee approved 
my proposal design, pending approval by the HMO. Next, I petitioned the HMO’s Internal 
Review Board, both for funding and permission to obtain the outlined information. In both 
cases authorization was given without incident.
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This study was a post hoc examination o f  data already in existence for clinical and 
administrative purposes. I eliminated any individual identifiers, such as name and patient 
record number, and substituted random case numbers in their place. In its final form, the 
HMO cannot identify any patients included in the study nor will my data files contain any 
information that will enable me to go back and update my records with additional patient 
information- Once this study is accepted in its final form, I will destroy those files showing 
any connection between the HMO’s identifiers and case number assignment. I will neither 
release nor publish any information on individual participants. The data analysis is for 
identifying possible links that enhance or detract from one group’s ability to self-manage 
chronic pain and to help evaluate program effectiveness in those areas.
The follow-up survey also serves as part o f a routine, secondary analysis o f  the 
program’s effectiveness and efficiency (Appendix B). Included with the survey was a 
letter, signed by both the director and the researcher, briefly explaining the study 
(Appendix C). This letter included an informed consent. Patients wanting to participate in 
the study chose to do so by returning the questionnaire.
I f  the results o f this analysis showed a  relation between workshop attendance, 
individual characteristics, and/or utilization, then assurances needed to be made that 
individuals would not be denied treatment merely because they did not fit a certain profile. 
The purpose o f  this study was to identify potential problem areas and address those issues 
in concurrent, pre-workshop, and follow-up interventions.
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Data Analysis
This study proposed to be a  quantitative analysis employing general statistical 
models and sound research designs to assess the effectiveness and efficiency o f  one pain 
management program- Also, I looked at statistical relationships o f  individually reported 
factors or characteristics with program completion, utilization, and the ability to self- 
manage chronic pain over time.
My ability to conduct this analysis related to my own interest in statistics (I tutor 
and lecture doctoral students in quantitative methods) and in research (I taught 
introductory research classes to graduate counseling students and counsel doctoral 
students in quantitative research design). Also, I have surrounded myself with a committee 
expert in statistical and economic modeling. This promised to give new and varied 
contexts into the research o f  chronic pain.
Background o f the Researcher 
In 1986 I was diagnosed with Carpal Tunnel Syndrome (CTS), a  painful 
compression o f  the median nerve. Carpal tunnel release surgery followed to remedy the 
problem. After two years, the symptoms returned and a second surgery was scheduled.
The latter surgery proved unsuccessful
Gradually, the CTS-type symptoms became more intense. Again, conservative 
treatment foiled to produce results, but the symptomology took on new characteristics. 
Fortunately, I had two caring physicians who, instead o f insisting that it was all in my 
head, took my complaints and symptoms seriously.
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After a year o f testing and treatments, I was diagnosed with Reflex Sympathetic 
Dystrophy (viz., Complex Regional Pain Syndrome, Type 1). “Reflex Sympathetic 
Dystrophy (RSD) is characterized by severe burning pain, swelling, and vasomotor, 
sudomotor, dystrophic, and atrophic changes in the affected body parts” (Schwartzman & 
Kerrigan, 1990, p. 57).
The Pain Management Program helped me to reframe and self-manage this painful 
condition. I also witnessed others making remarkable progress, assuming control o f their 
medical care. Still, some did not seem to get the message; somehow they were stuck and 
unable or unwilling to change or progress.
Eventually, I had a successful surgery, a cervical sympathectomy disconnecting 
portions o f  the sympathetic nervous system from the spinal column. Some research 
suggests that this method o f  treatment, if successful, stops pain an average o f  two or three 
years. In some managed care settings, this procedure is discouraged or not covered. It 
seems that the anticipated benefit o f being pain-free for two or three years does not justify 
the cost.
I firmly believe that education-based programs, such as a cognitive-behavioral pain 
management program, can help people live well with chronic conditions. By understanding 
more about chronic pain and treatment options, by regaining a sense o f self efficacy, 
patients are better able to become true partners in managing their own health and wellness. 
I recognize these biases and have tried to compensate with strict adherence to research 
doctrine.
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I would like to pursue a  career in health care and/or education. Teaching research 
methods and statistics, as well as delving more into chronic pain research should yield a 
rewarding career consistent with Rost’s (1997) definition o f  leadership, that ““Leadership is 
an influence relationship among leaders and (collaborators) who intend real changes that 
reflect their mutual purposes” (p. 102).
Summary
My purpose in investigating the effects o f chronic pain management satisfied both 
personal and professional interests. This project considered potential explanations about 
why some people succeed and others fail to self-manage chronic pain. Particularly, a better 
understanding o f  chronic pain may help patients accept their condition, reform  their 
identities, and create new meaning for their lives. Also, updating physicians and  other 
health care providers in chronic pain standards o f care, breaking down barriers to effective 
treatment, and helping to reframe societal views in expectations and efficacy-, should 
improve the quality o f  life for those experiencing chronic pain.
This study set up a framework to analyze chronic pain patients and uncover 
possible improvements to patients’ and providers’ training and treatment. B y  looking at 
the problem from both the patient’s and the provider’s perspective, a clearer appreciation 
o f  the need to educate ourselves and others will be realized. By understanding today’s 
stumbling blocks, lower health care costs, reduce frustration, and more effective treatment 
regimens may be uncovered.
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Half o f what we learn in medical school is out o f  date in five years, 
but our patients always tell us the truth.
Daniel Brookoff MD, PhD





The information used to compile this study originated from three sources. First, the 
Pain Management Program’s database identified all patients referred to the program. 
Preset parameters included all participants enrolled in one o f  63 classes beginning 
October 3, 1991, and ending May 9, 1996. The beginning date reflects the time at which 
weekly attendance records became available. Because my initial request for utilization 
information was in August 1997, and, wanting to have at least one year’s post-treatment 
utilization, I limited the data gathering to those classes ending by May 1996.
Completing the questionnaire was a necessary step in registering for class, but not 
all questionnaire completers enrolled in the Pain Management Program. This study 
included those patients referred to the program between August 1, 1991, and May 15, 
1996, who did not sign up for class. O f the non-participant group, 55.4% did not complete 
the pre-treatment questionnaire and were not invited to attend. The remaining 44.6% of 
nonparticipants completed questionnaires, were invited, but chose not to attend.
Data from the pain program included a patient’s identifying number, referral date, 
and the eight-page pre-treatment questionnaire. A total o f 2,561 patients (viz. Total 
Group) was referred during this period. The program’s database indicated 1,832 patients 
(viz. M PI Group) completed the pre-treatment questionnaire, which included the full
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chronic Pain 80
version o f the MPL Questionnaires were lost for 103 patients, therefore the size o f the 
pre-treatment questionnaire group was 1,729. Pain Management Program data was 
supplied primarily in paper form and required extensive manual entry to capture the data.
Next, the Information Technology (IT) department of the HMO, with limited 
access to the pain program’s database, captured attendance records, pain sites (if 
available), and class start dates. From the systemwide database, IT supplied updated 
names, addresses, age (as o f  12/97), and most medical utilization information. On 
December 17,1997, IT gathered data as shown in Table 8 below. The outpatient visits 
were called the Utilization Group, while pharmacy prescriptions (viz. Pharmacy Rs) 
represented the Opioid Group.
Table 8
Utilization Data from January 1. 1994 to August 31. 1997
Subject
Number o f 
participants 
(")




(Utilization Group) 2,430 131,280 Included Urgent Care, ER
Pharmacy Rs 
(Opioid Group) 1,860 38,913 Opioids only
One assumption o f this study was that all chronic pain patients had at least one 
Doctor Office Visit (DOV) each year that they had medical coverage. Erring on the side 
o f caution, those patients who had coverage but did not see at least one health care 
provider during the time in question were excluded in utilization analysis. Using this 
assumption, 131 patients either changed health care providers, lost their insurance
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coverage, expired, or for some other reason were not seen during the dates for which 
utilization information were gathered.
To see graphically how these groups interrelate, Figure 1 shows the relationship 
among the four groups in which information was gathered. To review, the Total Group 
was all patients referred to the Pain Management Program from August 1, 1991 and May 
9, 1996 (n = 2,561). The Utilization Group included all outpatient services rendered from 
January 1, 1994 to August 31, 1997 (n = 2,430). The difference between the Total Group 
and the Utilization Group were 131 pain patients with no detectible DO Vs.
Patients in the MPI Group came from the pool o f Total Group participants, but 
included only those specifically marked in the pain program’s database as having 
completed the pre-treatment questionnaire. Post-treatment questionnaires were sent to all 
those identified as the MPI group. In the MPI Group (« = 1,832), 103 questionnaires 
could not be found.
The Opioid Group represented those patients in the Utilization Group who filled 
opioid prescriptions at one o f the HMO’s pharmacies. Some employer groups offered 
drug coverage outside o f  the HMO pharmacy. Some patients did not have any drug 
coverage and were free to choose their own pharmacies, including those outside o f the 
HMO. Still, other patients did not receive any opioid prescriptions. Out o f  the Utilization 
Group, 1,860 patients received opioid medications through the HMO’s pharmacies.





/i = 2,561Opioid Group 






The third source o f data came from a mandatory governmental filing published by 
the HMO’s Underwriting Department. According to the 1997 Membership Utilization 
Data (1998), this Southern California HMO offered care to 2,300,231 patients. O f those 
patients, 774,676 were children (under the age o f 20), and their systemwide demographic 
and utilization information was eliminated because the study population was almost 
exclusively adult (#i = 7 under the age o f  20). What remained were data on adults: 
1,508,766 patients between the ages o f  20 and 64, and 16,789 patients age 65 or older. 
Patients obtained coverage through employer groups, from individual plans, or by
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accessing health care through Medicare or MediCaL O f the entire HMO population,
48.6% were male and 51.4% female. Removing children from these figures, the adult 
HMO population consisted o f  47.5% male and 52.5% female (median age found in the 
grouping between 40-44 years old).
The average adult was seen 1.338 times per year by a primary care physician 
(family practice, general practice, or internal medicine). Patients saw speciality group 
physicians an average o f .874 times per year. Emergency room encounters added another 
. 143 visits per patient per year. Non-physician encounters (mental health, chemical 
dependency, optometry, podiatry, physicians assistants and nurse practitioners added 
another 1.535 visits per year. Excluding pediatric visits, adult members had an average o f 
3.89 DOVs per year.
Information Technology Demographics
While a wealth o f information on utilization was made available through 
Information Technology (IT), demographic information on pain patients was limited to 
gender and age.
Gender
As in other examples o f chronic pain research (see Table 5), the total pain 
population o f this study was dominated by women. The percentage o f men and women for 
the Total Group is shown in Figure 2. The percentage o f  women participants in each 
group (Total, Utilization, MPI, and Opioid) varied from 74.4% (Utilization Group) to 
76.6% (MPI Group), but this variation was not statistically significant (p=.218).
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Figure 2




S  Fem ale
Using a one-sample case o f  proportion, the percentage o f women in the pain group 
was compared to that o f  the HMO’s general population The proportion o f  women to men 
in the pain population far exceeded that o f  the general population (z = 2965, p  < .001).
Age o f  the Total Group
A ge was another demographic factor considered when checking consistency 
among the  groups. The ages ranged from one participant as young as 14 to another as old 
as 102. Figure 3 shows the range and frequency o f  ages in the Total group.





Std. Dev = 14.48 
Mean = 52.9 
N = 2556.00
15.0 25.0 35.0 45.0 55.0 65.0 75.0 85.0 95.0 
20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 100.0
Age
The mean age for men was 53.64 years, while women averaged 52.56 years. 
However, these differences were not significant (7 = 1.546, df=  1070.201, p  = . 122). In 
other words, there was no difference in age between men and women referred to the pain 
management program.
The mean age for each group in the study population (see Figure 1) ranged from 
52.86 years (Total) to 53.40 years (MPI). The difference in mean ages among all groups 
was not significant As portrayed above, the arrangement o f ages approximated a  normal 
distribution.
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However, the pain patients under study were considerably older when compared to 
the HMO adult population. The 1997 Membership Utilization Data (1998) listed 
frequency o f ages in banded groups with the median age for the HMO population in the 
interval o f 40-44 years old. Due to the large size o f  the HMO population, one would 
expect the frequency distribution to approximate a normal distribution, signifying that the 
mean and the median were similar if not the same. Using 44  years as a conservative mean 
age, the pain population mean o f 52.86 years was significantly older (t = 30.924, p  <
.001).
Questionnaire Demographics
The Pain Management Program, as part o f a screening process, required the 
completion o f an eight-page questionnaire if referred patients were to attend the class 
(Appendix A). Pages one and two incorporated various demographic information as 
summarized in the following sections. I created a database o f responses on 1,729 
questionnaires, as these forms were kept by the program but had not been compiled or 
evaluated. Not every person completed every question on. the form, so the number of 
responses to each question varied. Also, responses were self-reported and not verified 
with any other source. Some information provided insight, while other data were merely 
anecdotal.
Marital Status
As seen in Figure 4, almost 66% o f 1,719 responses were married at the time the 
questionnaire was completed. The importance o f marriage could be viewed from several 
aspects, from social and psychological support to financial relief. As for health insurance,
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if the spouse were employed or retired, the pain patient may have access to health care 
through the spouse’s employer or retirement plan. Not to discount the importance o f  
friends and family, but one-third o f this population may not have had this access to 
financial, social, or psychological support as one might if  married or legally obligated to 
provide for basic needs. Because pain may effect one’s ability to work and can impact 
one’s admission into a health care plan, the ability to secure medical coverage as a legal 






Separated (2.15%) Mamed (65.58%)
More telling o f one’s support system to help manage chronic pain would be the 
question shown in Figure 5, With whom are you currently living? O f 1,715 respondents, 
85.13% mentioned living with someone else. Only 255 patients reported living alone. In
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further analysis, marital status and living arrangements could surface as a factor to one’s 
ability to manage chronic pain.
Similarly., another question asked patients to identify their significant other. In 
1,677 responses, 88.2% marked spouse or someone else as their significant other (friend, 
child, parent, other relative). Still, 198 responses hinted that no support system was in 
place.
Figure 5
With Whom Are You Currently Living?
Spouse/Child (24.08%)
Spouse/Partner (46.65%)Other (1.57%) P
Parents (3.15%) —  




The educational level o f  patients could also play a  factor in how well the concepts 
presented in the Pain Management Program were understood, practiced, and integrated 
into daily life. In Figure 6 below, almost one-half o f  the respondents (831 o f  1722) marked 
that they had experienced some college or vocational school and another one-quarter were 
college graduates or beyond. Superficially, this population appears highly educated. 
However, in a  world o f  exploding technology and increasing job changes during the
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average worker’s life, lifelong learning may be an increasingly necessary part o f  peoples’ 
lives. I f  society demands lifelong learning to keep up with daily activities, we will have a 
population that accesses learning beyond high school. When analyzing utilization 
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Employment Status
The image o f a chronic pain patient is often characterized as someone who seeks 
or is already on disability. When reviewing the demographic information on employment, 
however, only 412 out o f  1716 responders marked disabled under the question, “Which 
best describes your work situation now?” In Figure 7, the largest group o f  patients, 
30.71%, was employed full time (n = 527), with 43.06% (« = 739) employed in some 
capacity (part or full time). Given the widespread distribution o f  employment situations,
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we can investigate the role o f  employment on outcome measures and see if someone’s 




In Figure 8, the report o f  pain years was not a normal distribution, therefore 
violating the basic core o f parametric statistics. While the mean number o f  years with pain 
was 8.33 years, extreme scores affected the validity o f using the mean as an appropriate 
measurement. Therefore, the median (4.00 years) and the mode (1.00 year) become more 
important measures as they are usually unaffected by extreme values.
Also, the first and third quartiles (2.00 years and 10.00 years respectively), were 
more meaningful in understanding this group. These quartiles show that one-half o f  all 
patients were referred to the program between their second and tenth year in pain.
Stu(' ..............
Homemaker (
Retired (14.10%)— Full Time (30.71%)
Disabled (24.01 % ) ~ / ^ — Part Time (12.35%) 
Unemployed (9.67%)





£= 100 Std. Dev = 10.34 
Mean = 8.3 
N = 1660.00
0.0 10.0 20.0 30.0 40.0 50.0 60.0
5.0 15.0 25.0 35.0 45.0 55.0 65.0
Years In Pain
One assumption commonly used when comparing utilization information pre- and 
post-treatment is that patients seek medical treatment within the year before referral.
When all the tests and evaluations are completed and medicine offers no cure, referral to a 
pain management program is the logical next step. Here, because the mode indicates that 
more patients were referred in their first year with pain, the one and two-year pre­
treatment data could confirm or deny this assumption. N ot only was available pre­
treatment utilization analyzed, but a comparison linking the number o f  years with pain to 
annual utilization was needed.
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Pain Site and Cause
Qualitatively, the questionnaire asks patients to write, “Briefly describe your pain - 
when did it start, where is the pain, etc.” To quantify this question, I read the responses 
and categorized them into two areas, the part o f the body affected with pain (w=1679) and 
the perceived cause o f the pain (/7=593).
With the pain site, I was interested to see if  pain was found in a  specific area, or if  
patients experienced pain at multiple sites. In Table 9 below, pain sites reported by at least 
than 7% o f  respondents are listed.
Table 9 
Pain Site
Site Frequency Percent o f Total 
Responses
Multiple, upper and lower body 588 35.0
Multiple, lower body only 265 15.8
Back 215 12.8
Multiple, upper body only 204 12.2
Head 123 7.3
These five categories formed 83.1% o f all responses. The next categories were 
legs, with 53 responses (3.2%) and abdomen/pelvis with 44 responses (2.6%). Other sites, 
each at less than 2% o f respondents, included in order: neck, hand/wrist, feet/ankle, 
shoulder, arm, chest/breast, hips, genitalia, emotional pain, and kidney/bladder.
Fewer responses (n=593) included either a diagnosis or cause for pain. Table 10 
represents the eight most commonly listed causes.




Diagnosis o r Cause Frequency Percentage
Motor Vehicle Accident 99 16.7
Headaches/Migraines 90 15.2
Neurological 71 12.0
Work related 57 9.6
Herniated disc (back) 49 8.3
Fibromyalgia 49 8.3
Post Surgery 49 8.3
Arthritis (osteo and rheumatoid) 34 5.7
The remaining causes o f  pain comprising at least 1% o f  those reporting included, 
in order: fracture, degenerative disc/joint disease, carpel tunnel syndrome, cancer, chronic 
fatigue syndrome, spasms, and reflex sympathetic dystrophy. Again, since this information 
was voluntary and self-reported, causes remain anecdotal and should not be construed as 
representative or complete.
Pre-Treatment Inventories 
The three inventories incorporated into the pre-treatment questionnaire provided 
more information about how patients perceived pain Included were the 11 Point Box 
Scale, the PDS and the MPI. All subjects who signed up for the program completed the 
questionnaire. All o f those who did not complete questionnaires fell into the category of 
no participation. Of 1,310 patients who did not sign up for the program, 729 (55.6%) also
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did not complete questionnaires. The other 581 patients (44.4%) completed questionnaires 
but did not enroll in the pain management classes.
Eleven Point Box Scale
On pre-treatment questionnaires, 1,595 patients rated their level of pain as shown 
in Figure 9 below:
Figure 9
Eleven Point Box Scale
500 ------------------------------------------------------------------------------
Std. Dev = 1.91 
Mean =7 
N = 1595.00
11 Point Box Scale
Although negatively skewed (-0.68), the spread o f scores still adequately 
represents a normal distribution. The mean (x  = 7.23) is close to the median o f 7.0, with 
the mode clearly at 8.0. Quartiles are at 6.0 (25th percentile), 7.0 (50th percentile), and 8.0 
(75th percentile).
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Pain Discomfort Scale (TPS)
The Pain Discomfort Scale measures pain affect, or the suffering component o f  
chronic pain (see Appendix A, questionnaire page 8). Here, patients were asked to read 10 
statements and rank how accurately each statement reflected their own experience. Values 
were set between zero (very untrue) to four  (very true). In five o f  the questions, a  rating 
o f zero would represent low pain affect (less suffering), while in the other five questions, a 
rating o f  zero would indicate high pain affect.
For the 1,582 responses, I  recoded the statements so that an overall score o f  zero 
would represent low-to-no pain affect and a score o f  four would show high pain affect. 
Figure 10 below demonstrates the average scores for all respondents.
Figure 10
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Almost 80% o f  patients responding indicated that their pain affect fell in the 
moderate-to-high range, while 9.5% rated pain affect as very high and 11.0% felt low-to- 
no pain affect. Because a high pain affect is correlated to depression, scores in the three- 
to-four range warrant a closer look to see how this may effect outcome measures. 
Multidimensional Pain Inventory (MPD
As previously discussed, the MPI was a valuable instrument designed for pain 
patients and measured the unique factors effecting them. Before calculating the various 
scales from respondents, I looked at seven questions that some were not able to answer 
within the parameters given.
Per the pre-treatment questionnaire in Appendix A, the following questions were 
directed at finding how much pain influences one’s life and daily activities. Included were 
the total number o f  respondents and the number o f patients who could not respond on a 
scale from zero (not at all) to six (extreme):
• Since the time your pain began, how much has your pain changed your ability to 
work? («=1,678). Those who retired for reasons other than pain - 132 (7.9%).
• How much has your pain changed the amount o f  satisfaction or enjoyment you get 
from work? («=T,712). Those presently not working - 671 (39.2%).
How often do you do each o f these activities?
• Mow the lawn? («=1,712). Do not have a lawn - 608 (35.5%).
• Work in the garden? (n=l,715). Do not have a  garden - 550 (32.1%).
• Work on the car? («=1,700). Do not have a car - 69 (4.1%).
• Wash the car? («=1,709). Do not have a  car - 61 (3.6%).
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• Visit relatives? (w=l,714). Do not have relatives within 100 miles - 321 (18.7%).
Because the 13 scales were completed only if all the questions were answered, 
each o f the exception responses was revised to a score o f  three, the neutral response on a 
scale from zero to six. All other responses remained unchanged.
Another question asked on the MPI but not included in any o f the 13 scales was 
the frequency with which chronic pain patients engaged in sexual activities. Using an array 
from zero (never) to six (very often), Figure 11 below summarizes the 1,684 responses: 
Figure 11 
Sexual Activity
Std. Dev = 1 .6 7  
Mean = 2  
N =  1684.00
Scale from Never (0) to Very Often (6)
This figure is merely anecdotal and no other research data was used for 
comparison purposes. All the same, gender, age, and pain level were not associated with 
how participants rated sexual activity (p >.05).
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The 13 scales o f  the MPI are summarized below in Table 11. Calculations 
necessary to detect coping styles (adaptive, interpersonal^ distressed, and dysfunctional) 
were not available as these formulas are in the copyright process. Responses for Part I 
ranged from zero (no pain effect) to six (extreme). For Parts II and in , zero represented 
never and six is very often. Each o f  these scales was calculated by using between three and 
11 questionnaire responses.
Table 11
M PI Scores from Pre-Treatment Questionnaires
Scale Identifies
Total 
responses (n) Mean (x)
Standard 
Deviation (s)
Part I - Perceived pain intensity and impact on patients’ lives
1 Pain Severity 1687 4.31 1.04
2 Interference 1520 4.25 1.10
3 Life Control 1673 2.92 1.20
4 Affective Distress 1680 3.43 1.24
5 Support 1467 4.22 1.51
Part II - Responses o f others as perceived bj
(This section is completed only by those with a si:
r the patient
spificant other)
6 Punishing responses 1413 1.90 1.58
7 Solicitous responses 1344 3.48 1.25
8 Distraction responses 1384 2.16 1.40
Part EDI - Activity level
9 Household chores 1657 3.46 1.57
10 Outdoor work 1673 1.48 1.15
11 Activities away from the home 1668 2.45 1.18
12 Social activities 1685 2.03 1.10
13 General activity level 1568 2.37 .87
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How Gender Related to the MPI
In Part I, one’s pain perception and its impact on life, only the Support scale 
showed significant differences along gender lines. Men, on average, reported feeling 
higher levels o f  support from their spouses/significant others than did women, xm= 4.65 
vs. xw = 4.07, F (1, 1452) = 40.30, p  < .001. There was no difference detected by gender 
in reported scores for Pain Severity (F=  .89, p  — .35), Interference (F=  .57, p  =  .45), Life 
Control (F  = .02, p  = .89), or Affective Distress (F =  .02, p  =  .90).
When tallying the role o f  one’s significant other (Part II), all three scales were 
statistically different by gender, with men reporting more extreme values. While both 
genders conveyed relatively low levels, males reported more Punishing responses than did 
females, x m= 2.05 vs. xw =  1.84, F (1, 1398) = 4.80, p  = .029. Conversely, males also 
revealed that significant others gave higher Solicitous responses, xm= 3.62 vs. xw = 3.43,
F (1, 1329) = 5.79, p  = .016, and higher Distracting responses, x m= 2.45 vs. xw = 2.08, F 
(1, 1369) = 17.23,/? <.001.
Under Activity levels (Part III), women reported doing more household chores, 
xw= 3.73 vs. x m = 2.63, F (1, 1641) =  162.21, p  < .001, while men disclosed more 
outdoor work, xm= 1.95 vs. xw = 1.33, F (1, 1656) = 94.69, p  < .001. Activities away 
from  home (F  =  .74, p  = .39) and Social activities (F  = .97, p  = .33) displayed no 
significant difference between genders. However, the General activities level was higher 
for women than for men, x w= 2.40 vs. xm = 2.25, F (1, 1549) = 9.40, p  = .002.
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How Age Associated with the MPI
Each patient’s age was assigned to a decade so that post hoc studies could be 
done. Because only two teenagers completed pre-treatment questionnaires, they were 
omitted from this part o f  the study. Nine o f  the 13 MPI scales were associated with age.
Three o f the nine scales exhibited significant differences between patients in their 
twenties and those in their eighties. All other age groups, while following a  natural 
progression with age, remained too close to observe any significance. The remaining six 
scales verified differences between young adults and the elderly, as well as middle-aged 
and the elderly. Table 12 shows the significantly different ages and possible conclusions.
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Table 12













F (6, 1500) = 5.08 
/?<.001
Seaise of life control is 
significantly higher in over 59- 
year-olds than in twenties
Affective
Distress
20s (3.63) 80s (2.80) F (6, 1502) = 8.41 
p < .0 0 l
Distress is less in over 79-year- 
olds than those in twenties
Support 40s (4.06) 80s (4.89) F (6, 1315) = 4.42 
/?<.001
PaUients in forties have less 
support than older than 79.
Punishing
Responses
20s (2.47) 80s (1.29) F (6, 1265) = 4.86
p<.001
Sp«ouses punish more in 






80s (4.11) F (6, 1204) = 3.89
p  = .001
OWer spouses (> 79 years) are 







80s (2.90) F (6, 1235) = 2.16 
p  = .044
People over 79 years reported 
more spouse distraction than in 
fonties, fifties, and seventies.
Household
Chores
20s to 60s 
(3.4 to 3.7)
80s (2.72) F (6, 1482) = 3.94
p  = .001
People eighty and older report 




20s (2.47) 70s (1.92) 
80s (1.80)
F (6, 1506) = 3.39 
p  = .003
People in their twenties have 





20s (2.58) 80s (2.07) F (6, 1400) = 3.48
p  = .002
General activity level is less in 
those over 79 than those in their 
twenties.
PDS and the 11 Point Box Scale
The Pain Discomfort Scale, as previously discussed, wms designed to measure pain 
affect, also called suffering, as opposed to the 11 Point Box scale measuring perceived 
pain (the physical sensation o f  pain).
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The PDS inventory (see p. 8, Appendix A) incorporated ten questions requesting 
responses from zero (very untrue) to fo u r  (very true). Questions were posed so that 
someone with severe pain affect would answer five o f the questions with a four  and five 
with a zero. Recoding the database, I arranged the scales so that the lowest average score 
(zero) would represent no pain affect, and the highest average score (four) would indicate 
severe pain affect on all measures. Respondents with average PDS scores o f zero were 
deleted from this study due to their small number (n — 6). Table 13 below displays the post 
hoc testing results.
Table 13
Comparison o f the PDS with the 11 Point Box Scale ('Scheffea,bl
PDS
(Revised) N
11 Point Box Scale 
Subset for alpha = .05





Sig. 1.00 1.00 1.00 1.00
Means for groups in homogeneous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 237.456.
b. The group sizes are unequal. The harmonic mean o f  the group sizes is used. Type I error levels are not guaranteed.
Clearly and understandably, pain and suffering were closely linked. Since this was
not a  causal mode, it was not clear if pain effected suffering, or vice versa. An evaluation 
o f  patients’ pain issues needs to encompass both influences on pain.
R eproduced  with perm ission o f the copyright owner. Further reproduction prohibited without perm ission.
Chronic Pain 103
MPI and the 11 Point Box Scale
The most dramatic correlations were seen when comparing the MPI scales with the 
pre-treatment 11 Point Box scale. In other words, the higher the level o f perceived pain, 
the more pain influenced quality o f  life. Listed below are tables and narrative describing 
the six MPI scales associated with, one’s level o f pain.
Pain Severity
As one might expect, the MPI pain severity scale had a positive, moderate-to-high 
correlation with the 11 Point Box scale. This one variable alone demonstrated a  more 
associative quality that any other combination o f the thirteen MPI scales (adjusted R1 = 
.451, F (1, 1555) =  1278.75, p  <  .001). Since the MPI scales were ranked from zero to 
six, and the 11 Point Box Scale asked the participant to select a number between zero and 
ten, some adaptation was needed to correlate the 11 Point Box Scale to the MPI pain 
severity scale. To show the relationship with the 11 Point Box score, the linear regression 
equation calculated as Y  = 1.234 (Pain Severity scale) + 1.893.
Interference
Using a One-way ANOVA, the Interference scale correlated well to the 11 Point 
Box score, F (9, 1393) = 26.775, p  < .001. Using Scheffe for post hoc testing, Table 14 
illustrates how increases in the severity o f  pain directly impacted the Interference scale.
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Table 14




Subset for alpha =  .05
1 2 3 4 5
1 7 2.9740
3 31 3.1349 3.1349
2 15 3.4152 3.4152 3.4152
4 73 3.5392 3.5392 3.5392
5 113 3.6227 3.6227 3.6227 3.6227
6 168 3.9959 3.9959 3.9959 3.9959
7 315 4.2465 4.2465 4.2465
8 352 4.5276 4.5276
9 163 4.6263
10 166 4.7234
Sig. .603 .168 .213 .115 .418
Means for groups in homogeneous subsets are displayed.
a. Uses Harmonic Mean Sample Size = 34.667.
b. The group sizes are unequal. The harmonic mean o f the group sizes is used. Type I error levels are not guaranteed.
Life Control
One’s sense o f control over one’s life was also directly related to the reported 
levels o f physical pain. The higher the life control scale, the more one would feel in 
control. As expected, the higher the level o f pain, the lower the sense o f control. 
Significant differences were seen with pain scores o f  nine and ten (x 9 — 2.52, x 10 -- 2.48) 
and pain scores o f  two or three (x , = 3.67, x3 = 3.63), F (9, 1393) = 11.95, p  <  .001.
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Affective Distress
For affective distress, scales increased when self-reported pain levels were higher. 
Those disclosing level three pain were the least affected, x3 = 2.39, significantly lower 
than those reporting pain levels more than six [(x  from 3.44 to 3.88), F (9, 1539) = 12.89, 
/ 7< . 001].
Activity Level
The Outdoor Work scale showed significant differences between the genders, with 
men reporting more outdoor work than women (t = 8.736, p  < .001). However, outdoor 
work appeared unrelated to the level o f  pain. Patients reporting pain at levels two, six, 
eight, nine, and ten (x  scores from 1.48 to 1.33) participated less in outdoor activities than 
those who reported pain at level one, x , =  2.46, F (9, 1535) = 3.82, p  <  .001. No 
significant difference appeared among the other reported levels o f pain.
General activity scales appeared to have some relationship to pain levels. 
Understandably, patients with level one pain scored a higher overall activity level, x, = 
3.09, than those with pain levels more than seven [x  scores from 2.25 to 2.13; F (9, 1437) 
= 5.06, p < .  001].
Attendance
O f the 2,561 patients referred to the Pain Management program, four possible 
outcomes occurred. First, a  patient did not commit to attending the program, whether by 
not returning the questionnaire, returning the questionnaire but not responding to at least 
two follow-up phone requests to schedule a class, or by refusing to register. Another
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scenario was that a patient signed up for class, but never attended. Those who attended 
between one and four classes were labeled as having dropped out o f  the program. When 
patients attended five or more classes, they were identified as program completers. Figure 
12 below shows this breakdown o f  outcomes:
Figure 12
Referred Patient Outcomes
Approximately one-third o f referred patients completed the program. To 
understand the almost 46% o f  patients who attended at least one session, Figure 13 
demonstrates the attendance pattern.
Never Registered (24.40%)
Attended (33.46%)— ~
Dropped (12.30%)— Never Came to Class (29.83%)
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Figure 13
Number o f  Classes Attended
500 ---------------
1 2  3 4  5 6 7  8
Number o f Classes Attended
O f the 1,250 patients who attended at least one session, 12.7% did not return 
(including those who rescheduled for a later session). However, clearly one-third (33.1%) 
attended each and every session and approximately two-thirds those who came class 
(68.0%) completed the program.
Follow-up Survey
The follow-up survey was mailed to the 1,832 patients recorded as having 
completed the pre-treatment questionnaire, including those patients whose questionnaires 
were lost. This survey repeated the 11 Point Box Scale and eight MPI questions out of 61 
in the original version (viz. The Screening Version o f the MPI).
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Eleven Point Box Scale - Post-Treatment
As shown in Figure 14 below, the mean pain score for 700 respondents was 5.61, 
an overall average decrease o f  1.62 points. In  percentages, a  decrease in the pre-treatment 
mean o f  7.23 to a 5.61 represents a 22.4% decline in pain scores.
When observing Figure 14, notice the more platykurtic arch (kurtosis o f  -.835 vs. 
pre-treatment kurtosis o f .201). While the 75th percentile remained at 8.0, the 25th and 50th 
percentiles shifted down to 4.0 and 6.0 respectively.
Figure 14
Eleven Point Box Scale (Tost-Treatmentl
Std. Dev = 2.59 
Mean = 6 
N = 700.00
11 Point Box Scale
Comparing the responses o f 1,595 pre-treatment and 700 post-treatment 
questionnaires, 604 patients answered both 11 Point Box Scales. Using a paired-sample
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t test, these 604 patients reported significant decreases in pain (t  = 13.518, p  <  .001). To 
get a clearer picture o f  how patients’ reported levels o f  pain changed over time, Figure 15 
below compares the pre- and post-treatment responses, side-by-side:
Figure 15









9 1085 6 70 3 41 2
Pre-Treatment Post-Treatment
Graphically, more patients reported lower pain levels between one and five years 
after the initial questionnaire. Patients who attended classes reported lower pre- and post­
treatment pain levels (x pre = 6.81 and = 5.31). Those who did not attend reported the 
highest level o f  pre-treatment pain (xpre = 7.37 and x ^  = 5.87). Patients who dropped 
out reported the highest level o f post-treatment pain (x pre = 7.25 and ^post= 6.01). None 
o f  these differences, however, achieved statistical significance (p >  .05).
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MPI - Post-Treatment
The screening version o f  the MPI, included in the post-treatment survey, consisted 
o f  eight questions. Two questions each came from four o f  the MPI scale indicators: Pain 
Severity, Interference, Life Control, and Affective Distress.
Before comparing pre- and post-treatment scales for those who answered both 
questionnaires, I wanted to know the difference between the full scale scores, all pre­
treatment responses on the two-question set for each screening scale, the pre-treatment 
scales for those answering the post-treatment surveys, and the post-treatment scales.
Table 15 below summarizes these groups and their ratings.
Table 15
Comparison for Scales on the MPI



















Pain 4.31 4.13 4.00 3.52 Decreased
Severity (1,687) (1,699) (643) (643) /=8.42,p<.001
Interference 4.25 4.85 4.74 4.08 Decreased
(1,520) (1,706) (645) (645) /=I0.43,/K.001
Life Control 2.92 3.30 3.44 3.86 Increased
(1,673) (1,695) (645) (645) /=-6.51,/?<.001
Affective 3.43 3.61 3.51 3.27 Decreased
Distress (1,680) (1,702) (635) (635) /=3.78,/K.001
The first consideration was the difference between the full rating of these four 
scales as compared to the two-question screening version. Similarly, did the screening 
version adequately resemble the full version? Because o f the large number o f  subjects,
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significant differences were easier to detect. In  feet, all comparisons demonstrated 
statistical significance.
Full scale Pain Severity was computed using three questions from the pre­
treatment questionnaire. As with all the other scales, individual questions were answered 
on a Likert scale from zero (no pain or suffering) to six (extreme pain and/or suffering). 
The most severe rating found was for the full version (x fv = 4.31), higher than the pre- 
treatment screening version (x sv=  4.13) in a paired-samples t test (f = 18.78, p  <.001).
The Interference scale used 11 questions centering around how pain interferes with 
activities and relationships, where zero indicated no change at all and six measured an 
extreme change. Here, the full version rating (x fv = 4.25) was much lower than the 
screening version ( x ^  =  4.85, r =  -33.18,/7 <  .001).
For the Life Control scale, four questions were asked on the pre-treatment 
questionnaire, but for this measurement the scale was reversed. A score o f  zero in this set 
represented no control over pain, problems, planning and stressful situations, while a score 
o f six equated to success. The lowest (most dysfunctional) score came from the full 
version scale (2.92), significantly lower than the screening score (x sv = 3.30, t  = -25.65, p  
c .0 0 1 ).
Finally, the Affective Distress scale, based on three questions, was lower (less 
dysfunctional) than, using the screening version (t =-13.62, p  < .001). These questions 
asked participants to  rate their mood, irritability, and anxiety.
The size o f  each group on Table 13 represented the total number o f  participants 
answering all questions within the four scales. The number o f  those completing the
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screening version pre-treatment (two questions each) was larger than the number 
completing the full version (from three to eleven questions). Leaving even one question 
unanswered in any part resulted in no score for that particular scale.
Next, the question arose, did patients score better post-treatment? For this 
comparison, the screening version pre-treatment scores were matched to responses on the 
post-treatment survey. In each scale, patients demonstrated significantly less dysfunction 
and more control with time. Also, I ran a One-way ANOVA matching the full scale pre­
treatment and screening version pre-treatment to the screening version post-treatment 
scores. Once again, each o f  the four scales was significantly different pre- and post­
treatment (F  from 2.428 to 8.404,/? < .001).
Total Quality Questions on Follow-up Surveys
Most o f  the pre- and post-treatment results have already been analyzed during this 
study. Patient satisfaction, however, remained to be evaluated. Three questions about 
patient satisfaction were addressed in the post-treatment survey.
How useful has the Pain Management Program been in helping you to manage pain?
The focus o f  this question was to measure patients’ perception on the utility o f  the 
techniques taught in the Pain Management Program. The survey asked patients to rate 
their reply on a  scale from zero (not at all useful) to six (extremely useful). Computing a 
One-way ANOVA between usefulness ratings and class attendance, patients who did not 
come to class (n^) and those who dropped out (nd) rated the program’s usefulness on the 
negative side o f  neutral, = 2.47, xd = 2.57. Patients who completed at least five
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sessions o f  the program (wj indicated positive usefulness, significantly higher than those 
who dropped or never came [xc = 4.01, F (2, 673) =  46.33, p  < .001].
How satisfied were you with the Pain Management Program?
Patient satisfaction also remained high for program completers (x c =  4.47), while 
those who dropped or never came reported neutral scores (xd = 3.08, x^  = 3.17 
respectively). Satisfaction levels for those attending the program were high enough to 
achieve statistical significance, F  (2, 670) =  36.93, p  <  .001.
Today, how would you rate the cause or condition fo r  your referral to the progjram?
The parameters o f  this response ranged from zero (much worse) to six (much 
better). Even with high satisfaction and usefulness scores for program completers, all 
groups responded with averaged scores ranging from 3.16 to 3.39, despite attendance. 
What this means is that their condition had not changed. In some cases, the condition was 
even worse with time, confirming the notion that chronic pain was not curable.
Medical I Jtilizntion
Doctor Office Visits (DOVs) and opioid pain prescriptions were included in the 
HMO’s utilization information. The total data set was gathered for three years and eight 
months (e.g., 44 months). Because annual utilization (in whole years) was important in 
understanding and comparing these patients, data were further refined into total annual 
increments. Depending on the start and end dates o f  each class, counts and costs were 
divided into complete years, pre- and/or post-treatment. For approximately one-half o f  the 
patients, two complete years o f  utilization data were available. For the remaining patients, 
three years pre- and/or post-treatment data were gathered (x=2.54 years). The
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information captured here was for actual DOVs, and does not reflect the number o f 
referrals to specialty departments which may have been written but not scheduled. 
Outpatient DOVs
A total o f 131,256 DOVs for 2,430 patients was recorded between January 1,
1994 and August 31, 1997. For departments that saw at least 2% of total DOVs, Table 16 
below provides a breakdown o f  those visits.
Table 16
Summary o f  DOVs by Department
Department N um ber of DOVs
Percent of 
Total DOVs
Family Practice & Internal Medicine *54,313 41.4%




Ophthalmology & Optometry 6,533 5.0
Obstetrics & Gynecology 4,698 3.6
Dermatology 3,946 3.0
Neurology & Neurosurgery 3,838 2.9
Physical Medicine and Rehabilitation 3,827 2.9
Chemical Dependency and Recovery 2,783 2.1
* Included 5,105 Urgent Care visits (9.4% o f primary care visits, 3.9% o f total visits).
As expected, Primary Care (Family Practice and Internal Medicine) saw the most 
patients. Because Urgent Care is staffed by primary care physicians, Urgent Care visits 
were included under the umbrella o f  Primary Care. O f interest, however, was that chronic
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pain patients visited the Emergency Department 1.41 times more often than Urgent Care 
(7,260 vs. 5,105 visits). This data did not include a  diagnosis o r distinguish between acute 
pain, chronic pain, and non pain visits. With few exceptions, the Emergency Department is 
not the appropriate place to seek treatment for chronic pain. Learning where to seek 
appropriate treatment was one o f the topics covered in the Pain Management Program.
To further understand utilization patterns, Table 17 looks at how 2,430 chronic 
pain patients used HMO services in these same departments over the 44-month period 
from January 1, 1994 to August 31, 1997. Included were the total number o f patients 
using each department’s services as well as the respective percentage of all 2,430 chronic 
pain patients, the average number o f  visits for those patients using each department 
(annual and total) and the average number o f  annual visits for all 2,430 chronic pain 
patients. In contrast, the annual utilization o f  the total adult HMO population was 1.338 
DOVs for Primary Care, 0.87 for all specialities combined, and 0.14 for the Emergency 
Department per year. The assumption underlying the calculations below was that each 
chronic pain patient had coverage for all 44 months. Since some patients changed or lost 
their health coverage, these figures may be understated.
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Table 17
Analysis o f  Medical Services Used bv Chronic Pain Patients
Department
Number (and %) 
of pain patients 
using this dept.






for all pain 
patients
Family Practice & 2,398 6.17 6.10
Internal Medicine (98.7%) (22.65) (22.35)
Physical Therapy & 1,265 2.60 1.35
Occupational Therapy (52.1%) (9.54) (4.96)
Psychiatry and 935 2.31 0.89
Social Services (38.5%) (8.40) (3.26)
1,571 1.26 0.81
Emergency (64.7%) (4.62) (2.99)
1058 1.70 0.74
Orthopedics (43.5%) (6.22) (2.71)
Ophthalmology & 1,619 1.10 0.73
Optometry (66.7%) (4.04) (2.69)
Obstetrics & 925 1.39 0.53
Gynecology (38.1%) (5.08) (1.93)
905 1.19 0.44
Dermatology (37.2%) (4.36) (1.62)
Neurology & 1048 1.00 0.43
Neurosurgery (43.1%) (3.66) (1.58)
Physical Medicine and 977 1.07 0.43
Rehabilitation (40.2%) (3.92) (1.57)
Chemical Dependency and 186 4.08 0.31
Recovery (7.5%) (15.0) (1.15)
To examine whether the chronic pain patients seen in each o f the above
departments differed from all chronic pain patients in this group, each patient’s gender and 
age was calculated and compared to the demographics previously discussed. For Post-Hoc 
testing purposes, ages were grouped into seven different decades-, those less than 30 years
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old (group 2), the five decades between age 30 and 79 (groups 3-7), and all patients more 
than 79 years o f  age (group 8). Returning to the analysis o f  medical utilization by 
department, Table 18 below shows how close those using each specialty resembled the 
2,430 chronic pain patients recorded as having at least one DOV.
Table 18









Difference in # of 
DOVs by 
gender/age












No, p  = .476 
No, / = 0.31
No,/ =-1.60 
Yes, F=  5.55***






No, p  = .056 
Y es,/= 2.31*
No, t =-1.06 







Yes , p  = .003** 
Yes, / = -7.89**
Yes, t = -5.64*** 






No, p  = .444 
No, / = 0.26
No, t = -1.19 






No, p  = .444 
Yes, / = 4.07***
No,/ = 0.74 







Yes, /? = .038* 
Yes, / = 8.70***
No, / = -0.46 







Yes,p  <.001*** 
Yes, / = -9.33***
Yes****






Yes, p  = .026* 
Yes, / = 8.37***
No, / = -0.40 







No,/? = .359 
No, / = 0.50
No, /=  1.19 
No, F — 1.30






No, p  = .451 
No, / = 1.75
No, / = 0.43 







Yes,/? < .001*** 
Yes, / = -10.94***
No, t = 0.22 
No, F=  0.71
*-/?< .05  **/?<.01 ***/?<.001 **** t value not calculated as s = 0.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Chronic Pain 118
Visits by Specialty
In the last column o f  Table 17, the average annual DOVs fo r the each specialty 
were calculated based upon the 2,430 chronic pain patients included in the utilization data 
set. Compared with the total adult HMO population, chronic pain patients saw their 
Primary  Care physicians an average o f  6.10 times per year, or 4 .56  times more often than 
the general population. In the Emergency Department, chronic pain  patients were seen an 
average o f .81 times per year, or 5.66 times more often than average.
To understand the breakdown o f  visits to various departments by gender and age, 
Table 18 compared the 11 most commonly used specialties to see if these patients differed 
from the 2,430 chronic pain patients (study population) with utilization information.
In determining differences among specialties (column titled Difference from  Study 
Population), the proportion o f men-to-women in each group w ere  compared to the study 
population (a non-parametric binomial test o f frequency). Here, a  value is approximated 
and findings are reported as assumptive significance (p values). F o r  the age o f  patients 
seen, actual years were used to compare ages with those in the study population (one 
sample case o f the means, x = 52.86).
In the last column o f  Table 18, Difference in # o f  DOVs (gender/age), differences 
in the number o f  DOVs by gender were calculated using the two-sample case o f  the 
means, independent samples. In other words, the number o f D O V s for men was compared 
to the number o f DOVs for women in the study population to see if gender played a role 
in utilization. To compare patients by age, decades were used to compare the number o f
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DOVs by generation (one-way ANOVA with Scheflfe for post hoc testing). Listed below 
is a  summary  by department o f  significant findings.
Family Practice & Internal Medicine
Visits to P rim ary  Care most closely resembled the study population as 98.7% of 
utilization patients were seen by someone in Family Practice or Internal Medicine. 
Significant differences were seen in the number o f  visits by age. Patients in their 30s, 40s, 
and 50s averaged between 20.50 and 21.00 total visits (5.59 to 5.73 annual DOVs), while 
those more than 79 years o f age averaged 32.25 (8.79 annually).
Physical Therapy & Occupational Therapy
The pain patients who visited this specialty were slightly, but significantly, older 
than the study population. The small difference between the mean age o f 53.76 years for 
this group and 52.86 years o f age for the utilization group demonstrated how the relatively 
large sample size (n = 1,265) could detect minor differences and indicate that the results 
were significant.
Psychiatry and Social Services
Women were more likely to be seen in Psychiatry than men, when compared to the 
gender proportions o f the utilization group. Also this sample was significantly younger 
that the entire study group (49.57 years vs. 52.86, p  < .001). While there was no 
difference in the number o f DOVs by generation, women visited Psychiatry and Social 
Services more often than men (x w= 9.20 total visits and xm =  5.82 total visits, or xw=
2.51 annual visits to xm = 1.59 annual visits respectively).
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Emergency Department fEDl
Overall, the number o f  emergency visits decreased as patients got older. Patients in 
their 20's were significantly more likely to use ED than those in their 60s and 80s (6.25 
total DOVs vs. 3.44 - 3.52 total DOVs respectively, or annual rates o f  1.70 visits and 0.94 
- 0.96 visits). No other differences were detected.
Orthopedics
The only significant finding in Orthopedics was that these patients were slightly 
older than the utilization group (54.68 years vs. 52.86 years). All other comparisons 
reflected similar proportions to the study group.
Ophthalmology & Optometry
While gender was not an issue in eye-related DOVs, age had a tremendous impact 
on utilization. Patients on average were older for this group than the study group (55.96 
years vs. 52.86 years o f  age). Logically, patients in their 20s were the least likely to be 
seen (1.90 DOVs or 0.52 annual visits), significantly less than patients more than 59.
Those in their 60s were more likely to go to an eye specialist than those in their 20s, but 
less likely to be seen than those more than 69 (4.37 DOVs or 1.19 annual visits). Patients 
in their 70s and 80s visited Ophthalmology and Optometry significantly more than any 
other age (6.83 DOVs and 8.68 DOVs, or 1.86 and 2.37 annual visits respectively, p < 
.001).
Obstetrics & Gynecology fOB/GYN)
All patients visiting this department were women, obviously differing greatly from 
the gender mix o f the study population. With the exception o f  women more than 79 years
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o f age, the frequency o f DOVs had an inverse relationship to age. Women over 39 saw a 
gynecologist on average between 5.02 and 3.24 total times (annualized at 1.37 to 0.88 
DOVs). Women less than 30, in the traditional childbearing years, visited OB/GYNs the 
most (10.43 DOVs or 2.84 DOVs annually).
Dermatology
Similarly, women were more likely to go to Dermatology than men (77.6% o f 
Dermatology DOVs compared to 74.7% o f DOVs for women in the study population). 
However, this difference failed to achieve statistical significance between the genders. 
Nonetheless, as patients aged, they were seen significantly more often (those under 30 
were seen 2.48 total times vs. those in their 70s being seen 6.28 total times, p  = .03), but 
these differences were not enough to be detected using Schefife as a post hoc test. 
Neurology & Neurosurgery
No demographic discrepancies were detected for patients seen in Neurology. 
However, when comparing age in decades to gender, those more than 79 years o f age 
were more likely to be men than women when measured against those less than 70 years 
old (F  = 3.49, p  = .002.)
Physical Medicine and Rehabilitation fPM&R)
For the 977 patients seen in Physical Medicine, their age, gender, and number o f 
DOVs were not significantly different from the entire utilization population. Across the 
board, PM&R patients, while 40.2% o f the utilization group, adequately represented the 
utilization population o f  chronic pain patients.
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Chemical Dependency and Recovery Program fCDRPl
While men constituted only 25.3% o f chronic pain patients, they comprised 40.9% 
o f  patients seen in CDRP (p < .001). In other words, male pain patients were 1.62 times 
more likely than women to be seen in CDRP. Also, 91.3% o f  patients seen in CDRP were 
between 30 and 59 years old. Not one patient above 79 was seen, and only 16 patients 
were in their 20s, 60s, and 70s. The average number o f  DOVs was stable between the 
genders (x w = 14.56 vs. xm = 15.54 total visits, or 3.97 and 4.24 annual visits 
respectively). While 7.5% o f  chronic pain patients were seen over the 44-month period, 
the annualized rate was only 2.05% o f  this group. When investigating the total number of 
patients receiving opioid medications through the HMO, 2.52% o f  opioid patients were 
seen annually in CDRP.
Annualized Doctor Office Visits (DOVs)
O f the total 131,256 DOVs, 97,098 visits could be aggregated into 5,940 complete 
patient years pre- and/or post-treatment. The total utilization group included 2,430 
patients, but 88 patients did not have any complete years o f  utilization information 
reported pre- or post-treatment. Therefore, 2,342 patients used HMO services for a total 
o f 5,940 years (x  = 2.54 years per patient).
Following ErshofFs (1995) example, DOVs during the eight-week Pain 
Management Program attendance period were eliminated. Patients attending the program 
signed a statement promising not to seek new diagnostics or treatments during the eight- 
week program Therefore, the range o f  time spanned from two years pre-treatment to five 
years post-treatment. The data from IT included costs for 68,484 DOVs. The cost o f  the
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remaining visits was determined by using the most frequent (mode) cost associated with 
that department. Data on systemwide utilization was limited to age, gender, and annual 
frequency o f  DOVs. Table 19 summarizes the spread o f  values.
Table 19
Summary o f  Utilization Group DOVs
Yrs Pre/Post­
treatm ent
Num ber of 
DOVs






-2 6,564 390 16.83 $1,648.57
-1 23,349 1,067 21.88 2,113.51
1 23,742 1,456 16.31 1,552.34
2 17,851 1,234 14.47 1,342.11
3 14,564 1,024 14.19 1,335.81
4 7,957 536 14.85 1,389.32
5 3,071 231 13.29 1,240.45
Total £ =  97,098 1= 5 ,9 4 0 16.35 $1,551.55
The range o f DOVs per year per patient was between one and 206 visits with an 
associated annual cost o f  between $54.00 and $16,199.00. Because o f the extreme spread 
o f  values, the outliers were identified, also known as the “unusual score(s) in a distribution 
that may warrant special consideration” (Hinkle, Wiersma, & Jurs, 1998, p. 72). To assure 
outliers would not artificially distort the results, calculations were performed both with 
and without the outlying values. Outliers were identified as those patients older than 93 
years o f age, incurring more than 46 annual DOVs, and with a DOV cost o f  more than 
$4,376.00.
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Opioid Medications
The number and type o f  opioid medications filled at the HMO pharmacy served as 
another indicator o f each provider’s evaluation and treatment o f chronic pain. According 
to Marcus (2000), “Although NSAIDs and short-acting opioids may be helpful with pain 
flares, they should not be used chronically on a daily basis in most cases” (p. 1336). A 
move to long-acting opioid medications, Class II medications, “should be considered in 
patients who have a clear pain diagnosis, constant pain, pain with significant disability or 
regular analgesic overuse” (p. 1337).
In the State o f  California, however, long-acting opioids require a triplicate 
prescription where the original o f the three prescription copies is filed with the 
Department o f Justice (DOJ). These medications are not refillable and may not be called 
into a  pharmacy by phone. By definition, these controlled substances represent, “High 
abuse potential (and) severe dependence liability” (Tarascon, 2000, p.3). Instead, patients 
receive Class EH medications, ones defined as having “Moderate dependence liability” 
(p.3), NSAIDs or other analgesic medications.
This study included all opioid prescriptions (Class H and Class EH medications) 
from January 1994 through August 1997. Not all patients referred to the Pain 
Management Program received opioid medications. Also, not all patients had prescription 
drug coverage with the HMO. Some patients purchased their prescription medications at 
outside pharmacies, beyond the record keeping o f  the HMO. O f the 38,913 opioid 
prescriptions dispensed by the HMO’s pharmacy, drugs given in liquid form were 
eliminated because the quantity dispensed was reported in milliliters, a misleadingly high
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quantity when compared to the number o f  pills dispensed. Also, drugs commonly given to 
treat migraines were omitted as they were often dispensed in a one- o r two-dose form, 
distorting the number o f  prescriptions per patient. What remained were 35,299 
prescriptions for the entire period. When stratified into complete patient years, 26,488 
prescription medications were dispensed from the HMD’s pharmacies as shown in Table 
20 below.
Table 20
Class II and Class HI Medications Dispensed through the HMO Pharmacy










Lortab m 19,746 74.5
Aspirin w/Codeine Empirin m 7 0
Fentanyl Duragesic n 120 0.5
Hydromorphone HCL Dilaudid n 160 0.6
Meperidine HCL Demerol n 138 0.5
Methadone HCL Dolophine n 485 1.8
Morphine Sulfate
MS Contin 
Oramorph n 846 3.2




Roxicet n 1,385 5.2
Oxycodone w/Aspirin Percodan n 121 0.5
Total 26,488 100.0%
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Class EH medications were prescribed 87.7% of the time. Class II medications 
accounted for only 12.3% o f all opioid prescriptions.
As part o f  the Pain Management Program, almost one entire class was devoted to 
informing patients about their choices in the medications used for chronic pain. The 
optimal goal would have patients living full lives with or without opioids. In the meantime, 
one would expect an increase in the trials o f  long-acting opioid medications after 
attendance in the program. For some, this shift in long-term opioids should allow 
increased activity, thereby reversing the amount o f  pain caused by deconditioning. With 
new cognitive-behavioral skills, learned techniques would help control pain affect. Even 
so, others would need access to long-term opioids, as the condition causing pain would 
not improve or may even worsen. In addition, when conservative modalities fail to help 
manage chronic pain, one would also expect providers to be more open to this treatment 
option.
When tabulating the number o f  years pre- and post-treatment, all data during the 
eight-week cognitive-behavioral program were eliminated. Therefore, there was no 
treatment year, or “Year 0." One year pre-treatment (-1 year) included the 365 days prior 
to the first day o f  class and one year post-treatment (1 year) included the 365 days after 
the last day o f  class.
Figure 16 confirms that the proportion o f  Class II prescriptions, when compared to 
all opioid prescriptions, did increase in the post-treatment years (except for the second 
year after referral). At two years pre-treatment, patients received the lowest percentage o f  
Class II prescriptions (5.3%, p  <  .001), while patients at four years post-treatment
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reported the highest percent (20.2%, p  <.001). In years one, three, and five post- 
treatment, Class II prescriptions were similarly high (14.3%, 12.6%, and 16.1% 
respectively, p  = .035). However, no differences were detected among patients who 
completed, dropped out, or did not attend (F =  1.032, p  =  .357).
Figure 16
Class II and Class III Drugs Dispensed
Number of Years Post Treatment 
Hg|[ Class III H  Class II
Also, opioid patients who took Class H drugs got fewer prescriptions per year than 
opioid patients taking Class III drugs. The range in number o f  annual prescriptions for 
Class H drugs ran from one to 49, with a mean o f 6.07 prescriptions, a median o f three per 
year, and a mode o f  one per year. In comparison, Class III drugs ranged from one to 129 
prescriptions in one year, with a mean o f 7.72 prescriptions, median o f four, and mode of 
one (p<.001).
No differences were detected within the program participation categories. 
Separated into three types o f  program participants (i.e., attended, dropped, and never 
registered/never came to class), attended patients were categorized as having attended at
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least five classes, dropped patients as opting out o f the program (four or fewer classes 
attended), or never registered/never came to class patients as not coming to any class. 
Using a one-way ANOVA with attendance as the factor, there was no difference between 
the class o f  opioid medications filled at an HMO pharmacy (F=  1.032, p  = .357), the total 
number o f  pills dispensed (F =  1.00,/? = .369), or the number o f prescriptions filled (JF= 
1.02,/? = .362).
Prescriptions and Doctor Office Visits
By merging DOV data with aggregated prescription information, certain 
correlations come forth, albeit o f minor importance. For example, the higher the number 
o f  DOVs, the more likely:
• Questionnaires were returned (Pearson r = .094, p  < .001).
• Patients attended class (Pearson r  =  .120, p  < .001).
• Patients received Class II medications (Pearson r = .093, p  < .001).
• Patients secured more opioid prescriptions (Pearson r = .244, p  < .001).
The group o f patients receiving opioid prescriptions was broken down into three 
categories: 1) Those who received only Class II drugs; 2) those who were prescribed only 
Class HI drugs, and; 3) those who obtained some combination o f both Class n  and Class 
HI opioid medications. Looking at each o f  the groups, the following statistics came forth:
• Comparing the average number o f  opioid prescriptions per year, Class H-only and
Class Hi-only patients received nearly the same number o f prescriptions (x n =  7.95
vs. x m = 7.21, p  = .624). However, patients combining the two types o f  
medications secured an average o f  16.53 opioid prescriptions per year, more than
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double the number prescriptions filled for long-acting only or short-acting only 
opioid users (F=  156.94, p  <  .001).
• When comparing the average number o f  DOVs per year, there were no significant 
differences in outpatient office visits between Class II-only and Class Hi-only 
patients (17.98 vs. 18.88 DOVs respectively, p  = .790). Again, while not 
statistically significant, Class II-only patients in this sample actually saw their 
doctors less frequently than did Class El-only patients. As with the average 
number o f  annual opioid prescriptions above, those on a combined regimen 
appeared more unstable, averaging significantly more DOVs per year (x  = 28.08, 
F =  55.26, p <  .001).
Gender also played a role in who and how one utilized medical services. When 
comparing annualized DOVs and medication data for men and women (an average o f  2.54 
years, n = 2,342):
• Women had more DOVs (x w = 42.85 vs. xm = 37.40, p  = .001).
• Correspondingly, women cost more per year in DOVs ($1,562.89 vs. $1,430.22, p  
=  .021).
• Men were more likely to get Class E medications (14.0% o f men vs. 9.2% o f 
women, p  < .001).
• Men were more likely to get any opioid prescription (x m = 19.55 vs. xw = 15.02, p  
=  .001).
• Men received more opioid pills than did women (2007.29 vs. 1092.75, t — 3.13, p  
=  .002).
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• The ratio o f  men-to-women securing Class III medications mirrored the gender 
ratio for all pain patients referred to the program. However, men had greater 
access to the combination o f  medications and Class II-only medications than did 
women (F =  14.69, p  =  .001).
Questionnaires and Outcome Data
When comparing the utilization group to those who completed pre-treatment 
questionnaires, similar spreads were detected in the number o f opioid prescriptions (x  = 
8.44 Rs for the questionnaire group vs. x = 8.27 R s for non completers). However, the 
questionnaire-only group failed to achieve any statistical significance (F = 0.17, p  = .683). 
Also, whether or not one attended the Pain Management Program had no bearing on the 
number o f prescriptions filled (x attcnd = 8.41 R, x ^p  = 8.95 R, xnoshow = 8.20 R, F =  1.00, 
p  =  .369).
However, differences were detected in the number o f DOVs in those completing 
the questionnaire and in class attendance. Those who completed the pre-treatment 
questionnaire were seen by their providers more often than those who did not complete 
the questionnaire ( x ^  = 43.59 visits vs. xno = 36.29; t = 4.62, p  < .001). Also, those 
patients who attended any o f  the classes saw their providers more than those who never 
came to the program ( x ^  = 17.10, xdrop = 18.28, xnoshow = 15.17; F =  18.49, p  < .001). 
One possible interpretation is that those who saw their providers more were encouraged, 
or perhaps required, to attend the program. The higher number o f  DOVs for those who 
dropped (while not significantly different from those who attended) could mean that
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patients who dropped were still looking for more evaluation, a cause, and/or a solution to 
the pain, before learning how to cope with and manage chronic pain.
Can MPI Help Predict the Number o f DOVs?
For this test, the number o f  annual doctor visits was broken down into ranges o f  
visits by ten. The first category included those patients with between one and ten DOVs, 
on up to those with more than 80 visits. No discemable differences were appreciated in 
any o f  the MPI scales.
Opioid Medication and the MPI
Not everyone who received opioid prescriptions purchased their medications 
through the HMO. Therefore, results would not distinguish between those who obtained 
opioid pain medications through an outside pharmacy, those who did not obtain opioid 
prescriptions, or those who received prescriptions but did have them filled. However, we 
can look at the differences between those who received all Class II drugs, those who 
purchased mostly Class II drugs, those who bought mostly Class HI drugs, and those who 
were received only Class HI drugs.
Only three o f  the 13 MPI scales demonstrated significant differences based on the 
combination o f  opioid medications. In all three cases, the progression went from Class II- 
only, mostly Class II, mostly Class HI, and Class Hi-only:
• Interference. Class II-only patients reported significantly higher levels of
interference than those taking Class Hi-only medications, xn= 4.69 vs. xm = 4.23, 
F (3, 952) = 6.97,/? < .001.
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• Support. Conversely, those patients taking only Class II medications reported 
significantly higher levels o f support from spouses and significant others, xn= 5.02 
vs. x ra = 4.20, F ( l ,  922) = 5.56, p  =  .001.
• General Activity Level. While no discemable difference arose within the four 
individual activity scales, the overall activity level was significantly lower in post 
hoc testing for those taking only Class II medications over those with only Class 
III medications, xn= 1.92 vs. x ra =  2.35, p  < .05.
Noticeably missing from significant results was any correlation between the Pain 
Severity Scale and the class o f  medications prescribed. While Class II-only patients rated 
pain severity higher than the Class Ill-only patients, x n=  4.69 vs. x ra=  4.35, this difference 
was not enough to be meaningful (p > .05).
Chemical Dependency Visits and Opioid Medications
O f the 186 patients that were seen in CDRP, 154 purchased opioid medications 
through the HMO pharmacies. In order to figure out who goes to CDRP, the ratio o f 
Class II opioids received was compared to the Class HI opioids received. While Tarascon 
(2000) identified Class II opioids as having higher addiction potential, one would expect 
those supplied with a higher number o f  Class H opioids would be seen more often in 
CDRP. However, that was not the case. The average patient seen in CDRP received more 
Class IK opioids than Class H opioids and there was no difference in the mix o f  opioid 
medications from the remaining patients not seen in CDRP ( t — 1.916,/? = .057).
Next, the research looked at the number o f  prescriptions filled and the number o f  
pills dispensed through the HMO, comparing them to those both seen and not seen in
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CDRP. Here, major differences appeared. Patients seen in CDRP received almost twice as 
many opioid prescriptions than their counterparts ( x ^  =  28.15R total, xno = 14.96 R 
total; t = -4.392, p  < .001). Also, those patients seen in CDRP received more pills (x yes = 
1,994 pills total, xno = 1,269 pills total; t = -2.469, p  < .001).
Finally, the research looked at any differences in the number o f  prescriptions and 
the number o f CDRP visits, as well as the mix o f  Class H and Class HE opioids compared 
with the number o f visits to see if either had an influence on the length o f time needed for 
CDRP intervention. Once again, no differences were detected. Recoding the number of 
visits and prescriptions into quartiles, those with the highest number o f visits had the least 
number o f  prescriptions, but these differences were not significant (F =  1.54, p  =  .21). 
Also, patients receiving more Class III opioids tended to be seen the most in CDRP, but 
failed to achieve significance (F =  0.22, p  — .88).
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Excuses for inadequate pain control appear to have run their course 
and will no longer be accepted 
because poor pain control is unethical, 
clinically unsound, and economically wasteful.
Leadership Summit on Pain Management 
July 2000





The data collected for this study provides insight into the lives o f  chronic pain 
patients and the frustration o f  the health care industry in attempting to offer effective 
treatment while controlling the costs o f  this expensive patient population. As wise 
committee members warned, the enormity o f  the data collected could easily keep one busy 
for years; there are more years o f  analyses and reporting than one could ever cover in one 
dissertation study. Because available data was used, this study serves as a starting point 
for a more refined understanding o f how pain affects all stakeholders: patients, providers, 
managed care organizations, and insurance companies.
Presentation of Results 
The data captured in this study offered limited information on a varying number o f  
patients referred to the Pain Management Program. Because o f  mortality, loss o f 
employer-sponsored health insurance coverage, or changes in health care organizations, to 
name a few, the size of the referred population (n = 2,561) was larger than the utilization 
group, those with available DOV data (n = 2,430). The utilization group represented 
patients using the HMO’s services over a  44-month period, from January 1, 1994, to 
August 31, 1997. The sample included all patients referred to the Pain Management 
Program from October 1991 to May 1996. Therefore, the 44-month period o f  data
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collected represented patient utilization information spanning from two years pre­
treatment to five years post-treatment. Not all patients covered under this health plan had 
drug coverage through the HMO, and not all patients received prescriptions for opioid 
medications. As such, the opioid group (« =  1,860) was even smaller than the utilization 
group. Since only 72.6% o f patients referred to the Pain Management Program completed 
the pre-treatment questionnaire, only 1,720 questionnaires were located, and, since not all 
respondents completed every question, a variety o f  sample sizes was reported in various 
analyses. Still fewer patients (n — 700), responded to the post-treatment survey. O f the 
post-treatment respondents, only 604 could be matched to the pre-treatment 
questionnaires. While the changes in sample sizes may be disconcerting, I wanted to report 
the largest possible sample size for each area under study. For the amount o f time spent 
gathering this information and the size o f  available data, this study presents the largest 
group in each category rather than analyzing results on the few patients with all available 
variables.
Regardless o f the varying differences in sample sizes, all groups would be deemed 
large samples. The advantage o f large samples is that one may achieve statistical precision. 
“Increasing the sample size yields a more precise (smaller) estimate o f the standard error 
o f  the statistic” (Hinkle, et. al., 1998, p. 272). “It is sensible to view research findings 
based on large samples as more reliable than findings based on smaller samples . . . ” (p. 
310).
Also, large samples make statistical significance much easier to achieve. Critics o f  
inferential testing believe that “Virtually any study can be made to show significant results
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if  one uses enough subjects, regardless o f how nonsensical the content may be” (Hays, 
1973, p. 415). However, the key to a quality research design comes from attention to the 
number o f  variables and outcomes. “In a well-planned research study, in which the 
variance o f  the criterion variable is likely to be quite large and the treatment effects rather 
small, large samples are appropriate and justifiable” (Hinkle, et. al., 1998, p. 310).
Because minor differences can be detected with such large sample sizes, 
correlational studies report great statistical significance but small correlation coefficients 
(Pearson r). Each item fitting this description can be misleading if isolated on its own. 
However, I reported these differences because o f  their potential value in multiple 
regression analysis.
Per Table 5 (p. 56), all o f the research literature citing statistics relative to the 
number o f years in pain did so using the mean (x), a standard choice for large samples o f 
interval or ratio data. However, as seen in Figure 8 (p. 91), the mean can be misleading in 
distributions with many outliers and those situations where the data do not reflect a 
normal distribution. In this study, the mean number o f years in pain was 8.33 years, the 
median was 4.0 years, and the mode was one year. While 8.33 years in pain sounds 
impressive, less than 30% o f this sample had been in pain longer than eight years. By 
reviewing other studies where the range o f years is similarly broad, I purport that using the 
mean in these instances overstates the problem, thereby violating statistical precision. 
Research Questions
Going back to the original research questions proposed in Chapter 1, the following 
are responses to those areas o f concern based on the following analyses.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Chronic Pain 138
What is the profile o f  patients referred to the Pain Management Program and 
how does that profile compare with the research literature on chronic pain?
Using the means, medians, and modes, whichever was more appropriate in each 
instance, Table 21 below shows the profile o f a typical chronic pain patient referred to the 
Pain Management Program.
Table 21
Profile o f  a Typical Chronic Pain Patient
Gender Female
Marital Status





Some college or vocational school 
Full timeEmployed 
Mean years in pain 
Median years in pain 
Mode years in pain 
Pain site(s) 
Number o f doctor visits per year 
Preferred prescription pain reliever





More than seven on the 11 Point Scale
More than eight years 
Four (4) years 
One (1) year
Multiple, both upper and lower body 
More than 16 visits
Activity level Less than average
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This study’s population, like the other chronic pain research, had disproportionally 
more women than men, with a ratio o f approximately 3:1 overall. Using the other chronic 
pain studies in Table 5 (p. 56), the combination o f  all study groups (n = 2,593) consisted 
o f  26.8% male and 73.2% female. When comparing the gender mix of this study to Table 
5, Profiles o f  Populations in Chronic Pain Research, no discemable difference in gender 
mix could be found (z = 0.98, p  > .05). Therefore, no difference in gender mix was seen 
when comparing this study to a composite o f other chronic pain study groups.
From a stereotypical point o f  view, one might argue that a  man’s role in society is 
the breadwinner. Therefore, men would not participate in the program because o f real or 
perceived conflicts with work. I f  so, there would be differences in the proportion o f  men 
to women by work status. To see if this affected the gender-biased referral or attendance 
in the Pain Management Program, Table 22 displays a chi-square ( f f )  test for frequencies 
by work status.
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Table 22









Full Time 123 (114.2) 359 (367.8) 0.27
Part Time 23 (46.2) 172 (148.8) 15.29***
Unemployed 32 (35.3) 117(113.2) 0.41
Disabled 110(87.5) 259 (281.5) 7.62**
Retired 80 (54.5) 150 (175.5) 15.62***
Homemaker 1 (29.9) 125 (96.1) 36.43***
Student 3 (4.27) 15 (13.73) 0.49
TOTAL 372 1197
* p <  .05 ** p <  .01 *** p  < 001
As shown in Table 22, there was no difference in the proportion o f  men to women 
for those working fu ll time, for those who were unemployed, and for those who were 
students, when compared to the total group o f  patients. As one might expect, women 
dominated as homemakers. Women also were employed part time proportionally more 
than their male counterparts. A  proportionally higher number o f  men reported being 
retired  or disabled.
The distinction between homemaker, retired, and disabled may be influenced by 
stereotype, as well. A woman who no longer works because o f  pain may identify her role 
as a homemaker, rather than disabled. People on medical retirement may wish to portray 
their role as retired, or if a woman, as homemaker, rather than being disabled. Still others 
who have achieved a certain age may wish to consider themselves retired, rather than
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disabled or as a homemaker. To see if  semantics played a role, the categories o f  
homemaker., retired, and disabled were combined. Here, X2 =  2.80, p  > .05. In other 
words, no differences in frequencies could be detected with these categories combined. 
Without a more precise definition o f  the work status categories on the pre-treatment 
questionnaire, it remains uncertain, but unlikely, that gender played a role in work status 
and program referral or attendance.
To detect if age and work status were related, an ANOVA test was used to 
calculate any significant associations between these two categories [F(6, 1562) = 
139.322, p  < .001]. Table 23 below demonstrates the significant differences in work 
status by age.
Table 23
Association between Work Status and Age ('Scheffeabl
W ork Status N
Age
Subset for alpha = .05
1 2 3 4
Student 18 40.56
Full Time 482 47.64
Unemployed 149 48.50
Part Time 195 50.22
Disabled 369 52.86 52.86
Homemaker 126 57.89
Retired 230 72.41
Sig. 1.000 .200 .242 1.000
M eans for groups in hom ogeneous subsets are disp layed.
a . Uses H arm onic M ean Sam ple S ize ~ 8 2 .8 7 5 .
b. T he group sizes a re  unequal. T h e  harm onic  m ean o f  the group sizes is used. T ype I e rro r levels a re  n o t guaranteed.
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To review, Table 23 states the differences between age and work status. Retired 
patients were significantly older and students were significantly younger than the average 
patient. Because o f the small number o f  students (n = 18), students were removed from 
the calculation and the differences were even more dramatic [harmonic mean = 207.550, F  
(5, 1550) = 163.079, p  < .001], Without students, no differences could be detected 
between Full Time, Unemployed or Part Time. Likewise, there were no significant 
differences in age between Part Time and Disabled, even though disabled patients 
appeared older than those who worked. Homemakers were yet older than any other 
category except for Retired, significantly the oldest group. Considering that women’s 
work status as homemaker was more universal in years past, a possibility exists that 
identifying oneself in a particular role may be influenced by one’s age and culture.
Accordingly, did working full time affect either program referral or attendance? 
The highest proportion o f  patients referred to and participating in the program worked full 
time (30.7%). The proportion o f men-to-women working full time was essentially the 
same as the gender mix in the study population. Therefore, working foil time did not 
appear to be a  reasonable explanation o f  why women were referred more often than men.
While the average age (x  = 52.87 years), was similar to the research projects in 
chronic pain in Table 5 on page 56 (from x = 39 years to x = 53.1 years), this study’s 
pain patients were older than the aggregated ages in the other studies. Also, the study 
population was older than the total adult population o f  the HMO.
For a more complete understanding o f  this study’s population, Chapter 4 included 
detailed demographic information. As to how that compared to other study populations,
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research and journal articles similar to those in Table 5 (p. 56) typically lacked such 
itemized specifications. However, reviewing the presenting conditions stipulated in 
Table 5, the Pain Management Program’s population adequately reflected the multitude o f  
pain conditions researched in the field o f  chronic pain management.
Does referral to or participation in the Pain Management Program influence a 
patien t’s ability to self-manage chronic pain?
The findings o f  this study demonstrated that people who were referred to this 
education-based, cognitive-behavioral pain management program reported significantly 
less pain on the 11 Point Box Scale post-treatment when compared to the same scale 
asked pre-treatment (« =  604, mean difference =  1.453, t = 13.48, p  < .001), a  reduction 
in pain by 20.8% overall. However, reported levels o f pain pre-treatment and post­
treatment were no different among those who attended, dropped, or never came to class. 
Below, Table 24 compares the differences in pain levels by program attendance.
Table 24







Attended 7.13 5.55 1.42
(783) (453) (388)
Never Came 7.28 6.12 1.41
(519) (148) (133)
Dropped 7.41 5.90 1.28
(279) (84) (71)
Statistics F ( 2, 1578) = 2.47 F  (2, 682) = 3.21 F ( 2, 589) = .085
p  >  .05
©II p  > .05
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While the ANOVA comparing post-treatment pain levels to class attendance 
indicated significant differences (presumably between those who attended and those who 
never came), this statistic did not hold up in the post-hoc Scheffe (p = .054). Subjects who 
attended the Pain Management Program and responded to the follow-up survey reported 
almost identical results as those who never attended the program. Patients who dropped 
out (e.g., attend class between one and four times) showed the least improvement, but not 
enough to achieve statistical significance.
Patients referred to the Pain Management Program used health care services less 
often over time. As shown in Table 19 (p. 123), the average number o f  annualized DOVs 
ranged from an average high o f  21.88 DOVs one year pre-treatment to a  low of 13.29 
DOVs five years post-treatment. Also, differences were detected between the annualized 
average number o f DOVs and class attendance. Below, Table 25 shows the variation by 
program participation.
Table 25




Average Annual DOVs 
Subset for alpha =  .05
1 2




M eans for groups in homogeneous subsets are  displayed.
a . Uses H arm onic Mean S am ple S ize = 5 7 7 3 4 9 .
b. T he group sizes are unequal. T he harm onic m ean  o f  the group sizes is  used. T ype I error levels a re  no t guaranteed.
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In this scenario, patients who never came to class had significantly fewer D O V s 
than those who attended or dropped [F  (2, 2339) = 11.65, p  < .001], a  difference o f 
between two and three DOVs per year. In other words, those patients who came to th*e 
Pain Management Program saw their doctors more often than those who did not complete 
the questionnaire, did not sign up for class, or scheduled class but never came. This m ay  
suggest that doctors influenced high-utilization patients to attend the program, possiblw as 
a condition o f getting medications. However, it could also signal that patients who 
frequented their health care providers were more likely to go to class than those who cftid 
not go as often. Recalling that, on average, all HMO patients visited their health care 
providers an average o f  1.338 times per year, we see that chronic pain patients, regardless 
o f attendance, were still a  substantial drain on health care resources.
To understand the difference in patients’ 11-Point Box Scale over time, pain 
differences were reordered into three categories: worse (a pre-pain minus post-pain resu lt 
less than -1.00), the same (between -1.00 and 1.00), and better (more than a 1.00 
improvement in pain over time). No disparities in demographics could account for paira 
level outcomes, with the exception o f  gender. Using a  non-parametric chi-square test ffor 
frequencies, patients with differing marital status (%2 = 1.069), levels o f employment (X 2 = 
0.896), age (X2 =  0.121), support systems (X2 — 0.745), educational level (X2 =  0.075)_, 
and number o f  years in pain (X2 = 1.352) experienced essentially the same level o f pain*, 
improvement over time (all p  > .05). Therefore, non-gender demographic information did 
not appear to influence the net variations in pre-treatment and post-treatment levels of“ 
pain.
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Looking at gender, women (x w =  1.59) reported significantly higher improvement 
in reported pain than did men (x m =  0.96, t = -2.326, p  — -02), even in light o f  the feet that 
men received more pain prescriptions (x m = 19.55 R vs. xw =  15.02 R, t = 3.09, p  < .01), 
stronger pain medications (z = -4.166, p  < .001), and more pills (x m = 2,007 vs. xw = 
1,094, t  =  3.13, p  < .01), over time. Nevertheless, there was no difference by gender in 
those who got worse, stayed the same, or improved (%2 = 3.924, p  > .05).
“I f  extreme scores are used in a pretest-posttest design, they have on the average a 
greater probability o f  shifting toward the mean for a distribution because the scores are at 
the extreme o f the distribution” (Huck, et aL, 1974, p. 237). As such, there was a 
regression toward the mean when comparing the net difference in pain levels to reported 
pre-treatment and post-treatment pain. Those whose pain was worse over time reported 
the lowest levels o f  pre-treatment pain., while those whose pain was better reported the 
highest levels o f pre-treatment pain (%2 =  91.43, p  < .001). Likewise, those whose pain 
was worse reported the highest levels o f  post-treatment pain, while those whose pain was 
better reported the lowest levels o f post-treatment pain (%2 = 229.32, p <  .001).
Continuous quality improvement questions on the post-treatment survey disclosed 
that those patients who attended class reported high levels o f  satisfaction with the Pain 
Management Program. Also, attendees found the pain management tools useful. Those 
who dropped out and those who never came to class did not find these tools helpful. 
However, patients who did not complete the program were neutral when asked if they 
were satisfied with the Pain Management Program. In  other words, they were not 
dissatisfied that such a program was offered.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Chronic Pain 147
What is the economic impact o f  referring patients to the Pain Management 
Program, particularly the costs o f  and possible savings to the medical provider?
Financial outcomes were similar among patients who attended the program, those 
who dropped out, and those who never attended class. As a group, chronic pain patients 
taxed health care resources at a  rate o f at least four times that of the average population.
When comparing the improvement in levels o f pain to the total number o f DOVs 
OC2 = 8.39), the total cost o f DOVs (X2 =  7.84), the average annual DOVs ( j f  — 9.33), 
and the average annual cost o f  DOVs (xf = 8-77), significant differences occurred (all p  < 
.05). Performing a Kruskal-Wallis One-Way ANOVA for each category, those who 
reported their pain as worse over time saw their physicians more often than those whose 
pain remained the same, therefore burdening the health care system at a  higher rate. Those 
who reported better, or a lower level o f pain over time, had the fewest DOVs and the 
lowest costs.
The obvious conclusion is that people who had more pain simply went to their 
doctors more often than those who had less pain. However, a contributing factor could be 
that some patients were still looking for a cure, even though one was unlikely. They might 
have feet the need to retell their story, hoping at last to say it correctly so that something 
would be done to fix the pain. They may have been bargaining with providers, as if 
conveying that a certain amount o f suffering was enough to warrant a  cure. Furthermore, 
those who reported improved levels o f pain could also have reflected some component o f  
acceptance, therefore not looking to the health care system to fix the pain problem.
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In looking at the interactions between gender, medication, and utilization over 
time, conflicts in outcomes were more the rule than the exception. Women reported 
significantly more improvement in pain but also saw their health care providers 14.57% 
more often than men. This statistic was not unusual as women in general have a higher 
morbidity rate than men. In other words, women tend to be sicker and visit health care 
providers more than their male counterparts. A review o f the 1997 Membership Utilization 
Report (1998) confirmed this phenomenon. This document stated that, of the entire HMO 
population, females o f  all ages saw physicians and other professional providers on average 
5.93 times in 1997 while all males were seen an average o f 4.13 times. In other words, 
women were seen 1.44 times more often than men. In comparing the utilization o f  this 
study’s patients to the total population by gender, women in the study group saw 
professional health care providers on average 42.85 times, a rate o f  7.23 times more often 
than all females in the HMO. Men in the study visited their providers 37.40 times on 
average, a rate o f 9.06 times more often than all males in the HMO. Adjusting for 
underlying differences in morbidity, men in the study group saw their health care providers 
at a  rate o f 1.25 times higher than women.
While women in the study saw health care providers more often than men, the 
average cost o f  the DOV was less (x w = $93.48, xm = $94.45, F  = 3.916, p  — .048). This 
suggests that women may have accessed or been diverted to lower-cost providers more 
often than men (i.e., more nurse practitioners and physicians’ assistants appointments 
instead o f physicians, more general practice visits than in speciality departments). Because
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o f  the large sample size, this difference may be negligible, even though it was statistically 
significant. More investigation is needed before firm conclusions may be drawn.
Men in the study reported less improvement in pain but had greater access to 
opioid pain medications, both in quantity and strength. Women in the study were more 
likely to be referred to the Pain Management Program, complete questionnaires, and 
attend classes.
As a group, patients disclosed that their pain conditions did not improve over time 
and, in fact, reported that they were slightly worse years after their referral, as related in 
the post-treatment survey. However, these same patients reported than their perceived 
pain was less. Therefore, it would appear that a big key to reducing costs and utilization in 
this group would be to improve effective pain management and coping skills.
Outcome Data and the MPI
Certain associations came to light when comparing the demographic information to 
the Multidimensional Pain Inventory (MPI). For example, seven o f 13 scales appeared to 
be influenced by gender. Table 26 shows the extent o f  scale differences by gender using a 
two-sample case for the mean, independent samples.
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Table 26





(male/female) t  value
356 4.65
Support 1,098 4.07 7.00***
Punishing 335 2.05
Responses 1,065 1.84 2.19*
Solicitous 319 3.62
Responses 1,012 3.43 2.61**
Distracting 324 2.45
Responses 1,047 2.08 4.15***
394 2.63
Household Chores 1,249 3.73 -12.74***
404 1.95
Outdoor Work 1,254 1.33 8.81***
General Activity 379 2.23
Level 1,175 2.40 -3.01**
* p <  .05 ** p < .01 *** p < .001
On a Likert scale with zero being never and six being very often, men with chronic 
pain reported higher levels o f support, solicitous responses, and distracting responses, but 
also reported more punishing responses than did women. Along stereotypical gender lines, 
women with chronic pain reported doing more household chores than did men. Men 
reported performing more outdoor work, although outdoor work did not appear to be a 
regular activity among any o f the pain patients. Also, women reported a higher general 
activity level than their male counterparts.
R eproduced  with perm ission o f the copyright owner. Further reproduction prohibited without perm ission.
Chronic Pain 151
Conversely, six MPI scales did not vary by gender: Pain Severity, Interference,
Life Control, Affective Distress, Activities Away from Home, and Social Activities. 
Platitudes that women may exaggerate pain, may have a higher psychological component 
o f pain, or report that they suffer more than men did not materialize. No differences could 
be detected by gender in any o f  these areas.
While a  difference in age was not associated with a difference in the 11 Point Box 
Scale, age was associated with nine o f the 13 MPI scales: Life Control, Affect Distress, 
Punishing Responses, Solicitous Responses, Distracting Responses, Household Chores, 
Social Activities, and General Activity Level. Reviewing Table 12 (p. 101), the elderly 
reported more life control, less affective distress, fewer punishing responses, and 
decreases in household chores, social activities, and general activity level than those in 
their twenties. Also, the elderly reported more support and fewer solicitous and distracting 
responses than their middle-aged counterparts.
These age-related differences in MPI scores cannot necessarily be attributed to 
pain. In the adult developmental process, later adulthood is marked by senescence, or 
“The period o f  life during which losses in physical abilities and capacity are most 
common” (Kaplan, 1993, p. 454). Examples o f senescence could explain the decreased 
level of physical activity seen in household chores, social activities, and general activity 
level.
According to Erikson’s (1982) major stages in psychosocial development, the last 
stage, called old age, is marked by reassigning qualities o f  the past into new values. “The 
last stage finds one relatively freer o f neurotic anxiety” (p. 64). The shift from adulthood
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to old age (last stage) is marked by changes in basic strengths, from a point o f  caring for 
and contributing, to a position o f  wisdom. In binding ritualizadons, adulthood focuses on 
mentoring and mutual caretaking whilie old age rituals are more philosophical. Erikson’s 
life cycle could help explain the differences seen in the age-related scores o f life control, 
affective distress, and punishing respo*nses.
For those receiving Class II pain medications, the MPI scores were higher in the 
interference scale and support scale, b u t lower in general activity. Notice that pain severity 
could not be correlated to those receiving Class H medications. However, a major reason 
to prescribe Class II medications would be to improve function. As such, those who have 
higher support levels and where pain significantly interferes with function would be logical 
candidates for this form o f therapy.
As one might expect, the higher the 11 Point Box Scale, the higher the reported 
pain severity. Along with higher levels o f  pain, patients rated interference and affective 
distress as higher, while levels o f  life control and activity were lower.
Prescription Pain Medications and Outcomes
The most obvious finding o f th is  study involved the lack o f  long-term opioids 
being administered on a long-term basis as a tool for managing chronic pain, despite the 
recommendations o f pain experts, numerous and current research articles, professional 
websites, and pain conference presenters extolling the benefits o f  this form o f therapy. Of 
the 1,851 patients for whom pharmacy information was available (those who purchased an 
opioid prescription through the HM O pharmacy), only 445 patients (24.0%) were 
identified as having had the opportunity to try at least one Class II medication over a 44-
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month period. O f 38,210 non-liquid opioid pain prescriptions distributed, Class II 
medications accounted for only 11.1% o f  the opioid prescriptions dispensed.
I f  long-acting opioid therapy is touted as a  powerful long-term tool in managing 
chronic pain, then one would expect to see a substantial number o f  frequent but regular 
prescriptions filled within the HMO pharmacy. Because long-term opioid use has its own 
set o f  side effects, this method o f  treatment is certainly not for everyone. However, a trial 
would appear to be in order, especially for those who frequent the health care system with 
complaints o f unrelieved pain.
Since no provider could write a  prescription in excess o f  a 100-day supply, one 
would expect to find at least four Class II prescriptions per year or 13 prescriptions over 
the utilization period. I f  found, this might indicate that a Class H medication was being 
dispensed on an ongoing basis (although a cursory review o f  the database indicated that 
Class II medications were more often dispensed at monthly intervals). However, o f the 
445 patients who obtained Class II medications, 152 patients (34.2%) received only one 
prescription, while another 113 patients (totaling 59.6% o f the 445 patients) received 
between two and four prescriptions. Only 106 patients (23.9% o f  those who purchased 
Class H medications through the HMO pharmacy, or 5.7% o f all patients receiving opioid 
medication through the HMO pharmacy), had 13 or more prescriptions for Class II 
medications. O f those patients receiving 13 or more Class II prescriptions, 16 patients 
obtained more than 44 prescriptions, a possible red flag suggesting either stabilization 
problems or potential abuse. Therefore, only 90 patients (20.2% o f patients with access to 
Class II medications or 4.9% o f those receiving opioid prescriptions through the HMO
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pharmacy) received enough prescriptions to indicate long-term willingness on the part of 
the prescriber and long-term effectiveness on the part o f  the patient in using this form of 
therapy.
To the contrary, 1,816 patients (98.1%) had access to short-term, Class HI pain 
medications, especially hydrocodone with acetaminophen (better known by its trade name 
Vicodin®). O f those who received any opioid pain medication through the HMO 
pharmacy, only 35 patients (1.9%) did not obtain any Class m  prescriptions. O f the opioid 
pain medications dispensed, generic Vidodin® alone accounted for 77.6% o f all 
prescriptions.
For those patients obtaining Class III medications, 302 patients (16.6%) filled only 
one prescription through the HMO pharmacy. Another 406 patients (40.0% combined) 
obtained between two and four prescriptions. Two hundred and forty patients (13.2%) 
filled 45 or more prescriptions, a figure that again might suggest problems with sustained 
pain relief, unwillingness on the part o f  the prescriber to dispense effective medications for 
long range treatment, or potential abuse.
While Class III pain medications are recognized for effective management o f acute 
pain, problems with physical tolerance are well known with this type o f preparation. To 
the contrary, “Tolerance, or decreasing pain relief with the same dosage over time, has not 
proven to be a prevalent limitation to long-term (Class II) opioid use” (Haddox et al., p.
4).
Why Class HI medications appeared so readily available to chronic pain patients 
and Class H medications were not is ov concern. Heit (2000) suggested that “The medical
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profession and government have done an inadequate job o f  educating physicians about the 
laws in prescribing schedule II medications” (p. 2). According to th e  American Society o f 
Addiction Medicine, “Physicians’ concerns regarding possible legal, regulatory, licensing 
or other third party sanctions related to the prescription o f  opioids contribute significantly 
to the under treatment o f pain. Physicians are obligated to relieve pain and suffering in 
their patients. Though many types o f  pain are best addressed by non-opioid interventions, 
opioids are often required as a component o f effective pain treatment” (AS AM, 1997, 
p .l). The Society goes on to recommend, “Physicians who are practicing medicine in 
good faith and who use reasonable medical judgement regarding the  prescribing o f opioids 
for the treatment o f  pain should not be held responsible for the willfiil and deceptive 
behavior o f patients who successfully obtain opioids for non-medical purposes” (p. 2).
As presented in Chapter 4, gender was another issue in revealing which patients 
had access to opioid medications. Men were more likely to get opio id pain medications, 
received almost twice the number o f  pills, filled significantly more prescriptions (with 
significantly less DOVs), and, received more Class II drugs than wo*men. While any 
association between access to medications for pain management and substance abuse was 
not studied, men were more likely to be seen in Chemical Dependency and women were 
more likely to be seen in Psychiatry.
11 Point Box Scale
One major flaw in using the 11 Point Box Scale was that it represented the level o f 
pain perceived by the patient at a particular moment in time. As such, very few 
associations could be found with overall outcome data using this measurement. I f  11 Point
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Box scales were administered routinely, specifically at each DOV, then time series 
evaluations could provide rich data to fashion and fine tune treatment regimens.
The 11 Point Box Scale was secured from both the pre-treatment and post­
treatment surveys. These scales asked patients to rate their level o f  pain, but completion o f 
these questions did not correspond to any particular DOV, prescription, or change in 
treatment. As such, the reported severity o f  pain was not statistically associated with the 
sum o f DOVs or opioid prescriptions over time. In other words, patients with higher 
reported levels o f  perceived pain did not see their health care providers any more often nor 
did they receive any more pills or prescriptions than those who reported lower levels o f 
pain.
“One o f  the difficulties associated with the assessment o f  pain behavior is that it is 
nearly impossible to distinguish whether patients exhibit pain behaviors in response to 
positive or negative reinforcement or their pain behaviors are a response to physiological 
signs” (Turk & Okifuji, 1997, p. 261). In this study, a  positive correlation was 
demonstrated between the physiological 11 Point Box Scale and pain affect as measured 
by the PDS (n = 1,478, Adjusted r2 = .142, F =  245.11, p  <  .001). While modest, the 
association between the factors of perceived pain and pain affect demonstrated that the 
higher the 11 Point Box score, the more suffering a patient reported as measured by the 
PDS.
Review o f Stakeholders
Referring back to Table 4, this study provided some insight into whether the 
measurements o f  success were achieved by various stakeholders. Since no worker’s
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compensation or other disability records were available, no conclusions could be drawn 
from an insurance carrier’s standpoint.
The goal o f  patients was to eliminate or reduce pain and reduce emotional distress. 
Over time, patients did report lower levels o f perceived pain, as seen on the pre-treatment 
and post-treatment surveys with the 11 Point Box Scales and the Pain Severity portion o f 
the MPI. Using the screening version o f  the MPI post-treatment, patients also reported 
lower levels o f  interference and affective distress, as well as an increase in life control, 
when compared to the MPI questions asked at the time o f  referral. The total quality 
questions on the post-treatment survey indicated that patients’ pain conditions were 
slightly worse than when they were originally referred. Also, the techniques taught to 
manage pain were not useful to those who did not attend or to those who dropped.
Success for the managed care organization could be measured by decreased 
utilization o f  the health care system. Using Table 19, Summary o f  DOVs (p. 123), patients 
did see their health care providers less often over time. However, at five years post­
treatment, this group still taxed the health care system at a  rate o f  more than four times 
(409.0%) that o f  the systemwide average.
The goal o f  doctors was to reduce opioid use, most likely because of the myths o f 
addiction, secondary gain, and perceived sanctions by regulatory agencies. However, this 
goal was not realized. There was no significant difference in the number of prescriptions 
filled at the HMO pharmacy over time. The only difference detected was in the number o f 
pills dispensed by the HMO pharmacy and then only between two years pre-treatment and 
four years post-treatment (x.2yrs = 476.49 vs. x4yrs = 1,007.03, F = 2.727,/? = .012).
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Logically, if patients’ pain conditions do not improve over time, then managing 
pain is the only available option. With better pain management, the demand for health care 
services should decrease with time. Therefore, it appears that patients’ and managed 
care’s objectives are consistent with each other. However, if the goal o f physicians is to 
restrict access to opioid pain medications, then their goal is incongruous with patients’ 
demands and managed care’s objectives. As long as these goals are at cross purposes, the 
ability to manage pain patients will not be effective. Until all tools to effective pain 
management are provided, no stakeholder really wins.
Obstacles in the Study
The complexity o f adult development, the influence o f psychosocial and spiritual 
variables, the human condition, especially in one with chronic pain, are all too perplexing 
to be answered in one modest study. Evaluating only the influence o f one eight-week pain 
management program over seven years o f  stratified data neglected too many variables to 
grasp the essence o f  successful treatment.
While the Pain Management Program was based on cognitive-behavioral theory, 
the classes were not cognitive-behavior therapy in the strictest sense. With medical experts 
facilitating the program rather than mental health therapists, it remained difficult to 
separate the overall outcomes and attribute results to the effects o f cognitive-behavioral 
theory, the passion and personality o f the program’s staff, influences both within and 
outside o f  the health care system, family dynamics, societal beliefs, and many o f  the other 
variables needed to paint a  clear understanding in the successful (or unsuccessful) 
management o f  chronic pain.
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In other instances, variables were not controlled for because to do so would be 
unethical. Medical research walks a fine line between the rigors o f  scientific study and the 
Hippocratic oath to do no harm. Digging deeper to obtain more information (e.g., 
accessing psychological records), could violate basic privacy rights, pitting an individual’s 
protection against the standards o f  good research design- Finally, a multiplicity of data 
presented itself here, but the scope was too broad for one study.
Prediction equations, while statistically significant, did not produce high 
correlations. O f question would be whether this was due to the large sample size or due to 
the complexity and interaction o f  numerous variables that help explain human behavior.
Implications o f  the Study
A large sample size does not necessarily make for a better study. However, it does 
provide rich information not assembled anywhere else. While proving statistical 
significance was easier with a large data set, not finding significance also confirmed that 
there were truly no differences or associations. With an appetite to get as much data 
included and analyzed as possible, one drawback o f this study was its assortment of 
sample sizes. However, the breadth o f  variables studied still makes respectable 
contributions to the field of pain management.
In addition to answering the three research questions proposed for this study, 
important evidence emerged about potential gender bias, particularly in the distribution o f 
opioid medications. While the ratio o f  specialty visits was similar by gender, the quantity 
and quality o f  opioid pain relievers were different. Metabolism, not weight, is the key to 
dosing opioid medications. As such, one would expect that women would require more
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pills than men. However, that was not the case. The findings here confirm the latest 
information coming from pain researchers today: that chronic pain in general is under 
treated, and that women are discriminated against in access to pain medications, even 
though there is no discemable difference in pain levels, interference, affective distress, or 
life control.
The progression o f  chronic pain disorders over time resulted from much more than 
those factors explored in the Pain Management Program. It remains difficult to assess 
one’s improvement as the result o f  the pain program when serious barriers to effective 
treatment exist in the health care system.
Future Research
To better understand the volume and scope o f  DOVs, more information needs to 
be gathered on pain-related utilization. One way to get a clearer understanding of the role 
o f chronic pain and its treatment would be to record reported pain levels (e.g., 11 Point 
Box Scale) at each DOV or change in treatment. With pain now encouraged to be the fifth 
vital sign, new standards for assessing pain are presently being adopted and charted as part 
o f routine patient care. The evolution o f paperless charts, preferably formatted into 
relational data bases, could improve the scope and depth o f  available information.
I f  this study’s data were updated, three more years o f  utilization information could 
provide rich, large, longitudinal information so desperately lacking in pain research. 
Improved data gathering may create more insight into the association between many 
individual variables in chronic pain, psychosocial contributions, single versus multiple pain 
conditions, and the complexity o f both pain and non-pain related disorders. Still, smaller
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and more comprehensive studies with qualitative components may help pinpoint themes 
possibly overlooked. Also, newer assessment tools tailored especially for chronic pain 
patients could be incorporated with routine assessments to see if new measures may better 
explain the chronic pain experience.
Furthermore, studies should delve into gender differences and gender bias with the 
perception and treatment of chronic pain. The attitudes and beliefs o f patients and their 
health care providers should be explored to ensure that treatment is given equitably.
Future study could compare patients who have the option o f taking Class II 
medications with those who cannot or chose not to use this treatment option. By 
comparing utilization, satisfaction, quality o f life, perceived pain, affective pain and other 
variables discussed in this study, a clearer understanding may develop as to why and under 
what conditions Class H medications increase function and benefit patients. Also, 
antidepressants and other non-opioid medications helpfid in the treatment o f  chronic pain 
could be explored.
A study could be done exploring providers’ perspectives on medications, 
assessing their patients’ confidence and satisfaction with treatment and care (especially 
through primary care), and designing clinical guidelines to better manage chronic pain 
patients. After that, education programs for providers could update their skills, provide the 
latest information on chronic pain treatment, increase proficiency in recognizing addiction 
versus pseudoaddiction, and examine costs and patient satisfaction after training.
Other related studies could focus on the higher incidence o f depression in those 
with chronic pain. O f interest would be whether mental illness is more prevalent with
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chronic pain than with other physical disorders. Also, a study could view how other 
chronic illnesses compare to chronic pain in terms o f  utilization, medication, other costs, 
patient functioning and well-being.
Along the same vein, a  study o f  the impact o f  tailored treatment programs for 
chronic pain patients and coordinated pain services through the use o f a case manager 
could be statistically matched to those who negotiate the health care system on their own. 
If  collaborative relationships were formed, would one find a difference in the efficacy o f 
treatment?
A statistical critique advanced in this study was the prevalence o f  researchers who 
present data using means without considering outliers. While appearing scientific, these 
figures are misleading and not all statistics fit a normal distribution. Consumers o f research 
data would be wise to secure a basic understanding o f statistics and keep a wary eye on 
methodology.
Chronic pain is a complex issue with no obvious or easy solutions. Pain patients do 
not fit the model o f medicine’s scientific precision and mastery over nature. As a group, 
chronic pain patients do not get better. They show up frequently at doctors’ offices, a 
reminder to providers that medicine does not have all the answers. As shown in this study, 
one cognitive-behavioral program worked by improving patients’ satisfaction with the 
health care system. However, this alone is far from the solution. Chronic pain must be 
attacked from a variety o f fronts: comprehensive evaluation, appropriate medications, 
cognitive restructuring, alternative therapies, and biopsychosocial support from medical 
providers, complimentary medicine, and the community at large.
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. . .  That’s all, Folks
Porky P ig
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Q u e s t i o n n a i r e
Today's Date:. . Medical Record Number:
;jSp m e? in fo rjn a i£ 6 h-:a b < ^^ ;
Name:
Last ■ F irst In itia l
Address:
No. S tree t C ity Z ip
Work Phone: H om e Phone:
Area Code+Number Area Code-t-Number
Date of Birth: Sex: Male □  Female □
Marital Status: M arried □ Separated Q Divorced □ Widowed □  Single □
With whom are you currently living: (Please check’ ALL that apply)
Live alone □  Spouse/partner Q  Parents Q  Children □
Other (please specify):
Roommate □
What is the highest grade o r year of school that you completed?
Grade School or less □  Some H igh School □  High School Graduate □
Some College/Vocational School Q  College Graduate □  Post Graduate □
Which best describes your w ork situation now?
Employed Full Time □  Employed Part Time □  Unemployed □  Disabled □  
Retired □  Homemaker □  Student □
When d id  your pain  first start?______________
1 M onth/Year
Briefly describe your pain - w hen did it start, where is the pain,, etc.
Page 1
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Throughout the questionnaire which follows, there w ill be  several item s that ask  about your 
spouse or significant other. For those of you who are n o t currently m arried, w e w ould  like to 
know who you consider to be your significant other. Y our significant other should  be someone 
w ith whom you spend a  great deal of time. This person  m ay or m ay  no t be currently  living w ith 
you. For example, your significant other m ay be your child that lives w ith you or a  close friend 
who lives next door.
Is your significant o ther your spouse or someone else?
Spouse Q  Someone Else Q  Don’t have significant o ther Q
If your significant other is no t your spouse (that is, y o u  checked “som eone else” in  the question
above), please specify the  relationship: -----------------------------------------------------------------------
(child, parent, o ther relative, friend, co-worker, etc.)
If you don 't have a  significant other, please skip Section II (page 6 of the questionnaire). 
In stru ction s‘ • r  y  : .  _
An im portant p a rt of o u r evaluation includes exam ination of p a in  from  your perspective 
because you know your pain  better than anyone else. The following questions are designed to 
help us leam  m ore about your pain and how  it affects y ou r life. Beside each question is a scale 
to m ark your answer. Read each question carefully and  then circle a num ber on th e  scale beside 
that question to indicate how  that specific question applies to you. A n  example m ay  help you to 
better understand how  you  should answer these questions.
Example:
N ot a t all Extremely
n e rv o u s_________________ nervous
1. How nervous are you w hen you ride in a car 0 1 2 3 4 5 6
when the traffic is heavy?
If you are not a t all nervous w hen riding in a car in  heavy traffic, you 
w ould w ant to circle the num ber 0. If you are very  nervous w hen riding in  
a car in heavy traffic, you w ould then circle the num ber 6. Low er numbers 
are for less nervousness, and higher numbers fo r more nervousness.
Page 2
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2. In  general, how m uch does your pain  interfere w ith 
your day-to-day activities?
3. Since the time your pain began, how  much has your 
pain  changed your ability to work? (Check here, if 
you have retired for reasons o ther than  your pain. □  )
4. H ow  much has your pain changed the amount of 
satisfaction or enjoyment you get from  taking part 
in  social and recreational activities?
5. H ow  supportive o r helpful is your spouse
(significant other) to you in relation to your pain?
6. Rate your overall mood during the past week.
Extreme 
interference








0 1 2 3 4 5 6
N ot a t all 
supportive  










7. H ow  much has your pain interfered w ith your 
ability to get enough sleep?
8. O n the average, how  severe has your pain been 
during the last week?
9. H ow  able are you to predict w hen your pain will 
start, get better or get worse?
No Extreme
interference__________ interference
0 1 2  3 4 5 6
N ot at all Extremely
severe severe
0 1 2  3 4 5 6
Not at all able Very able
to predict to predict
0 1 2 3 4 5 6
Page 3
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Extreme
iO. How m uch has yo u r pain  changed your ability to 
take part in  recreational and other social activities?
11. How m uch do you  lim it your activities in  order 
to keep your pain  from  getting worse?
12. How m uch has yo u r pain  changed the am ount 
of satisfaction or enjoym ent you get from family- 
related activities?
13. How worried is your spouse (significant other) 
about you because of your pain?
14. During the past week, how m uch control do you 
feel that you have had  over your life?
15. On an average day, how  much does your pain 
vary (increase o r decrease)?
16. How m uch suffering do you experience because 
of your pain?
17. How often are you able to do something that 
helps to reduce your pain?
18. How m uch has your pain changed your relation­
ship w ith  your spouse, family or significant other?
19. How m uch has your pain changed the am ount of 
satisfaction or enjoyment you get from work? 
(Check here if you are not presently working. □  )
No change
0 1 2 3 4 5 6
Not at all Very m uch




0 1 2 3 4 5 6


















0 1 2 3 4 5 6
N ever Very often








0 1 2 3 4 5 6
Page 4
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20. H ow  attentive is your spouse (significant other) 
to you because of your pain?
21. D uring the past week, how  much do y ou  feel
tha t you've been able to deal with your problems?
22. H ow  m uch control do you  feel that you  have 
over your pain?
23. H ow  m uch has your pain  changed your ability 
to do household chores?
24. D uring the past week, how  successful w ere you 
in  coping w ith  stressful situations in  you r life?
25. H ow  m uch has your p a in  interfered w ith  your 
ability to p lan  activities?
26. D uring the past week, how  irritable have you been?




0 1 2 3 4 5 6
N ot at all
Extremely
well
0 1 2 3 4 5 6
No control 
at alh
A great deal 
of control




0 1 2 3 4 5 6








0 1 2 3 4 5 6




27. H ow  m uch has your pain  changed or interfered 
w ith your friendships w ith  people o ther than 
your family?
28. D uring the past week, how  tense or anxious 
have you been?
N o change
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In this section, w e are interested in knowing how  your spouse (significant other) responds to you 
w hen he o r she knows you are in pain. On the scale listed next to each question, circle a n u m b er 
to indicate how often your spouse (significant other) responds to you in that particu lar way w hen  
you are in  pain. Please answer all of the 14 questions.
Never____________________ Very O ften
1. Ignores me 0 1 2 3 4 5 6
2. Asks me w hat h e /sh e  can do to help 0 1 2 3 4 5 6
3. Reads to me 0 1 2 3 4 5 6
4. Gets irritated w ith me 0 1 2 3 4 5 6
5. Takes over m y job or duties 0 1 2 3 4 5 6
6. Talks to me about something else to take m y 
m ind off the pain
0 1 2 3 4 5 6
7. Gets frustrated w ith me 0 1 2 3 4 5 6
8. Tries to get me to rest 0 1 2 3 ‘4 5 6
9. Tries to involve m e in some activity 0 1 2 3 4 5 6
10. Gets angry w ith  me 0 1 2 3 4 5 6
11. Gets me pain medication 0 1 2 3 4 5 6
12. Encourages me to work on a hobby 0 1 2 3 4 5 6
13. Gets me something to eat or drink 0 1 2 3 4 5 6
14. Turns on the TV to take my m ind off m y pain 0 1 2 3 4 5 6
Page 6
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Listed below are 19 daily activities. Please indicate how  often you do each of these by circling a 
num ber on the scale listed next to each activity. Please complete all 19 questions.
N ev er Verv O ften
1. Wash dishes 0 1 2 3 4 5 6
2. Mow the law n (Check here if you do n o t have a 
lawn to mow. □ )
0 1 2 3 4 5 6
3. Go out to eat 0 -1 2 3 4 5 6
4. Play cards or other games 0 1 2 3 4 5 6
5. Go grocery shopping 0 1 2 3 4 5 6
6. Work in the garden (Check here if you do not 
have a garden. □ )
0 1 2 3 4 5 6
7. Go to a movie 0 1 2 3 4 5 6
8. Visit friends 0 1 2 3 4 5 6
9. Help w ith  the house cleaning 0 1 2 3 4 5 6
10. Work on the car (Check here if you d on ’t  have a car. □  ) 0 1 2 3 4 5 6
11. Take a ride in a car or bus 0 1 2 3 4 5 6
12. Visit relatives (Check here if you do no t have relatives 
within 100 miles. □ )
0 1 2 3 4 5 6
13. Prepare a meal 0 1 2 3 4 5 6
14. Wash the car (Check here if you don’t  have a car. Q ) 0 1 2 3 4 5 6
15. Take a trip 0 1 2 3 4 5 6
16. Go to a park  or beach 0 1 2 3 4 5 6
17. Do the laundry 0 1 2 3 4 5 6
18. Work on a needed household repair 0 1 2 3 4 5 6
19. Engage in sexual activities 0 1 2 3 4 5 6
Page 7
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ir a zero (0) means “no pain” and  a ten  (10) means “pain as bad as it could be,” on this- scale of 0 to  
10, w hat is your level of pain? P u t an  X through that number.
0 1 2 3 4 5 6 7 8 9 10
Please indicate by circling the appropriate num ber w hether each of the  statements b e lo w  is m ore 
true or false for you. Please answ er every question and circle only one num ber p e r cjuestion. 
Answer by circling the appropriate num ber (0 through 4) according to the following scale.
0 = This is very u n tru e  for me.
1 = This is som ew hat untrue for me.
2 = This is neither tru e  nor untrue for me (or it does no t apply to m e).
3 = This is som ew hat true for me.





l. I am scared of the pain I feel- 0 1 2 ' 3 4
2. The pain I experience is unbearable. 0 1 2 3 4
3. The pain I feel is torturing me. 0 1 2 3 4
4. My pain does no t stop me from  enjoying life. 0 1 2 3 4
5. I have learned to tolerate the  pain  I  feel. o 1 2 3 4
6. I feel helpless about my pain. 0 . 1 2 3 4
7. My pain is a minor annoyance to me. 0 1 2 3 4
8. When I feel pain, I am hurting; bu t I am not distressed. 0 1 2 3 4
9. I never let the pain in my body affect m y outlook on life. 0 1 2 3 4
10. When I am in pain, I become almost a different person. 0 1 2 3 4
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CHRONIC PAIN MANAGEMENT PROGRAM 
FOLLOW-UP SURVEY
Below are several questions to help us leam  about your pain now and how it affects your life.
Under each question is a scale to mark your answer. Read each question carefully and then
circle a number on the scale under that question to indicate how that specific question applies
to you.
1. Rate the level of your pain at the present moment.
0 1 2 3 4 5 6
No pain Very intense pain
2. How much has your pain changed the amount of satisfaction or enjoyment you get 
from taking part in social and recreational activities?
0 1 2 3 4 5 6
No change Extreme change
3. During the past week how tense or anxious have you been?
0 1 2 3 4 5 6
N ot at all Extremely
tense or anxious Tense and anxious
4- How much has your pain changed your ability to take part in recreational and other
social activities?
0 1 2 3 4 5 6
No change Extreme change
5. During the past week how well do you feel that you’ve been able to deal with your 
problems?
0 1 2 3 4 5 6
N ot at all Extremely well
6. O n the average, how severe has your pain been during the last week?
0 1 2 3 4 5 6
N ot at all severe Extremely severe
7. During the past week, how successful were you in coping with stressful situations in 
your life?
0 1 2 3 4 5 6
Not at all successful Extremely successful
See over “S*
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8 . During the past week how irritable have you been?
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0 1 
Not at ah irritable Extremely irritable
9. If a zero (0) means “no pain” and a ten (10) means “pain as bad as it could be,” on this 
scale of 0 to 10, what is your level of pain? Put an X through that number.





How useful has the Chronic Pain Management Program been in helping you to 
manage pain?
0 1 2 3 4 5 6
Not at all useful Extremely useful
How satisfied were you with the Chronic Pain Management Program?
0 1 2  
Not at all satisfied Extremely satisfied
Looking back to the original cause or condition for your referral to the Pain 
Management Program, how would you rate that cause or condition today?
0 1 2 3 4 5 6
Much worse Much better
W hat techniques or topics discussed in class have work best for you?
1. In your opinion, what changes would make to the Chronic Pain Management Program 
better?
15. Comments
Thank you for your participation. We appreciate hearing from you.
Please return this survey form in the enclosed, postage-paid envelope. See over
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